{"idB": "1095981_12_item7_p9_s3", "idA": "1095981_11_item7_p102_s0", "sentA": "During 2010, we expanded our commercialization activities while simultaneously pursuing available financing sources to support operations and growth.", "sentB": "This registry will allow us to collect further data to support reimbursement and government payors, and help expand market access.", "type": 1, "words": ["<tag1>", "During", "2010,", "we", "expanded", "our", "commercialization", "activities", "while", "simultaneously", "pursuing", "available", "financing", "sources", "to", "support", "operations", "and", "growth.", "<tag2>", "This", "registry", "will", "allow", "us", "to", "collect", "further", "data", "to", "support", "reimbursement", "and", "government", "payors,", "and", "help", "expand", "market", "access.", "<tag3>"], "wordsA": ["During", "2010,", "we", "expanded", "our", "commercialization", "activities", "while", "simultaneously", "pursuing", "available", "financing", "sources", "to", "support", "operations", "and", "growth."], "wordsB": ["This", "registry", "will", "allow", "us", "to", "collect", "further", "data", "to", "support", "reimbursement", "and", "government", "payors,", "and", "help", "expand", "market", "access."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p13_s2", "idA": "1095981_11_item7_p106_s2", "sentA": "a two year right of first refusal to enter into a development and commercialization collaboration with us regarding the use of our technology, on a worldwide basis, for the treatment of liver conditions.", "sentB": "Furthermore, the use of ADRCs was acknowledged by the British Association of Plastic, Reconstructive Aesthetic Surgeons (BPRAS) in their latest breast surgery guidelines, demonstrating progress in developing market access.", "type": 1, "words": ["<tag1>", "a", "two", "year", "right", "of", "first", "refusal", "to", "enter", "into", "a", "development", "and", "commercialization", "collaboration", "with", "us", "regarding", "the", "use", "of", "our", "technology,", "on", "a", "worldwide", "basis,", "for", "the", "treatment", "of", "liver", "conditions.", "<tag2>", "Furthermore,", "the", "use", "of", "ADRCs", "was", "acknowledged", "by", "the", "British", "Association", "of", "Plastic,", "Reconstructive", "Aesthetic", "Surgeons", "(BPRAS)", "in", "their", "latest", "breast", "surgery", "guidelines,", "demonstrating", "progress", "in", "developing", "market", "access.", "<tag3>"], "wordsA": ["a", "two", "year", "right", "of", "first", "refusal", "to", "enter", "into", "a", "development", "and", "commercialization", "collaboration", "with", "us", "regarding", "the", "use", "of", "our", "technology,", "on", "a", "worldwide", "basis,", "for", "the", "treatment", "of", "liver", "conditions."], "wordsB": ["Furthermore,", "the", "use", "of", "ADRCs", "was", "acknowledged", "by", "the", "British", "Association", "of", "Plastic,", "Reconstructive", "Aesthetic", "Surgeons", "(BPRAS)", "in", "their", "latest", "breast", "surgery", "guidelines,", "demonstrating", "progress", "in", "developing", "market", "access."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p93_s0", "idA": "1095981_11_item7_p107_s0", "sentA": "In order to continue the operations of our regenerative cell business at or near current levels, we will need to either substantially increase revenues or continue to raise additional capital in the future.", "sentB": "Management recognizes the need to generate positive cash flows in future periods and/or to obtain additional capital from various sources.", "type": 1, "words": ["<tag1>", "In", "order", "to", "continue", "the", "operations", "of", "our", "regenerative", "cell", "business", "at", "or", "near", "current", "levels,", "we", "will", "need", "to", "either", "substantially", "increase", "revenues", "or", "continue", "to", "raise", "additional", "capital", "in", "the", "future.", "<tag2>", "Management", "recognizes", "the", "need", "to", "generate", "positive", "cash", "flows", "in", "future", "periods", "and/or", "to", "obtain", "additional", "capital", "from", "various", "sources.", "<tag3>"], "wordsA": ["In", "order", "to", "continue", "the", "operations", "of", "our", "regenerative", "cell", "business", "at", "or", "near", "current", "levels,", "we", "will", "need", "to", "either", "substantially", "increase", "revenues", "or", "continue", "to", "raise", "additional", "capital", "in", "the", "future."], "wordsB": ["Management", "recognizes", "the", "need", "to", "generate", "positive", "cash", "flows", "in", "future", "periods", "and/or", "to", "obtain", "additional", "capital", "from", "various", "sources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p17_s4", "idA": "1095981_11_item7_p108_s0", "sentA": "From January 1, 2008 to December 31, 2010, we have financed our operations primarily by:", "sentB": "Two countries of note where we have made recent progress include Australia and India.", "type": 1, "words": ["<tag1>", "From", "January", "1,", "2008", "to", "December", "31,", "2010,", "we", "have", "financed", "our", "operations", "primarily", "by:", "<tag2>", "Two", "countries", "of", "note", "where", "we", "have", "made", "recent", "progress", "include", "Australia", "and", "India.", "<tag3>"], "wordsA": ["From", "January", "1,", "2008", "to", "December", "31,", "2010,", "we", "have", "financed", "our", "operations", "primarily", "by:"], "wordsB": ["Two", "countries", "of", "note", "where", "we", "have", "made", "recent", "progress", "include", "Australia", "and", "India."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p63_s1", "idA": "1095981_11_item7_p108_s0", "sentA": "From January 1, 2008 to December 31, 2010, we have financed our operations primarily by:", "sentB": "The awards provide certain employees until January 1, 2012 to achieve certain performance goals established by the Compensation Committee.", "type": 1, "words": ["<tag1>", "From", "January", "1,", "2008", "to", "December", "31,", "2010,", "we", "have", "financed", "our", "operations", "primarily", "by:", "<tag2>", "The", "awards", "provide", "certain", "employees", "until", "January", "1,", "2012", "to", "achieve", "certain", "performance", "goals", "established", "by", "the", "Compensation", "Committee.", "<tag3>"], "wordsA": ["From", "January", "1,", "2008", "to", "December", "31,", "2010,", "we", "have", "financed", "our", "operations", "primarily", "by:"], "wordsB": ["The", "awards", "provide", "certain", "employees", "until", "January", "1,", "2012", "to", "achieve", "certain", "performance", "goals", "established", "by", "the", "Compensation", "Committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p13_s5", "idA": "1095981_11_item7_p10_s4", "sentA": "By working with our customers to fully integrate Cytori technology into their practices, we are providing a valuable service and further distinguishing our brand.", "sentB": "In Japan, we are working with the Pharmaceuticals and Medical Devices Agency (PMDA), to leverage our global clinical data for Japanese approval of our technology for breast reconstruction.", "type": 1, "words": ["<tag1>", "By", "working", "with", "our", "customers", "to", "fully", "integrate", "Cytori", "technology", "into", "their", "practices,", "we", "are", "providing", "a", "valuable", "service", "and", "further", "distinguishing", "our", "brand.", "<tag2>", "In", "Japan,", "we", "are", "working", "with", "the", "Pharmaceuticals", "and", "Medical", "Devices", "Agency", "(PMDA),", "to", "leverage", "our", "global", "clinical", "data", "for", "Japanese", "approval", "of", "our", "technology", "for", "breast", "reconstruction.", "<tag3>"], "wordsA": ["By", "working", "with", "our", "customers", "to", "fully", "integrate", "Cytori", "technology", "into", "their", "practices,", "we", "are", "providing", "a", "valuable", "service", "and", "further", "distinguishing", "our", "brand."], "wordsB": ["In", "Japan,", "we", "are", "working", "with", "the", "Pharmaceuticals", "and", "Medical", "Devices", "Agency", "(PMDA),", "to", "leverage", "our", "global", "clinical", "data", "for", "Japanese", "approval", "of", "our", "technology", "for", "breast", "reconstruction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p13_s6", "idA": "1095981_11_item7_p11_s0", "sentA": "In addition to our commercial activities in Europe and the United States where we are focused primarily on reconstructive and cosmetic surgery, we are also pursuing commercialization strategies for the Celution System into Japan and other Asia-Pacific markets, with limited sales into the translational medicine markets.", "sentB": "In other geographic markets, we intend to grow product sales where we are approved to sell.", "type": 1, "words": ["<tag1>", "In", "addition", "to", "our", "commercial", "activities", "in", "Europe", "and", "the", "United", "States", "where", "we", "are", "focused", "primarily", "on", "reconstructive", "and", "cosmetic", "surgery,", "we", "are", "also", "pursuing", "commercialization", "strategies", "for", "the", "Celution", "System", "into", "Japan", "and", "other", "Asia-Pacific", "markets,", "with", "limited", "sales", "into", "the", "translational", "medicine", "markets.", "<tag2>", "In", "other", "geographic", "markets,", "we", "intend", "to", "grow", "product", "sales", "where", "we", "are", "approved", "to", "sell.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "commercial", "activities", "in", "Europe", "and", "the", "United", "States", "where", "we", "are", "focused", "primarily", "on", "reconstructive", "and", "cosmetic", "surgery,", "we", "are", "also", "pursuing", "commercialization", "strategies", "for", "the", "Celution", "System", "into", "Japan", "and", "other", "Asia-Pacific", "markets,", "with", "limited", "sales", "into", "the", "translational", "medicine", "markets."], "wordsB": ["In", "other", "geographic", "markets,", "we", "intend", "to", "grow", "product", "sales", "where", "we", "are", "approved", "to", "sell."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p93_s1", "idA": "1095981_11_item7_p133_s1", "sentA": "In the absence of fair value for a delivered element, we allocate revenue first to the fair value of the undelivered elements and allocate the residual revenue to the delivered elements.", "sentB": "In the continued absence of positive cash flows from operations, no assurance can be given that we can generate sufficient revenue to cover operating costs or that additional financing will be available to us and, if available, on terms acceptable to us in the future.", "type": 1, "words": ["<tag1>", "In", "the", "absence", "of", "fair", "value", "for", "a", "delivered", "element,", "we", "allocate", "revenue", "first", "to", "the", "fair", "value", "of", "the", "undelivered", "elements", "and", "allocate", "the", "residual", "revenue", "to", "the", "delivered", "elements.", "<tag2>", "In", "the", "continued", "absence", "of", "positive", "cash", "flows", "from", "operations,", "no", "assurance", "can", "be", "given", "that", "we", "can", "generate", "sufficient", "revenue", "to", "cover", "operating", "costs", "or", "that", "additional", "financing", "will", "be", "available", "to", "us", "and,", "if", "available,", "on", "terms", "acceptable", "to", "us", "in", "the", "future.", "<tag3>"], "wordsA": ["In", "the", "absence", "of", "fair", "value", "for", "a", "delivered", "element,", "we", "allocate", "revenue", "first", "to", "the", "fair", "value", "of", "the", "undelivered", "elements", "and", "allocate", "the", "residual", "revenue", "to", "the", "delivered", "elements."], "wordsB": ["In", "the", "continued", "absence", "of", "positive", "cash", "flows", "from", "operations,", "no", "assurance", "can", "be", "given", "that", "we", "can", "generate", "sufficient", "revenue", "to", "cover", "operating", "costs", "or", "that", "additional", "financing", "will", "be", "available", "to", "us", "and,", "if", "available,", "on", "terms", "acceptable", "to", "us", "in", "the", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p15_s2", "idA": "1095981_11_item7_p139_s0", "sentA": "Proportional performance methodology was elected due to the nature of our development obligations and efforts in support of the Joint Venture including product development activities and regulatory efforts to support the commercialization of the Joint Venture products.", "sentB": "Due to the platform nature of our technology and products, we are able to simultaneously pursue transactions for multiple indications in core areas like cardiovascular disease and other non-core areas such as liver disease for which Astellas Pharma has negotiation rights.", "type": 1, "words": ["<tag1>", "Proportional", "performance", "methodology", "was", "elected", "due", "to", "the", "nature", "of", "our", "development", "obligations", "and", "efforts", "in", "support", "of", "the", "Joint", "Venture", "including", "product", "development", "activities", "and", "regulatory", "efforts", "to", "support", "the", "commercialization", "of", "the", "Joint", "Venture", "products.", "<tag2>", "Due", "to", "the", "platform", "nature", "of", "our", "technology", "and", "products,", "we", "are", "able", "to", "simultaneously", "pursue", "transactions", "for", "multiple", "indications", "in", "core", "areas", "like", "cardiovascular", "disease", "and", "other", "non-core", "areas", "such", "as", "liver", "disease", "for", "which", "Astellas", "Pharma", "has", "negotiation", "rights.", "<tag3>"], "wordsA": ["Proportional", "performance", "methodology", "was", "elected", "due", "to", "the", "nature", "of", "our", "development", "obligations", "and", "efforts", "in", "support", "of", "the", "Joint", "Venture", "including", "product", "development", "activities", "and", "regulatory", "efforts", "to", "support", "the", "commercialization", "of", "the", "Joint", "Venture", "products."], "wordsB": ["Due", "to", "the", "platform", "nature", "of", "our", "technology", "and", "products,", "we", "are", "able", "to", "simultaneously", "pursue", "transactions", "for", "multiple", "indications", "in", "core", "areas", "like", "cardiovascular", "disease", "and", "other", "non-core", "areas", "such", "as", "liver", "disease", "for", "which", "Astellas", "Pharma", "has", "negotiation", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p17_s2", "idA": "1095981_11_item7_p15_s1", "sentA": "We filed a 510(k) marketing application for use in aesthetic body contouring and/or filling of soft tissue voids with the FDA in November 2009.", "sentB": "In the US, receiving the IDE approval was a key development for the company that signals a positive and clearer pathway with the FDA.", "type": 1, "words": ["<tag1>", "We", "filed", "a", "510(k)", "marketing", "application", "for", "use", "in", "aesthetic", "body", "contouring", "and/or", "filling", "of", "soft", "tissue", "voids", "with", "the", "FDA", "in", "November", "2009.", "<tag2>", "In", "the", "US,", "receiving", "the", "IDE", "approval", "was", "a", "key", "development", "for", "the", "company", "that", "signals", "a", "positive", "and", "clearer", "pathway", "with", "the", "FDA.", "<tag3>"], "wordsA": ["We", "filed", "a", "510(k)", "marketing", "application", "for", "use", "in", "aesthetic", "body", "contouring", "and/or", "filling", "of", "soft", "tissue", "voids", "with", "the", "FDA", "in", "November", "2009."], "wordsB": ["In", "the", "US,", "receiving", "the", "IDE", "approval", "was", "a", "key", "development", "for", "the", "company", "that", "signals", "a", "positive", "and", "clearer", "pathway", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p4_s0", "idA": "1095981_11_item7_p16_s0", "sentA": "We also intend to build upon the 2010 advancements made to our cardiovascular pipeline and to take the next step in potentially bringing these applications for the Celution System to market.", "sentB": "Our goal is to build shareholder value by focusing on novel, high-value cell-based therapeutics to market in core geographies:", "type": 1, "words": ["<tag1>", "We", "also", "intend", "to", "build", "upon", "the", "2010", "advancements", "made", "to", "our", "cardiovascular", "pipeline", "and", "to", "take", "the", "next", "step", "in", "potentially", "bringing", "these", "applications", "for", "the", "Celution", "System", "to", "market.", "<tag2>", "Our", "goal", "is", "to", "build", "shareholder", "value", "by", "focusing", "on", "novel,", "high-value", "cell-based", "therapeutics", "to", "market", "in", "core", "geographies:", "<tag3>"], "wordsA": ["We", "also", "intend", "to", "build", "upon", "the", "2010", "advancements", "made", "to", "our", "cardiovascular", "pipeline", "and", "to", "take", "the", "next", "step", "in", "potentially", "bringing", "these", "applications", "for", "the", "Celution", "System", "to", "market."], "wordsB": ["Our", "goal", "is", "to", "build", "shareholder", "value", "by", "focusing", "on", "novel,", "high-value", "cell-based", "therapeutics", "to", "market", "in", "core", "geographies:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p13_s1", "idA": "1095981_11_item7_p20_s0", "sentA": "Olympus paid $30,000,000 for its 50% interest in the Joint Venture.", "sentB": "In Europe, the NHS National Innovation Centre in the UK indicated that our technology may be cost-effective for lumpectomy breast reconstruction.", "type": 1, "words": ["<tag1>", "Olympus", "paid", "$30,000,000", "for", "its", "50%", "interest", "in", "the", "Joint", "Venture.", "<tag2>", "In", "Europe,", "the", "NHS", "National", "Innovation", "Centre", "in", "the", "UK", "indicated", "that", "our", "technology", "may", "be", "cost-effective", "for", "lumpectomy", "breast", "reconstruction.", "<tag3>"], "wordsA": ["Olympus", "paid", "$30,000,000", "for", "its", "50%", "interest", "in", "the", "Joint", "Venture."], "wordsB": ["In", "Europe,", "the", "NHS", "National", "Innovation", "Centre", "in", "the", "UK", "indicated", "that", "our", "technology", "may", "be", "cost-effective", "for", "lumpectomy", "breast", "reconstruction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p17_s0", "idA": "1095981_11_item7_p20_s0", "sentA": "Olympus paid $30,000,000 for its 50% interest in the Joint Venture.", "sentB": "Regulatory processes are well underway in the US, Canada, the EU, Australia, Japan, Russia and other countries.", "type": 1, "words": ["<tag1>", "Olympus", "paid", "$30,000,000", "for", "its", "50%", "interest", "in", "the", "Joint", "Venture.", "<tag2>", "Regulatory", "processes", "are", "well", "underway", "in", "the", "US,", "Canada,", "the", "EU,", "Australia,", "Japan,", "Russia", "and", "other", "countries.", "<tag3>"], "wordsA": ["Olympus", "paid", "$30,000,000", "for", "its", "50%", "interest", "in", "the", "Joint", "Venture."], "wordsB": ["Regulatory", "processes", "are", "well", "underway", "in", "the", "US,", "Canada,", "the", "EU,", "Australia,", "Japan,", "Russia", "and", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p9_s2", "idA": "1095981_11_item7_p20_s0", "sentA": "Olympus paid $30,000,000 for its 50% interest in the Joint Venture.", "sentB": "Should we receive approval, we would target select hospital customers in the G5 countries and likely implement a patient registry.", "type": 1, "words": ["<tag1>", "Olympus", "paid", "$30,000,000", "for", "its", "50%", "interest", "in", "the", "Joint", "Venture.", "<tag2>", "Should", "we", "receive", "approval,", "we", "would", "target", "select", "hospital", "customers", "in", "the", "G5", "countries", "and", "likely", "implement", "a", "patient", "registry.", "<tag3>"], "wordsA": ["Olympus", "paid", "$30,000,000", "for", "its", "50%", "interest", "in", "the", "Joint", "Venture."], "wordsB": ["Should", "we", "receive", "approval,", "we", "would", "target", "select", "hospital", "customers", "in", "the", "G5", "countries", "and", "likely", "implement", "a", "patient", "registry."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p10_s0", "idA": "1095981_11_item7_p28_s0", "sentA": "We account for our investment in the Joint Venture under the equity method of accounting.", "sentB": "The 2012 goals for our commercial business are twofold.", "type": 1, "words": ["<tag1>", "We", "account", "for", "our", "investment", "in", "the", "Joint", "Venture", "under", "the", "equity", "method", "of", "accounting.", "<tag2>", "The", "2012", "goals", "for", "our", "commercial", "business", "are", "twofold.", "<tag3>"], "wordsA": ["We", "account", "for", "our", "investment", "in", "the", "Joint", "Venture", "under", "the", "equity", "method", "of", "accounting."], "wordsB": ["The", "2012", "goals", "for", "our", "commercial", "business", "are", "twofold."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p63_s0", "idA": "1095981_11_item7_p28_s0", "sentA": "We account for our investment in the Joint Venture under the equity method of accounting.", "sentB": "We granted 246,225 performance-based restricted stock awards under the 2004 Equity Incentive Plan in February 2011.", "type": 1, "words": ["<tag1>", "We", "account", "for", "our", "investment", "in", "the", "Joint", "Venture", "under", "the", "equity", "method", "of", "accounting.", "<tag2>", "We", "granted", "246,225", "performance-based", "restricted", "stock", "awards", "under", "the", "2004", "Equity", "Incentive", "Plan", "in", "February", "2011.", "<tag3>"], "wordsA": ["We", "account", "for", "our", "investment", "in", "the", "Joint", "Venture", "under", "the", "equity", "method", "of", "accounting."], "wordsB": ["We", "granted", "246,225", "performance-based", "restricted", "stock", "awards", "under", "the", "2004", "Equity", "Incentive", "Plan", "in", "February", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p31_s0", "idA": "1095981_11_item7_p32_s1", "sentA": "We retained all rights to Thin Film business in Japan (subject to a purchase option of MAST, which expired in May 2007), and we received back from MAST a license of all rights to Thin Film technologies in the spinal field, exclusive at least until 2012, and the field of regenerative medicine, non-exclusive on a perpetual basis.", "sentB": "Our product sales in the current year were significantly impacted by the major earthquake, tsunami and the aftermath that occurred in Japan in March.", "type": 1, "words": ["<tag1>", "We", "retained", "all", "rights", "to", "Thin", "Film", "business", "in", "Japan", "(subject", "to", "a", "purchase", "option", "of", "MAST,", "which", "expired", "in", "May", "2007),", "and", "we", "received", "back", "from", "MAST", "a", "license", "of", "all", "rights", "to", "Thin", "Film", "technologies", "in", "the", "spinal", "field,", "exclusive", "at", "least", "until", "2012,", "and", "the", "field", "of", "regenerative", "medicine,", "non-exclusive", "on", "a", "perpetual", "basis.", "<tag2>", "Our", "product", "sales", "in", "the", "current", "year", "were", "significantly", "impacted", "by", "the", "major", "earthquake,", "tsunami", "and", "the", "aftermath", "that", "occurred", "in", "Japan", "in", "March.", "<tag3>"], "wordsA": ["We", "retained", "all", "rights", "to", "Thin", "Film", "business", "in", "Japan", "(subject", "to", "a", "purchase", "option", "of", "MAST,", "which", "expired", "in", "May", "2007),", "and", "we", "received", "back", "from", "MAST", "a", "license", "of", "all", "rights", "to", "Thin", "Film", "technologies", "in", "the", "spinal", "field,", "exclusive", "at", "least", "until", "2012,", "and", "the", "field", "of", "regenerative", "medicine,", "non-exclusive", "on", "a", "perpetual", "basis."], "wordsB": ["Our", "product", "sales", "in", "the", "current", "year", "were", "significantly", "impacted", "by", "the", "major", "earthquake,", "tsunami", "and", "the", "aftermath", "that", "occurred", "in", "Japan", "in", "March."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p121_s1", "idA": "1095981_11_item7_p33_s4", "sentA": "Commercialization will occur when one or more Thin Film product registrations are completed with the Japanese Ministry of Health, Labour and Welfare, or MHLW.", "sentB": "Stem cell banks typically consist of a complex array of equipment and proprietary knowledge, and services, including one or more StemSource devices, a cryogenic freezer, measuring and monitoring equipment, and a database patient tracking system.", "type": 1, "words": ["<tag1>", "Commercialization", "will", "occur", "when", "one", "or", "more", "Thin", "Film", "product", "registrations", "are", "completed", "with", "the", "Japanese", "Ministry", "of", "Health,", "Labour", "and", "Welfare,", "or", "MHLW.", "<tag2>", "Stem", "cell", "banks", "typically", "consist", "of", "a", "complex", "array", "of", "equipment", "and", "proprietary", "knowledge,", "and", "services,", "including", "one", "or", "more", "StemSource", "devices,", "a", "cryogenic", "freezer,", "measuring", "and", "monitoring", "equipment,", "and", "a", "database", "patient", "tracking", "system.", "<tag3>"], "wordsA": ["Commercialization", "will", "occur", "when", "one", "or", "more", "Thin", "Film", "product", "registrations", "are", "completed", "with", "the", "Japanese", "Ministry", "of", "Health,", "Labour", "and", "Welfare,", "or", "MHLW."], "wordsB": ["Stem", "cell", "banks", "typically", "consist", "of", "a", "complex", "array", "of", "equipment", "and", "proprietary", "knowledge,", "and", "services,", "including", "one", "or", "more", "StemSource", "devices,", "a", "cryogenic", "freezer,", "measuring", "and", "monitoring", "equipment,", "and", "a", "database", "patient", "tracking", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p17_s3", "idA": "1095981_11_item7_p33_s4", "sentA": "Commercialization will occur when one or more Thin Film product registrations are completed with the Japanese Ministry of Health, Labour and Welfare, or MHLW.", "sentB": "We also feel that the multiple opportunities we have in other countries increase the possibility that one or more meaningful markets could open up for Cytori.", "type": 1, "words": ["<tag1>", "Commercialization", "will", "occur", "when", "one", "or", "more", "Thin", "Film", "product", "registrations", "are", "completed", "with", "the", "Japanese", "Ministry", "of", "Health,", "Labour", "and", "Welfare,", "or", "MHLW.", "<tag2>", "We", "also", "feel", "that", "the", "multiple", "opportunities", "we", "have", "in", "other", "countries", "increase", "the", "possibility", "that", "one", "or", "more", "meaningful", "markets", "could", "open", "up", "for", "Cytori.", "<tag3>"], "wordsA": ["Commercialization", "will", "occur", "when", "one", "or", "more", "Thin", "Film", "product", "registrations", "are", "completed", "with", "the", "Japanese", "Ministry", "of", "Health,", "Labour", "and", "Welfare,", "or", "MHLW."], "wordsB": ["We", "also", "feel", "that", "the", "multiple", "opportunities", "we", "have", "in", "other", "countries", "increase", "the", "possibility", "that", "one", "or", "more", "meaningful", "markets", "could", "open", "up", "for", "Cytori."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p8_s2", "idA": "1095981_11_item7_p39_s0", "sentA": "Beginning in March of 2008, we began sales and shipments of our Celution 800/CRS System to the European and Asia-Pacific reconstructive surgery markets and during 2010 we began sales of our PureGraft System in the United States and Europe.", "sentB": "In the meantime, we have already qualified 27 sites with an emphasis on sites in the European G5.", "type": 1, "words": ["<tag1>", "Beginning", "in", "March", "of", "2008,", "we", "began", "sales", "and", "shipments", "of", "our", "Celution", "800/CRS", "System", "to", "the", "European", "and", "Asia-Pacific", "reconstructive", "surgery", "markets", "and", "during", "2010", "we", "began", "sales", "of", "our", "PureGraft", "System", "in", "the", "United", "States", "and", "Europe.", "<tag2>", "In", "the", "meantime,", "we", "have", "already", "qualified", "27", "sites", "with", "an", "emphasis", "on", "sites", "in", "the", "European", "G5.", "<tag3>"], "wordsA": ["Beginning", "in", "March", "of", "2008,", "we", "began", "sales", "and", "shipments", "of", "our", "Celution", "800/CRS", "System", "to", "the", "European", "and", "Asia-Pacific", "reconstructive", "surgery", "markets", "and", "during", "2010", "we", "began", "sales", "of", "our", "PureGraft", "System", "in", "the", "United", "States", "and", "Europe."], "wordsB": ["In", "the", "meantime,", "we", "have", "already", "qualified", "27", "sites", "with", "an", "emphasis", "on", "sites", "in", "the", "European", "G5."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p3_s1", "idA": "1095981_11_item7_p3_s2", "sentA": "These stem and regenerative cells may help to improve blood flow in damaged or diseased tissues and therefore can potentially be used to treat multiple conditions resulting from a lack of blood supply (ischemia).", "sentB": "Our scientific data suggest ADRCs improve blood flow, moderate the immune response and keep tissue at risk of dying alive.", "type": 1, "words": ["<tag1>", "These", "stem", "and", "regenerative", "cells", "may", "help", "to", "improve", "blood", "flow", "in", "damaged", "or", "diseased", "tissues", "and", "therefore", "can", "potentially", "be", "used", "to", "treat", "multiple", "conditions", "resulting", "from", "a", "lack", "of", "blood", "supply", "(ischemia).", "<tag2>", "Our", "scientific", "data", "suggest", "ADRCs", "improve", "blood", "flow,", "moderate", "the", "immune", "response", "and", "keep", "tissue", "at", "risk", "of", "dying", "alive.", "<tag3>"], "wordsA": ["These", "stem", "and", "regenerative", "cells", "may", "help", "to", "improve", "blood", "flow", "in", "damaged", "or", "diseased", "tissues", "and", "therefore", "can", "potentially", "be", "used", "to", "treat", "multiple", "conditions", "resulting", "from", "a", "lack", "of", "blood", "supply", "(ischemia)."], "wordsB": ["Our", "scientific", "data", "suggest", "ADRCs", "improve", "blood", "flow,", "moderate", "the", "immune", "response", "and", "keep", "tissue", "at", "risk", "of", "dying", "alive."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p11_s1", "idA": "1095981_11_item7_p41_s0", "sentA": "Shipping and handling costs that are billed to our customers are classified as revenue.", "sentB": "Looking forward, we intend to target larger market segments and grow therapeutically oriented consumable revenue.", "type": 1, "words": ["<tag1>", "Shipping", "and", "handling", "costs", "that", "are", "billed", "to", "our", "customers", "are", "classified", "as", "revenue.", "<tag2>", "Looking", "forward,", "we", "intend", "to", "target", "larger", "market", "segments", "and", "grow", "therapeutically", "oriented", "consumable", "revenue.", "<tag3>"], "wordsA": ["Shipping", "and", "handling", "costs", "that", "are", "billed", "to", "our", "customers", "are", "classified", "as", "revenue."], "wordsB": ["Looking", "forward,", "we", "intend", "to", "target", "larger", "market", "segments", "and", "grow", "therapeutically", "oriented", "consumable", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p32_s1", "idA": "1095981_11_item7_p51_s1", "sentA": "The QTDP, administered by the Department of Health and Human Services and the Department of the Treasury, was enacted to encourage biomedical research for projects that show the greatest potential to create and sustain high-quality, high-paying U.S. jobs and to advance U.S. competitiveness in life, biological and medical sciences.", "sentB": "We will sell the products to a diverse group of customers in Europe, Asia and the U.S., who may apply the products towards reconstructive surgery, soft tissue repair, research, aesthetics, and cell and tissue banking.", "type": 1, "words": ["<tag1>", "The", "QTDP,", "administered", "by", "the", "Department", "of", "Health", "and", "Human", "Services", "and", "the", "Department", "of", "the", "Treasury,", "was", "enacted", "to", "encourage", "biomedical", "research", "for", "projects", "that", "show", "the", "greatest", "potential", "to", "create", "and", "sustain", "high-quality,", "high-paying", "U.S.", "jobs", "and", "to", "advance", "U.S.", "competitiveness", "in", "life,", "biological", "and", "medical", "sciences.", "<tag2>", "We", "will", "sell", "the", "products", "to", "a", "diverse", "group", "of", "customers", "in", "Europe,", "Asia", "and", "the", "U.S.,", "who", "may", "apply", "the", "products", "towards", "reconstructive", "surgery,", "soft", "tissue", "repair,", "research,", "aesthetics,", "and", "cell", "and", "tissue", "banking.", "<tag3>"], "wordsA": ["The", "QTDP,", "administered", "by", "the", "Department", "of", "Health", "and", "Human", "Services", "and", "the", "Department", "of", "the", "Treasury,", "was", "enacted", "to", "encourage", "biomedical", "research", "for", "projects", "that", "show", "the", "greatest", "potential", "to", "create", "and", "sustain", "high-quality,", "high-paying", "U.S.", "jobs", "and", "to", "advance", "U.S.", "competitiveness", "in", "life,", "biological", "and", "medical", "sciences."], "wordsB": ["We", "will", "sell", "the", "products", "to", "a", "diverse", "group", "of", "customers", "in", "Europe,", "Asia", "and", "the", "U.S.,", "who", "may", "apply", "the", "products", "towards", "reconstructive", "surgery,", "soft", "tissue", "repair,", "research,", "aesthetics,", "and", "cell", "and", "tissue", "banking."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p32_s2", "idA": "1095981_11_item7_p52_s0", "sentA": "We may recognize additional development revenues during 2011, as the anticipated completion for the next phase of our Joint Venture and other Olympus product development performance obligations is in 2011.", "sentB": "It is anticipated sales in Japan will improve as the country continues to recover from the natural disaster in March 2011.", "type": 1, "words": ["<tag1>", "We", "may", "recognize", "additional", "development", "revenues", "during", "2011,", "as", "the", "anticipated", "completion", "for", "the", "next", "phase", "of", "our", "Joint", "Venture", "and", "other", "Olympus", "product", "development", "performance", "obligations", "is", "in", "2011.", "<tag2>", "It", "is", "anticipated", "sales", "in", "Japan", "will", "improve", "as", "the", "country", "continues", "to", "recover", "from", "the", "natural", "disaster", "in", "March", "2011.", "<tag3>"], "wordsA": ["We", "may", "recognize", "additional", "development", "revenues", "during", "2011,", "as", "the", "anticipated", "completion", "for", "the", "next", "phase", "of", "our", "Joint", "Venture", "and", "other", "Olympus", "product", "development", "performance", "obligations", "is", "in", "2011."], "wordsB": ["It", "is", "anticipated", "sales", "in", "Japan", "will", "improve", "as", "the", "country", "continues", "to", "recover", "from", "the", "natural", "disaster", "in", "March", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p41_s4", "idA": "1095981_11_item7_p53_s2", "sentA": "Accordingly, we expect to recognize approximately $1,129,000 (consisting of $879,000 in deferred revenues plus a non-refundable payment of $250,000 to be received upon commercialization) in revenues associated with this milestone arrangement if and when regulatory approval is achieved.", "sentB": "There can be no assurance given of whether, or when, this regulatory approval might be received to allow us to proceed with commercialization.", "type": 1, "words": ["<tag1>", "Accordingly,", "we", "expect", "to", "recognize", "approximately", "$1,129,000", "(consisting", "of", "$879,000", "in", "deferred", "revenues", "plus", "a", "non-refundable", "payment", "of", "$250,000", "to", "be", "received", "upon", "commercialization)", "in", "revenues", "associated", "with", "this", "milestone", "arrangement", "if", "and", "when", "regulatory", "approval", "is", "achieved.", "<tag2>", "There", "can", "be", "no", "assurance", "given", "of", "whether,", "or", "when,", "this", "regulatory", "approval", "might", "be", "received", "to", "allow", "us", "to", "proceed", "with", "commercialization.", "<tag3>"], "wordsA": ["Accordingly,", "we", "expect", "to", "recognize", "approximately", "$1,129,000", "(consisting", "of", "$879,000", "in", "deferred", "revenues", "plus", "a", "non-refundable", "payment", "of", "$250,000", "to", "be", "received", "upon", "commercialization)", "in", "revenues", "associated", "with", "this", "milestone", "arrangement", "if", "and", "when", "regulatory", "approval", "is", "achieved."], "wordsB": ["There", "can", "be", "no", "assurance", "given", "of", "whether,", "or", "when,", "this", "regulatory", "approval", "might", "be", "received", "to", "allow", "us", "to", "proceed", "with", "commercialization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p16_s1", "idA": "1095981_11_item7_p56_s0", "sentA": "The decrease in research and development expenses for the year ended December 31, 2010 as compared to the same period in 2009 is primarily due to the decrease in clinical and preclinical study expense of $967,000 and decrease in supplies related expense of $412,000 primarily due to the decreased research and development experiment supplies usage as well as supplies purchased for prototype work prior to the related product commercialization.", "sentB": "Our 2012 budget calls for a reduction of approximately $6 million in combined Sales Marketing and General and Administrative expenses for 2012 as compared to 2011.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "as", "compared", "to", "the", "same", "period", "in", "2009", "is", "primarily", "due", "to", "the", "decrease", "in", "clinical", "and", "preclinical", "study", "expense", "of", "$967,000", "and", "decrease", "in", "supplies", "related", "expense", "of", "$412,000", "primarily", "due", "to", "the", "decreased", "research", "and", "development", "experiment", "supplies", "usage", "as", "well", "as", "supplies", "purchased", "for", "prototype", "work", "prior", "to", "the", "related", "product", "commercialization.", "<tag2>", "Our", "2012", "budget", "calls", "for", "a", "reduction", "of", "approximately", "$6", "million", "in", "combined", "Sales", "Marketing", "and", "General", "and", "Administrative", "expenses", "for", "2012", "as", "compared", "to", "2011.", "<tag3>"], "wordsA": ["The", "decrease", "in", "research", "and", "development", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "as", "compared", "to", "the", "same", "period", "in", "2009", "is", "primarily", "due", "to", "the", "decrease", "in", "clinical", "and", "preclinical", "study", "expense", "of", "$967,000", "and", "decrease", "in", "supplies", "related", "expense", "of", "$412,000", "primarily", "due", "to", "the", "decreased", "research", "and", "development", "experiment", "supplies", "usage", "as", "well", "as", "supplies", "purchased", "for", "prototype", "work", "prior", "to", "the", "related", "product", "commercialization."], "wordsB": ["Our", "2012", "budget", "calls", "for", "a", "reduction", "of", "approximately", "$6", "million", "in", "combined", "Sales", "Marketing", "and", "General", "and", "Administrative", "expenses", "for", "2012", "as", "compared", "to", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p15_s0", "idA": "1095981_11_item7_p5_s1", "sentA": "Cytori s near term strategy is to focus first on development and sales of our approved products into the cosmetic and reconstructive surgery (CRS) market and the cell banking market, which we believe can be successfully penetrated more quickly than our other target markets.", "sentB": "One of our top priorities is to establish a strategic partnership, which could accelerate core or non-core opportunities and potentially bring in significant minimally or non-dilutive capital.", "type": 1, "words": ["<tag1>", "Cytori", "s", "near", "term", "strategy", "is", "to", "focus", "first", "on", "development", "and", "sales", "of", "our", "approved", "products", "into", "the", "cosmetic", "and", "reconstructive", "surgery", "(CRS)", "market", "and", "the", "cell", "banking", "market,", "which", "we", "believe", "can", "be", "successfully", "penetrated", "more", "quickly", "than", "our", "other", "target", "markets.", "<tag2>", "One", "of", "our", "top", "priorities", "is", "to", "establish", "a", "strategic", "partnership,", "which", "could", "accelerate", "core", "or", "non-core", "opportunities", "and", "potentially", "bring", "in", "significant", "minimally", "or", "non-dilutive", "capital.", "<tag3>"], "wordsA": ["Cytori", "s", "near", "term", "strategy", "is", "to", "focus", "first", "on", "development", "and", "sales", "of", "our", "approved", "products", "into", "the", "cosmetic", "and", "reconstructive", "surgery", "(CRS)", "market", "and", "the", "cell", "banking", "market,", "which", "we", "believe", "can", "be", "successfully", "penetrated", "more", "quickly", "than", "our", "other", "target", "markets."], "wordsB": ["One", "of", "our", "top", "priorities", "is", "to", "establish", "a", "strategic", "partnership,", "which", "could", "accelerate", "core", "or", "non-core", "opportunities", "and", "potentially", "bring", "in", "significant", "minimally", "or", "non-dilutive", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p5_s1", "idA": "1095981_11_item7_p5_s3", "sentA": "In addition to our near term growth drivers, we are also working toward Celution System claims for cardiovascular disease applications through ongoing and planned European clinical trials.", "sentB": "To take advantage of our limited resources, we are committing our internal resources to cardiovascular disease and soft tissue defect repair, offering the technology to customers and/or partners to identify and explore additional potential indications, and are seeking partners to accelerate core or non-core opportunities.", "type": 1, "words": ["<tag1>", "In", "addition", "to", "our", "near", "term", "growth", "drivers,", "we", "are", "also", "working", "toward", "Celution", "System", "claims", "for", "cardiovascular", "disease", "applications", "through", "ongoing", "and", "planned", "European", "clinical", "trials.", "<tag2>", "To", "take", "advantage", "of", "our", "limited", "resources,", "we", "are", "committing", "our", "internal", "resources", "to", "cardiovascular", "disease", "and", "soft", "tissue", "defect", "repair,", "offering", "the", "technology", "to", "customers", "and/or", "partners", "to", "identify", "and", "explore", "additional", "potential", "indications,", "and", "are", "seeking", "partners", "to", "accelerate", "core", "or", "non-core", "opportunities.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "near", "term", "growth", "drivers,", "we", "are", "also", "working", "toward", "Celution", "System", "claims", "for", "cardiovascular", "disease", "applications", "through", "ongoing", "and", "planned", "European", "clinical", "trials."], "wordsB": ["To", "take", "advantage", "of", "our", "limited", "resources,", "we", "are", "committing", "our", "internal", "resources", "to", "cardiovascular", "disease", "and", "soft", "tissue", "defect", "repair,", "offering", "the", "technology", "to", "customers", "and/or", "partners", "to", "identify", "and", "explore", "additional", "potential", "indications,", "and", "are", "seeking", "partners", "to", "accelerate", "core", "or", "non-core", "opportunities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p12_s1", "idA": "1095981_11_item7_p61_s1", "sentA": "The following table summarizes the components of our sales and marketing expenses for the years ended December 31, 2010, 2009 and 2008:", "sentB": "The impact of this reduction along with other sales and marketing costs will result in reduced overall spend in 2012, while maintaining our ability to achieve 2012 growth objectives.", "type": 1, "words": ["<tag1>", "The", "following", "table", "summarizes", "the", "components", "of", "our", "sales", "and", "marketing", "expenses", "for", "the", "years", "ended", "December", "31,", "2010,", "2009", "and", "2008:", "<tag2>", "The", "impact", "of", "this", "reduction", "along", "with", "other", "sales", "and", "marketing", "costs", "will", "result", "in", "reduced", "overall", "spend", "in", "2012,", "while", "maintaining", "our", "ability", "to", "achieve", "2012", "growth", "objectives.", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "the", "components", "of", "our", "sales", "and", "marketing", "expenses", "for", "the", "years", "ended", "December", "31,", "2010,", "2009", "and", "2008:"], "wordsB": ["The", "impact", "of", "this", "reduction", "along", "with", "other", "sales", "and", "marketing", "costs", "will", "result", "in", "reduced", "overall", "spend", "in", "2012,", "while", "maintaining", "our", "ability", "to", "achieve", "2012", "growth", "objectives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p17_s1", "idA": "1095981_11_item7_p64_s0", "sentA": "We expect sales and marketing expenditures related to the regenerative cell technology to increase as we continue to expand our base of distribution partners, strategic alliances and co-development partners, as well as our direct marketing sales force for our Celution System and StemSource Cell Bank.", "sentB": "We expect progress in many of these markets during 2012 that could expand our commercial opportunities.", "type": 1, "words": ["<tag1>", "We", "expect", "sales", "and", "marketing", "expenditures", "related", "to", "the", "regenerative", "cell", "technology", "to", "increase", "as", "we", "continue", "to", "expand", "our", "base", "of", "distribution", "partners,", "strategic", "alliances", "and", "co-development", "partners,", "as", "well", "as", "our", "direct", "marketing", "sales", "force", "for", "our", "Celution", "System", "and", "StemSource", "Cell", "Bank.", "<tag2>", "We", "expect", "progress", "in", "many", "of", "these", "markets", "during", "2012", "that", "could", "expand", "our", "commercial", "opportunities.", "<tag3>"], "wordsA": ["We", "expect", "sales", "and", "marketing", "expenditures", "related", "to", "the", "regenerative", "cell", "technology", "to", "increase", "as", "we", "continue", "to", "expand", "our", "base", "of", "distribution", "partners,", "strategic", "alliances", "and", "co-development", "partners,", "as", "well", "as", "our", "direct", "marketing", "sales", "force", "for", "our", "Celution", "System", "and", "StemSource", "Cell", "Bank."], "wordsB": ["We", "expect", "progress", "in", "many", "of", "these", "markets", "during", "2012", "that", "could", "expand", "our", "commercial", "opportunities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p11_s2", "idA": "1095981_11_item7_p65_s0", "sentA": "General and administrative expenses include costs for administrative personnel, legal and other professional expenses and general corporate expenses.", "sentB": "To accomplish this goal, we are focusing on driving essential market access elements such as published clinical and health economics data, physician education and indication-specific therapeutic claims, while maintaining a critical eye on expenses.", "type": 1, "words": ["<tag1>", "General", "and", "administrative", "expenses", "include", "costs", "for", "administrative", "personnel,", "legal", "and", "other", "professional", "expenses", "and", "general", "corporate", "expenses.", "<tag2>", "To", "accomplish", "this", "goal,", "we", "are", "focusing", "on", "driving", "essential", "market", "access", "elements", "such", "as", "published", "clinical", "and", "health", "economics", "data,", "physician", "education", "and", "indication-specific", "therapeutic", "claims,", "while", "maintaining", "a", "critical", "eye", "on", "expenses.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "include", "costs", "for", "administrative", "personnel,", "legal", "and", "other", "professional", "expenses", "and", "general", "corporate", "expenses."], "wordsB": ["To", "accomplish", "this", "goal,", "we", "are", "focusing", "on", "driving", "essential", "market", "access", "elements", "such", "as", "published", "clinical", "and", "health", "economics", "data,", "physician", "education", "and", "indication-specific", "therapeutic", "claims,", "while", "maintaining", "a", "critical", "eye", "on", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p5_s0", "idA": "1095981_11_item7_p6_s0", "sentA": "Cardiovascular disease is a multi-billion dollar worldwide market.", "sentB": "Celution is a platform technology that we believe could potentially address multiple diseases and conditions.", "type": 1, "words": ["<tag1>", "Cardiovascular", "disease", "is", "a", "multi-billion", "dollar", "worldwide", "market.", "<tag2>", "Celution", "is", "a", "platform", "technology", "that", "we", "believe", "could", "potentially", "address", "multiple", "diseases", "and", "conditions.", "<tag3>"], "wordsA": ["Cardiovascular", "disease", "is", "a", "multi-billion", "dollar", "worldwide", "market."], "wordsB": ["Celution", "is", "a", "platform", "technology", "that", "we", "believe", "could", "potentially", "address", "multiple", "diseases", "and", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p63_s4", "idA": "1095981_11_item7_p74_s1", "sentA": "The grant date fair value of the awards was $2.00 per share.", "sentB": "Once earned, the awards will remain unvested until January 1, 2013.", "type": 1, "words": ["<tag1>", "The", "grant", "date", "fair", "value", "of", "the", "awards", "was", "$2.00", "per", "share.", "<tag2>", "Once", "earned,", "the", "awards", "will", "remain", "unvested", "until", "January", "1,", "2013.", "<tag3>"], "wordsA": ["The", "grant", "date", "fair", "value", "of", "the", "awards", "was", "$2.00", "per", "share."], "wordsB": ["Once", "earned,", "the", "awards", "will", "remain", "unvested", "until", "January", "1,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p17_s5", "idA": "1095981_11_item7_p79_s0", "sentA": "We will continue to grant options (which will result in an expense) to our employees and, as appropriate, to non-employee service providers.", "sentB": "We will provide greater detail on these markets as these opportunities mature and grow.", "type": 1, "words": ["<tag1>", "We", "will", "continue", "to", "grant", "options", "(which", "will", "result", "in", "an", "expense)", "to", "our", "employees", "and,", "as", "appropriate,", "to", "non-employee", "service", "providers.", "<tag2>", "We", "will", "provide", "greater", "detail", "on", "these", "markets", "as", "these", "opportunities", "mature", "and", "grow.", "<tag3>"], "wordsA": ["We", "will", "continue", "to", "grant", "options", "(which", "will", "result", "in", "an", "expense)", "to", "our", "employees", "and,", "as", "appropriate,", "to", "non-employee", "service", "providers."], "wordsB": ["We", "will", "provide", "greater", "detail", "on", "these", "markets", "as", "these", "opportunities", "mature", "and", "grow."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p13_s0", "idA": "1095981_11_item7_p7_s2", "sentA": "Adoption of cell-enriched breast reconstruction has been strengthened by interim results from our RESTORE 2 trial for partial mastectomy defect reconstruction reported in May 2009 and June 2010.", "sentB": "Our most advanced therapeutic indication is breast reconstruction.", "type": 1, "words": ["<tag1>", "Adoption", "of", "cell-enriched", "breast", "reconstruction", "has", "been", "strengthened", "by", "interim", "results", "from", "our", "RESTORE", "2", "trial", "for", "partial", "mastectomy", "defect", "reconstruction", "reported", "in", "May", "2009", "and", "June", "2010.", "<tag2>", "Our", "most", "advanced", "therapeutic", "indication", "is", "breast", "reconstruction.", "<tag3>"], "wordsA": ["Adoption", "of", "cell-enriched", "breast", "reconstruction", "has", "been", "strengthened", "by", "interim", "results", "from", "our", "RESTORE", "2", "trial", "for", "partial", "mastectomy", "defect", "reconstruction", "reported", "in", "May", "2009", "and", "June", "2010."], "wordsB": ["Our", "most", "advanced", "therapeutic", "indication", "is", "breast", "reconstruction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p63_s6", "idA": "1095981_11_item7_p81_s0", "sentA": "Effective January 1, 2009, we changed our method of accounting for certain common stock purchase warrants with exercise price reset features due to the adoption of a new accounting standard.", "sentB": "Effective January 2012, the outstanding awards ceased vesting based upon decision of Compensation Committee that performance criteria has not been met as of January 1, 2012.", "type": 1, "words": ["<tag1>", "Effective", "January", "1,", "2009,", "we", "changed", "our", "method", "of", "accounting", "for", "certain", "common", "stock", "purchase", "warrants", "with", "exercise", "price", "reset", "features", "due", "to", "the", "adoption", "of", "a", "new", "accounting", "standard.", "<tag2>", "Effective", "January", "2012,", "the", "outstanding", "awards", "ceased", "vesting", "based", "upon", "decision", "of", "Compensation", "Committee", "that", "performance", "criteria", "has", "not", "been", "met", "as", "of", "January", "1,", "2012.", "<tag3>"], "wordsA": ["Effective", "January", "1,", "2009,", "we", "changed", "our", "method", "of", "accounting", "for", "certain", "common", "stock", "purchase", "warrants", "with", "exercise", "price", "reset", "features", "due", "to", "the", "adoption", "of", "a", "new", "accounting", "standard."], "wordsB": ["Effective", "January", "2012,", "the", "outstanding", "awards", "ceased", "vesting", "based", "upon", "decision", "of", "Compensation", "Committee", "that", "performance", "criteria", "has", "not", "been", "met", "as", "of", "January", "1,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p122_s0", "idA": "1095981_11_item7_p85_s0", "sentA": "The expected life is based on the remaining term of the warrants.", "sentB": "The FASB guidance of the Codification establishes a selling price hierarchy for determining the selling price of a deliverable, which is based on: (a) vendor-specific objective evidence ( VSOE (b) third-party evidence ( TPE or (c) management estimates.", "type": 1, "words": ["<tag1>", "The", "expected", "life", "is", "based", "on", "the", "remaining", "term", "of", "the", "warrants.", "<tag2>", "The", "FASB", "guidance", "of", "the", "Codification", "establishes", "a", "selling", "price", "hierarchy", "for", "determining", "the", "selling", "price", "of", "a", "deliverable,", "which", "is", "based", "on:", "(a)", "vendor-specific", "objective", "evidence", "(", "VSOE", "(b)", "third-party", "evidence", "(", "TPE", "or", "(c)", "management", "estimates.", "<tag3>"], "wordsA": ["The", "expected", "life", "is", "based", "on", "the", "remaining", "term", "of", "the", "warrants."], "wordsB": ["The", "FASB", "guidance", "of", "the", "Codification", "establishes", "a", "selling", "price", "hierarchy", "for", "determining", "the", "selling", "price", "of", "a", "deliverable,", "which", "is", "based", "on:", "(a)", "vendor-specific", "objective", "evidence", "(", "VSOE", "(b)", "third-party", "evidence", "(", "TPE", "or", "(c)", "management", "estimates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item7_p8_s1", "idA": "1095981_11_item7_p89_s1", "sentA": "The Put has been classified as a liability.", "sentB": "In aggregate, these protocol amendments should help harmonize the current country to country requirements for cell processing and accelerate country approvals, which has been the rate-limiting step in site initiation.", "type": 1, "words": ["<tag1>", "The", "Put", "has", "been", "classified", "as", "a", "liability.", "<tag2>", "In", "aggregate,", "these", "protocol", "amendments", "should", "help", "harmonize", "the", "current", "country", "to", "country", "requirements", "for", "cell", "processing", "and", "accelerate", "country", "approvals,", "which", "has", "been", "the", "rate-limiting", "step", "in", "site", "initiation.", "<tag3>"], "wordsA": ["The", "Put", "has", "been", "classified", "as", "a", "liability."], "wordsB": ["In", "aggregate,", "these", "protocol", "amendments", "should", "help", "harmonize", "the", "current", "country", "to", "country", "requirements", "for", "cell", "processing", "and", "accelerate", "country", "approvals,", "which", "has", "been", "the", "rate-limiting", "step", "in", "site", "initiation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p7_s2", "idA": "1095981_12_item7_p0_s1", "sentA": "All statements, other than statements of historical fact, that address activities, events or developments that we intend, expect, project, believe or anticipate and similar expressions or future conditional verbs such as will, should, would, could or may occur in the future are forward-looking statements.", "sentB": "This will provide us with flexibility to invest more in areas of higher strategic importance such as in the ATHENA refractory heart failure trial, and in the government funded activities under our BARDA contract.", "type": 1, "words": ["<tag1>", "All", "statements,", "other", "than", "statements", "of", "historical", "fact,", "that", "address", "activities,", "events", "or", "developments", "that", "we", "intend,", "expect,", "project,", "believe", "or", "anticipate", "and", "similar", "expressions", "or", "future", "conditional", "verbs", "such", "as", "will,", "should,", "would,", "could", "or", "may", "occur", "in", "the", "future", "are", "forward-looking", "statements.", "<tag2>", "This", "will", "provide", "us", "with", "flexibility", "to", "invest", "more", "in", "areas", "of", "higher", "strategic", "importance", "such", "as", "in", "the", "ATHENA", "refractory", "heart", "failure", "trial,", "and", "in", "the", "government", "funded", "activities", "under", "our", "BARDA", "contract.", "<tag3>"], "wordsA": ["All", "statements,", "other", "than", "statements", "of", "historical", "fact,", "that", "address", "activities,", "events", "or", "developments", "that", "we", "intend,", "expect,", "project,", "believe", "or", "anticipate", "and", "similar", "expressions", "or", "future", "conditional", "verbs", "such", "as", "will,", "should,", "would,", "could", "or", "may", "occur", "in", "the", "future", "are", "forward-looking", "statements."], "wordsB": ["This", "will", "provide", "us", "with", "flexibility", "to", "invest", "more", "in", "areas", "of", "higher", "strategic", "importance", "such", "as", "in", "the", "ATHENA", "refractory", "heart", "failure", "trial,", "and", "in", "the", "government", "funded", "activities", "under", "our", "BARDA", "contract."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p67_s0", "idA": "1095981_12_item7_p12_s1", "sentA": "The impact of this reduction along with other sales and marketing costs will result in reduced overall spend in 2012, while maintaining our ability to achieve 2012 growth objectives.", "sentB": "Without this additional capital, cash generated from sales and containment of costs will not provide adequate funding indefinitely at their current levels.", "type": 1, "words": ["<tag1>", "The", "impact", "of", "this", "reduction", "along", "with", "other", "sales", "and", "marketing", "costs", "will", "result", "in", "reduced", "overall", "spend", "in", "2012,", "while", "maintaining", "our", "ability", "to", "achieve", "2012", "growth", "objectives.", "<tag2>", "Without", "this", "additional", "capital,", "cash", "generated", "from", "sales", "and", "containment", "of", "costs", "will", "not", "provide", "adequate", "funding", "indefinitely", "at", "their", "current", "levels.", "<tag3>"], "wordsA": ["The", "impact", "of", "this", "reduction", "along", "with", "other", "sales", "and", "marketing", "costs", "will", "result", "in", "reduced", "overall", "spend", "in", "2012,", "while", "maintaining", "our", "ability", "to", "achieve", "2012", "growth", "objectives."], "wordsB": ["Without", "this", "additional", "capital,", "cash", "generated", "from", "sales", "and", "containment", "of", "costs", "will", "not", "provide", "adequate", "funding", "indefinitely", "at", "their", "current", "levels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p10_s0", "idA": "1095981_12_item7_p13_s3", "sentA": "In 2012, we intend to seek a technology assessment in the UK specific to our Celution System for the RESTORE procedure as a way to both improve healthcare and lower the overall costs for women with breast cancer, which will help support our reimbursement efforts in the UK.", "sentB": "In 2012, we amended our ADVANCE trial and enrolled patients across a small number of European trial centers.", "type": 1, "words": ["<tag1>", "In", "2012,", "we", "intend", "to", "seek", "a", "technology", "assessment", "in", "the", "UK", "specific", "to", "our", "Celution", "System", "for", "the", "RESTORE", "procedure", "as", "a", "way", "to", "both", "improve", "healthcare", "and", "lower", "the", "overall", "costs", "for", "women", "with", "breast", "cancer,", "which", "will", "help", "support", "our", "reimbursement", "efforts", "in", "the", "UK.", "<tag2>", "In", "2012,", "we", "amended", "our", "ADVANCE", "trial", "and", "enrolled", "patients", "across", "a", "small", "number", "of", "European", "trial", "centers.", "<tag3>"], "wordsA": ["In", "2012,", "we", "intend", "to", "seek", "a", "technology", "assessment", "in", "the", "UK", "specific", "to", "our", "Celution", "System", "for", "the", "RESTORE", "procedure", "as", "a", "way", "to", "both", "improve", "healthcare", "and", "lower", "the", "overall", "costs", "for", "women", "with", "breast", "cancer,", "which", "will", "help", "support", "our", "reimbursement", "efforts", "in", "the", "UK."], "wordsB": ["In", "2012,", "we", "amended", "our", "ADVANCE", "trial", "and", "enrolled", "patients", "across", "a", "small", "number", "of", "European", "trial", "centers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p5_s1", "idA": "1095981_12_item7_p15_s2", "sentA": "Due to the platform nature of our technology and products, we are able to simultaneously pursue transactions for multiple indications in core areas like cardiovascular disease and other non-core areas such as liver disease for which Astellas Pharma has negotiation rights.", "sentB": "The early sales of systems, consumables and ancillary products contributes margins that partially offset our operating expenses and play an important strategic role in fostering familiarity within the medical community with our technology and to facilitate the discovery of potential new applications for Cytori s cell therapy by customers conducting investigator-initiated and funded research.", "type": 1, "words": ["<tag1>", "Due", "to", "the", "platform", "nature", "of", "our", "technology", "and", "products,", "we", "are", "able", "to", "simultaneously", "pursue", "transactions", "for", "multiple", "indications", "in", "core", "areas", "like", "cardiovascular", "disease", "and", "other", "non-core", "areas", "such", "as", "liver", "disease", "for", "which", "Astellas", "Pharma", "has", "negotiation", "rights.", "<tag2>", "The", "early", "sales", "of", "systems,", "consumables", "and", "ancillary", "products", "contributes", "margins", "that", "partially", "offset", "our", "operating", "expenses", "and", "play", "an", "important", "strategic", "role", "in", "fostering", "familiarity", "within", "the", "medical", "community", "with", "our", "technology", "and", "to", "facilitate", "the", "discovery", "of", "potential", "new", "applications", "for", "Cytori", "s", "cell", "therapy", "by", "customers", "conducting", "investigator-initiated", "and", "funded", "research.", "<tag3>"], "wordsA": ["Due", "to", "the", "platform", "nature", "of", "our", "technology", "and", "products,", "we", "are", "able", "to", "simultaneously", "pursue", "transactions", "for", "multiple", "indications", "in", "core", "areas", "like", "cardiovascular", "disease", "and", "other", "non-core", "areas", "such", "as", "liver", "disease", "for", "which", "Astellas", "Pharma", "has", "negotiation", "rights."], "wordsB": ["The", "early", "sales", "of", "systems,", "consumables", "and", "ancillary", "products", "contributes", "margins", "that", "partially", "offset", "our", "operating", "expenses", "and", "play", "an", "important", "strategic", "role", "in", "fostering", "familiarity", "within", "the", "medical", "community", "with", "our", "technology", "and", "to", "facilitate", "the", "discovery", "of", "potential", "new", "applications", "for", "Cytori", "s", "cell", "therapy", "by", "customers", "conducting", "investigator-initiated", "and", "funded", "research."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p26_s4", "idA": "1095981_12_item7_p17_s3", "sentA": "We also feel that the multiple opportunities we have in other countries increase the possibility that one or more meaningful markets could open up for Cytori.", "sentB": "We also granted Astellas Pharma Inc.", "type": 1, "words": ["<tag1>", "We", "also", "feel", "that", "the", "multiple", "opportunities", "we", "have", "in", "other", "countries", "increase", "the", "possibility", "that", "one", "or", "more", "meaningful", "markets", "could", "open", "up", "for", "Cytori.", "<tag2>", "We", "also", "granted", "Astellas", "Pharma", "Inc.", "<tag3>"], "wordsA": ["We", "also", "feel", "that", "the", "multiple", "opportunities", "we", "have", "in", "other", "countries", "increase", "the", "possibility", "that", "one", "or", "more", "meaningful", "markets", "could", "open", "up", "for", "Cytori."], "wordsB": ["We", "also", "granted", "Astellas", "Pharma", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p12_s0", "idA": "1095981_12_item7_p21_s0", "sentA": "The Joint Venture currently has exclusive access to our Celution System device technology for the development, manufacture, and supply of such systems to us.", "sentB": "In addition to our cardiovascular disease therapeutic pipeline, Cytori is also developing its cell therapy platform for the treatment of thermal burns combined with radiation injury.", "type": 1, "words": ["<tag1>", "The", "Joint", "Venture", "currently", "has", "exclusive", "access", "to", "our", "Celution", "System", "device", "technology", "for", "the", "development,", "manufacture,", "and", "supply", "of", "such", "systems", "to", "us.", "<tag2>", "In", "addition", "to", "our", "cardiovascular", "disease", "therapeutic", "pipeline,", "Cytori", "is", "also", "developing", "its", "cell", "therapy", "platform", "for", "the", "treatment", "of", "thermal", "burns", "combined", "with", "radiation", "injury.", "<tag3>"], "wordsA": ["The", "Joint", "Venture", "currently", "has", "exclusive", "access", "to", "our", "Celution", "System", "device", "technology", "for", "the", "development,", "manufacture,", "and", "supply", "of", "such", "systems", "to", "us."], "wordsB": ["In", "addition", "to", "our", "cardiovascular", "disease", "therapeutic", "pipeline,", "Cytori", "is", "also", "developing", "its", "cell", "therapy", "platform", "for", "the", "treatment", "of", "thermal", "burns", "combined", "with", "radiation", "injury."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p7_s0", "idA": "1095981_12_item7_p21_s2", "sentA": "We have retained all marketing rights (subject to our various distribution agreements and regulatory rights) to sell the Celution System devices for all therapeutic applications of adipose stem and regenerative cells.", "sentB": "We have also refined our corporate priorities to focus on what we believe represents the greatest near term value to our shareholders with our existing capital resources.", "type": 1, "words": ["<tag1>", "We", "have", "retained", "all", "marketing", "rights", "(subject", "to", "our", "various", "distribution", "agreements", "and", "regulatory", "rights)", "to", "sell", "the", "Celution", "System", "devices", "for", "all", "therapeutic", "applications", "of", "adipose", "stem", "and", "regenerative", "cells.", "<tag2>", "We", "have", "also", "refined", "our", "corporate", "priorities", "to", "focus", "on", "what", "we", "believe", "represents", "the", "greatest", "near", "term", "value", "to", "our", "shareholders", "with", "our", "existing", "capital", "resources.", "<tag3>"], "wordsA": ["We", "have", "retained", "all", "marketing", "rights", "(subject", "to", "our", "various", "distribution", "agreements", "and", "regulatory", "rights)", "to", "sell", "the", "Celution", "System", "devices", "for", "all", "therapeutic", "applications", "of", "adipose", "stem", "and", "regenerative", "cells."], "wordsB": ["We", "have", "also", "refined", "our", "corporate", "priorities", "to", "focus", "on", "what", "we", "believe", "represents", "the", "greatest", "near", "term", "value", "to", "our", "shareholders", "with", "our", "existing", "capital", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p66_s2", "idA": "1095981_12_item7_p30_s0", "sentA": "Shipping and handling costs that are billed to our customers are classified as revenue.", "sentB": "In order to fund operations and our continued commercialization efforts through the next twelve months, we are pursuing additional funding through either strategic corporate partnerships, debt restructuring or future issuances of equity or debt securities in addition to our gross profits.", "type": 1, "words": ["<tag1>", "Shipping", "and", "handling", "costs", "that", "are", "billed", "to", "our", "customers", "are", "classified", "as", "revenue.", "<tag2>", "In", "order", "to", "fund", "operations", "and", "our", "continued", "commercialization", "efforts", "through", "the", "next", "twelve", "months,", "we", "are", "pursuing", "additional", "funding", "through", "either", "strategic", "corporate", "partnerships,", "debt", "restructuring", "or", "future", "issuances", "of", "equity", "or", "debt", "securities", "in", "addition", "to", "our", "gross", "profits.", "<tag3>"], "wordsA": ["Shipping", "and", "handling", "costs", "that", "are", "billed", "to", "our", "customers", "are", "classified", "as", "revenue."], "wordsB": ["In", "order", "to", "fund", "operations", "and", "our", "continued", "commercialization", "efforts", "through", "the", "next", "twelve", "months,", "we", "are", "pursuing", "additional", "funding", "through", "either", "strategic", "corporate", "partnerships,", "debt", "restructuring", "or", "future", "issuances", "of", "equity", "or", "debt", "securities", "in", "addition", "to", "our", "gross", "profits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p10_s3", "idA": "1095981_12_item7_p34_s1", "sentA": "Fluctuation in this percentage is to be expected due to the product mix as well as mix of distributor and direct sales comprising the revenue for the period.", "sentB": "The goal for 2013 is to bring the total ADVANCE enrollment to 25 patients with an interim analysis to be performed after the first 72 patients.", "type": 1, "words": ["<tag1>", "Fluctuation", "in", "this", "percentage", "is", "to", "be", "expected", "due", "to", "the", "product", "mix", "as", "well", "as", "mix", "of", "distributor", "and", "direct", "sales", "comprising", "the", "revenue", "for", "the", "period.", "<tag2>", "The", "goal", "for", "2013", "is", "to", "bring", "the", "total", "ADVANCE", "enrollment", "to", "25", "patients", "with", "an", "interim", "analysis", "to", "be", "performed", "after", "the", "first", "72", "patients.", "<tag3>"], "wordsA": ["Fluctuation", "in", "this", "percentage", "is", "to", "be", "expected", "due", "to", "the", "product", "mix", "as", "well", "as", "mix", "of", "distributor", "and", "direct", "sales", "comprising", "the", "revenue", "for", "the", "period."], "wordsB": ["The", "goal", "for", "2013", "is", "to", "bring", "the", "total", "ADVANCE", "enrollment", "to", "25", "patients", "with", "an", "interim", "analysis", "to", "be", "performed", "after", "the", "first", "72", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p26_s2", "idA": "1095981_12_item7_p36_s0", "sentA": "The following table summarizes the components of our development revenues for the years ended December 31, 2011, 2010 and 2009:", "sentB": "a two year right of first refusal to enter into a development and commercialization collaboration with us regarding the use of our technology, on a worldwide basis, for the treatment of liver conditions.", "type": 1, "words": ["<tag1>", "The", "following", "table", "summarizes", "the", "components", "of", "our", "development", "revenues", "for", "the", "years", "ended", "December", "31,", "2011,", "2010", "and", "2009:", "<tag2>", "a", "two", "year", "right", "of", "first", "refusal", "to", "enter", "into", "a", "development", "and", "commercialization", "collaboration", "with", "us", "regarding", "the", "use", "of", "our", "technology,", "on", "a", "worldwide", "basis,", "for", "the", "treatment", "of", "liver", "conditions.", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "the", "components", "of", "our", "development", "revenues", "for", "the", "years", "ended", "December", "31,", "2011,", "2010", "and", "2009:"], "wordsB": ["a", "two", "year", "right", "of", "first", "refusal", "to", "enter", "into", "a", "development", "and", "commercialization", "collaboration", "with", "us", "regarding", "the", "use", "of", "our", "technology,", "on", "a", "worldwide", "basis,", "for", "the", "treatment", "of", "liver", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p11_s2", "idA": "1095981_12_item7_p41_s1", "sentA": "We are still awaiting regulatory clearance from the MHLW in order for initial commercialization to occur.", "sentB": "Results from the APOLLO trial for acute heart attack demonstrated safety and sustained improvement in infarct size and perfusion.", "type": 1, "words": ["<tag1>", "We", "are", "still", "awaiting", "regulatory", "clearance", "from", "the", "MHLW", "in", "order", "for", "initial", "commercialization", "to", "occur.", "<tag2>", "Results", "from", "the", "APOLLO", "trial", "for", "acute", "heart", "attack", "demonstrated", "safety", "and", "sustained", "improvement", "in", "infarct", "size", "and", "perfusion.", "<tag3>"], "wordsA": ["We", "are", "still", "awaiting", "regulatory", "clearance", "from", "the", "MHLW", "in", "order", "for", "initial", "commercialization", "to", "occur."], "wordsB": ["Results", "from", "the", "APOLLO", "trial", "for", "acute", "heart", "attack", "demonstrated", "safety", "and", "sustained", "improvement", "in", "infarct", "size", "and", "perfusion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p9_s1", "idA": "1095981_12_item7_p41_s4", "sentA": "There can be no assurance given of whether, or when, this regulatory approval might be received to allow us to proceed with commercialization.", "sentB": "The trial will measure several endpoints, including peak oxygen consumption (VO 2 Max).", "type": 1, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "given", "of", "whether,", "or", "when,", "this", "regulatory", "approval", "might", "be", "received", "to", "allow", "us", "to", "proceed", "with", "commercialization.", "<tag2>", "The", "trial", "will", "measure", "several", "endpoints,", "including", "peak", "oxygen", "consumption", "(VO", "2", "Max).", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "given", "of", "whether,", "or", "when,", "this", "regulatory", "approval", "might", "be", "received", "to", "allow", "us", "to", "proceed", "with", "commercialization."], "wordsB": ["The", "trial", "will", "measure", "several", "endpoints,", "including", "peak", "oxygen", "consumption", "(VO", "2", "Max)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p6_s2", "idA": "1095981_12_item7_p42_s0", "sentA": "Research and development expenses include costs associated with the design, development, testing and enhancement of our products, regulatory fees, the purchase of laboratory supplies, pre-clinical studies and clinical studies.", "sentB": "The approval will also allow independent European investigators to conduct their own vascular studies.", "type": 1, "words": ["<tag1>", "Research", "and", "development", "expenses", "include", "costs", "associated", "with", "the", "design,", "development,", "testing", "and", "enhancement", "of", "our", "products,", "regulatory", "fees,", "the", "purchase", "of", "laboratory", "supplies,", "pre-clinical", "studies", "and", "clinical", "studies.", "<tag2>", "The", "approval", "will", "also", "allow", "independent", "European", "investigators", "to", "conduct", "their", "own", "vascular", "studies.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "include", "costs", "associated", "with", "the", "design,", "development,", "testing", "and", "enhancement", "of", "our", "products,", "regulatory", "fees,", "the", "purchase", "of", "laboratory", "supplies,", "pre-clinical", "studies", "and", "clinical", "studies."], "wordsB": ["The", "approval", "will", "also", "allow", "independent", "European", "investigators", "to", "conduct", "their", "own", "vascular", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p13_s1", "idA": "1095981_12_item7_p43_s1", "sentA": "These expenses, in conjunction with continued development efforts related to our Celution System, result primarily from the broad expansion of our research and development efforts enabled by the funding we received from Olympus in 2005 and 2006 and from other investors during the last few years.", "sentB": "The initial base period includes $4.7 million over two years and covers preclinical research and continued development of Cytori s Celution System to improve cell processing.", "type": 1, "words": ["<tag1>", "These", "expenses,", "in", "conjunction", "with", "continued", "development", "efforts", "related", "to", "our", "Celution", "System,", "result", "primarily", "from", "the", "broad", "expansion", "of", "our", "research", "and", "development", "efforts", "enabled", "by", "the", "funding", "we", "received", "from", "Olympus", "in", "2005", "and", "2006", "and", "from", "other", "investors", "during", "the", "last", "few", "years.", "<tag2>", "The", "initial", "base", "period", "includes", "$4.7", "million", "over", "two", "years", "and", "covers", "preclinical", "research", "and", "continued", "development", "of", "Cytori", "s", "Celution", "System", "to", "improve", "cell", "processing.", "<tag3>"], "wordsA": ["These", "expenses,", "in", "conjunction", "with", "continued", "development", "efforts", "related", "to", "our", "Celution", "System,", "result", "primarily", "from", "the", "broad", "expansion", "of", "our", "research", "and", "development", "efforts", "enabled", "by", "the", "funding", "we", "received", "from", "Olympus", "in", "2005", "and", "2006", "and", "from", "other", "investors", "during", "the", "last", "few", "years."], "wordsB": ["The", "initial", "base", "period", "includes", "$4.7", "million", "over", "two", "years", "and", "covers", "preclinical", "research", "and", "continued", "development", "of", "Cytori", "s", "Celution", "System", "to", "improve", "cell", "processing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p27_s1", "idA": "1095981_12_item7_p43_s1", "sentA": "These expenses, in conjunction with continued development efforts related to our Celution System, result primarily from the broad expansion of our research and development efforts enabled by the funding we received from Olympus in 2005 and 2006 and from other investors during the last few years.", "sentB": "The initial base period includes $4.7 million over two years and covers preclinical research and continued development of Cytori s Celution system to improve cell processing.", "type": 1, "words": ["<tag1>", "These", "expenses,", "in", "conjunction", "with", "continued", "development", "efforts", "related", "to", "our", "Celution", "System,", "result", "primarily", "from", "the", "broad", "expansion", "of", "our", "research", "and", "development", "efforts", "enabled", "by", "the", "funding", "we", "received", "from", "Olympus", "in", "2005", "and", "2006", "and", "from", "other", "investors", "during", "the", "last", "few", "years.", "<tag2>", "The", "initial", "base", "period", "includes", "$4.7", "million", "over", "two", "years", "and", "covers", "preclinical", "research", "and", "continued", "development", "of", "Cytori", "s", "Celution", "system", "to", "improve", "cell", "processing.", "<tag3>"], "wordsA": ["These", "expenses,", "in", "conjunction", "with", "continued", "development", "efforts", "related", "to", "our", "Celution", "System,", "result", "primarily", "from", "the", "broad", "expansion", "of", "our", "research", "and", "development", "efforts", "enabled", "by", "the", "funding", "we", "received", "from", "Olympus", "in", "2005", "and", "2006", "and", "from", "other", "investors", "during", "the", "last", "few", "years."], "wordsB": ["The", "initial", "base", "period", "includes", "$4.7", "million", "over", "two", "years", "and", "covers", "preclinical", "research", "and", "continued", "development", "of", "Cytori", "s", "Celution", "system", "to", "improve", "cell", "processing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p4_s3", "idA": "1095981_12_item7_p47_s0", "sentA": "The costs associated with the development of the device were comprised of labor and related benefits, consulting and other professional services, supplies and other miscellaneous expenses.", "sentB": "The system is comprised of a central device and requires single-use, per-procedure consumable cartridges.", "type": 1, "words": ["<tag1>", "The", "costs", "associated", "with", "the", "development", "of", "the", "device", "were", "comprised", "of", "labor", "and", "related", "benefits,", "consulting", "and", "other", "professional", "services,", "supplies", "and", "other", "miscellaneous", "expenses.", "<tag2>", "The", "system", "is", "comprised", "of", "a", "central", "device", "and", "requires", "single-use,", "per-procedure", "consumable", "cartridges.", "<tag3>"], "wordsA": ["The", "costs", "associated", "with", "the", "development", "of", "the", "device", "were", "comprised", "of", "labor", "and", "related", "benefits,", "consulting", "and", "other", "professional", "services,", "supplies", "and", "other", "miscellaneous", "expenses."], "wordsB": ["The", "system", "is", "comprised", "of", "a", "central", "device", "and", "requires", "single-use,", "per-procedure", "consumable", "cartridges."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p27_s2", "idA": "1095981_12_item7_p6_s0", "sentA": "The primary therapeutic area within our clinical development pipeline is cardiovascular disease.", "sentB": "The additional contract options, if fully executed, could cover clinical development through FDA approval under a device-based PMA regulatory pathway.", "type": 1, "words": ["<tag1>", "The", "primary", "therapeutic", "area", "within", "our", "clinical", "development", "pipeline", "is", "cardiovascular", "disease.", "<tag2>", "The", "additional", "contract", "options,", "if", "fully", "executed,", "could", "cover", "clinical", "development", "through", "FDA", "approval", "under", "a", "device-based", "PMA", "regulatory", "pathway.", "<tag3>"], "wordsA": ["The", "primary", "therapeutic", "area", "within", "our", "clinical", "development", "pipeline", "is", "cardiovascular", "disease."], "wordsB": ["The", "additional", "contract", "options,", "if", "fully", "executed,", "could", "cover", "clinical", "development", "through", "FDA", "approval", "under", "a", "device-based", "PMA", "regulatory", "pathway."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p19_s2", "idA": "1095981_12_item7_p7_s1", "sentA": "Enrollment is expected to begin in the second quarter of 2012 and be completed within 12 to 18 months.", "sentB": "This clearance is expected to facilitate sales growth in Japan and it is anticipated that demand will come mostly from researchers at academic hospitals seeking to perform investigator-initiated and funded studies using Cytori s cell therapy.", "type": 1, "words": ["<tag1>", "Enrollment", "is", "expected", "to", "begin", "in", "the", "second", "quarter", "of", "2012", "and", "be", "completed", "within", "12", "to", "18", "months.", "<tag2>", "This", "clearance", "is", "expected", "to", "facilitate", "sales", "growth", "in", "Japan", "and", "it", "is", "anticipated", "that", "demand", "will", "come", "mostly", "from", "researchers", "at", "academic", "hospitals", "seeking", "to", "perform", "investigator-initiated", "and", "funded", "studies", "using", "Cytori", "s", "cell", "therapy.", "<tag3>"], "wordsA": ["Enrollment", "is", "expected", "to", "begin", "in", "the", "second", "quarter", "of", "2012", "and", "be", "completed", "within", "12", "to", "18", "months."], "wordsB": ["This", "clearance", "is", "expected", "to", "facilitate", "sales", "growth", "in", "Japan", "and", "it", "is", "anticipated", "that", "demand", "will", "come", "mostly", "from", "researchers", "at", "academic", "hospitals", "seeking", "to", "perform", "investigator-initiated", "and", "funded", "studies", "using", "Cytori", "s", "cell", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p9_s2", "idA": "1095981_12_item7_p7_s1", "sentA": "Enrollment is expected to begin in the second quarter of 2012 and be completed within 12 to 18 months.", "sentB": "Additional endpoints include perfusion defect, left ventricle end-systolic and diastolic volume and ejection fraction at six and 12 months.", "type": 1, "words": ["<tag1>", "Enrollment", "is", "expected", "to", "begin", "in", "the", "second", "quarter", "of", "2012", "and", "be", "completed", "within", "12", "to", "18", "months.", "<tag2>", "Additional", "endpoints", "include", "perfusion", "defect,", "left", "ventricle", "end-systolic", "and", "diastolic", "volume", "and", "ejection", "fraction", "at", "six", "and", "12", "months.", "<tag3>"], "wordsA": ["Enrollment", "is", "expected", "to", "begin", "in", "the", "second", "quarter", "of", "2012", "and", "be", "completed", "within", "12", "to", "18", "months."], "wordsB": ["Additional", "endpoints", "include", "perfusion", "defect,", "left", "ventricle", "end-systolic", "and", "diastolic", "volume", "and", "ejection", "fraction", "at", "six", "and", "12", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p10_s2", "idA": "1095981_12_item7_p8_s0", "sentA": "In our ADVANCE trial, we are amending our European clinical protocol to conform to the evolving country-specific regulatory policies for good manufacturing practices for the control of the cell output from our technology.", "sentB": "In light of the required resources to complete enrollment in an accelerated fashion and competing corporate priorities at this time, we are only prepared to commit a minimal level of investment in ADVANCE for 2013.", "type": 1, "words": ["<tag1>", "In", "our", "ADVANCE", "trial,", "we", "are", "amending", "our", "European", "clinical", "protocol", "to", "conform", "to", "the", "evolving", "country-specific", "regulatory", "policies", "for", "good", "manufacturing", "practices", "for", "the", "control", "of", "the", "cell", "output", "from", "our", "technology.", "<tag2>", "In", "light", "of", "the", "required", "resources", "to", "complete", "enrollment", "in", "an", "accelerated", "fashion", "and", "competing", "corporate", "priorities", "at", "this", "time,", "we", "are", "only", "prepared", "to", "commit", "a", "minimal", "level", "of", "investment", "in", "ADVANCE", "for", "2013.", "<tag3>"], "wordsA": ["In", "our", "ADVANCE", "trial,", "we", "are", "amending", "our", "European", "clinical", "protocol", "to", "conform", "to", "the", "evolving", "country-specific", "regulatory", "policies", "for", "good", "manufacturing", "practices", "for", "the", "control", "of", "the", "cell", "output", "from", "our", "technology."], "wordsB": ["In", "light", "of", "the", "required", "resources", "to", "complete", "enrollment", "in", "an", "accelerated", "fashion", "and", "competing", "corporate", "priorities", "at", "this", "time,", "we", "are", "only", "prepared", "to", "commit", "a", "minimal", "level", "of", "investment", "in", "ADVANCE", "for", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p4_s1", "idA": "1095981_12_item7_p91_s0", "sentA": "The following is a summary of our key liquidity measures at December 31, 2011 and 2010:", "sentB": "Adipose tissue is a rich and accessible source of ADRCs.", "type": 1, "words": ["<tag1>", "The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2011", "and", "2010:", "<tag2>", "Adipose", "tissue", "is", "a", "rich", "and", "accessible", "source", "of", "ADRCs.", "<tag3>"], "wordsA": ["The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2011", "and", "2010:"], "wordsB": ["Adipose", "tissue", "is", "a", "rich", "and", "accessible", "source", "of", "ADRCs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p26_s8", "idA": "1095981_12_item7_p97_s0", "sentA": "In July 2011, we entered into a common stock purchase agreement with Seaside 88, LP relating to the offering and sale of a total of up to 6,326,262 shares of our common stock.", "sentB": "This difference was recorded as deferred revenue since, conceptually, the excess proceeds represent a value paid by Astellas Pharma Inc. attributable to the scientific advisory board seat, the non-voting observer seat on our Board of Directors, and the two year right of first refusal to enter into a development and commercialization collaboration with us regarding the use of our technology, on a worldwide basis, for the treatment of liver conditions, rather than an additional equity investment in Cytori.", "type": 1, "words": ["<tag1>", "In", "July", "2011,", "we", "entered", "into", "a", "common", "stock", "purchase", "agreement", "with", "Seaside", "88,", "LP", "relating", "to", "the", "offering", "and", "sale", "of", "a", "total", "of", "up", "to", "6,326,262", "shares", "of", "our", "common", "stock.", "<tag2>", "This", "difference", "was", "recorded", "as", "deferred", "revenue", "since,", "conceptually,", "the", "excess", "proceeds", "represent", "a", "value", "paid", "by", "Astellas", "Pharma", "Inc.", "attributable", "to", "the", "scientific", "advisory", "board", "seat,", "the", "non-voting", "observer", "seat", "on", "our", "Board", "of", "Directors,", "and", "the", "two", "year", "right", "of", "first", "refusal", "to", "enter", "into", "a", "development", "and", "commercialization", "collaboration", "with", "us", "regarding", "the", "use", "of", "our", "technology,", "on", "a", "worldwide", "basis,", "for", "the", "treatment", "of", "liver", "conditions,", "rather", "than", "an", "additional", "equity", "investment", "in", "Cytori.", "<tag3>"], "wordsA": ["In", "July", "2011,", "we", "entered", "into", "a", "common", "stock", "purchase", "agreement", "with", "Seaside", "88,", "LP", "relating", "to", "the", "offering", "and", "sale", "of", "a", "total", "of", "up", "to", "6,326,262", "shares", "of", "our", "common", "stock."], "wordsB": ["This", "difference", "was", "recorded", "as", "deferred", "revenue", "since,", "conceptually,", "the", "excess", "proceeds", "represent", "a", "value", "paid", "by", "Astellas", "Pharma", "Inc.", "attributable", "to", "the", "scientific", "advisory", "board", "seat,", "the", "non-voting", "observer", "seat", "on", "our", "Board", "of", "Directors,", "and", "the", "two", "year", "right", "of", "first", "refusal", "to", "enter", "into", "a", "development", "and", "commercialization", "collaboration", "with", "us", "regarding", "the", "use", "of", "our", "technology,", "on", "a", "worldwide", "basis,", "for", "the", "treatment", "of", "liver", "conditions,", "rather", "than", "an", "additional", "equity", "investment", "in", "Cytori."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p72_s2", "idA": "1095981_12_item7_p97_s2", "sentA": "At the initial closing, the offering price was $4.52, which equaled to 88% of our common stock s volume-weighted average trading prices, or VWAP, during the ten-day trading period immediately prior to the initial closing date, raising approximately $6,000,000 in gross proceeds.", "sentB": "The transaction was completed on December 19, 2012 raising approximately $20,007,000 in gross proceeds before deducting underwriting discounts and commissions and other offering expenses payable by us.", "type": 1, "words": ["<tag1>", "At", "the", "initial", "closing,", "the", "offering", "price", "was", "$4.52,", "which", "equaled", "to", "88%", "of", "our", "common", "stock", "s", "volume-weighted", "average", "trading", "prices,", "or", "VWAP,", "during", "the", "ten-day", "trading", "period", "immediately", "prior", "to", "the", "initial", "closing", "date,", "raising", "approximately", "$6,000,000", "in", "gross", "proceeds.", "<tag2>", "The", "transaction", "was", "completed", "on", "December", "19,", "2012", "raising", "approximately", "$20,007,000", "in", "gross", "proceeds", "before", "deducting", "underwriting", "discounts", "and", "commissions", "and", "other", "offering", "expenses", "payable", "by", "us.", "<tag3>"], "wordsA": ["At", "the", "initial", "closing,", "the", "offering", "price", "was", "$4.52,", "which", "equaled", "to", "88%", "of", "our", "common", "stock", "s", "volume-weighted", "average", "trading", "prices,", "or", "VWAP,", "during", "the", "ten-day", "trading", "period", "immediately", "prior", "to", "the", "initial", "closing", "date,", "raising", "approximately", "$6,000,000", "in", "gross", "proceeds."], "wordsB": ["The", "transaction", "was", "completed", "on", "December", "19,", "2012", "raising", "approximately", "$20,007,000", "in", "gross", "proceeds", "before", "deducting", "underwriting", "discounts", "and", "commissions", "and", "other", "offering", "expenses", "payable", "by", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item7_p26_s5", "idA": "1095981_12_item7_p99_s0", "sentA": "The following summarizes our contractual obligations and other commitments at December 31, 2011, and the effect such obligations could have on our liquidity and cash flow in future periods:", "sentB": "a non-voting observer seat on our Board of Directors and the right to designate a representative member to our Scientific Advisory Board.", "type": 1, "words": ["<tag1>", "The", "following", "summarizes", "our", "contractual", "obligations", "and", "other", "commitments", "at", "December", "31,", "2011,", "and", "the", "effect", "such", "obligations", "could", "have", "on", "our", "liquidity", "and", "cash", "flow", "in", "future", "periods:", "<tag2>", "a", "non-voting", "observer", "seat", "on", "our", "Board", "of", "Directors", "and", "the", "right", "to", "designate", "a", "representative", "member", "to", "our", "Scientific", "Advisory", "Board.", "<tag3>"], "wordsA": ["The", "following", "summarizes", "our", "contractual", "obligations", "and", "other", "commitments", "at", "December", "31,", "2011,", "and", "the", "effect", "such", "obligations", "could", "have", "on", "our", "liquidity", "and", "cash", "flow", "in", "future", "periods:"], "wordsB": ["a", "non-voting", "observer", "seat", "on", "our", "Board", "of", "Directors", "and", "the", "right", "to", "designate", "a", "representative", "member", "to", "our", "Scientific", "Advisory", "Board."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p5_s1", "idA": "1095981_13_item7_p26_s3", "sentA": "In addition, we have agreed to use reasonable efforts to file a registration statement with the Securities and Exchange Commission to register the shares of common stock for resale upon the request of Astellas Pharma Inc.", "sentB": "In addition, we also received approval from the FDA to expand the ATHENA program to include a higher cell dose.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "have", "agreed", "to", "use", "reasonable", "efforts", "to", "file", "a", "registration", "statement", "with", "the", "Securities", "and", "Exchange", "Commission", "to", "register", "the", "shares", "of", "common", "stock", "for", "resale", "upon", "the", "request", "of", "Astellas", "Pharma", "Inc.", "<tag2>", "In", "addition,", "we", "also", "received", "approval", "from", "the", "FDA", "to", "expand", "the", "ATHENA", "program", "to", "include", "a", "higher", "cell", "dose.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "agreed", "to", "use", "reasonable", "efforts", "to", "file", "a", "registration", "statement", "with", "the", "Securities", "and", "Exchange", "Commission", "to", "register", "the", "shares", "of", "common", "stock", "for", "resale", "upon", "the", "request", "of", "Astellas", "Pharma", "Inc."], "wordsB": ["In", "addition,", "we", "also", "received", "approval", "from", "the", "FDA", "to", "expand", "the", "ATHENA", "program", "to", "include", "a", "higher", "cell", "dose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p63_s0", "idA": "1095981_13_item7_p26_s4", "sentA": "We also granted Astellas Pharma Inc.", "sentB": "d e f a ult und e r th e l oa n ag r ee m e nt .", "type": 1, "words": ["<tag1>", "We", "also", "granted", "Astellas", "Pharma", "Inc.", "<tag2>", "d", "e", "f", "a", "ult", "und", "e", "r", "th", "e", "l", "oa", "n", "ag", "r", "ee", "m", "e", "nt", ".", "<tag3>"], "wordsA": ["We", "also", "granted", "Astellas", "Pharma", "Inc."], "wordsB": ["d", "e", "f", "a", "ult", "und", "e", "r", "th", "e", "l", "oa", "n", "ag", "r", "ee", "m", "e", "nt", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p63_s1", "idA": "1095981_13_item7_p26_s4", "sentA": "We also granted Astellas Pharma Inc.", "sentB": "o ur g ross profit s.", "type": 1, "words": ["<tag1>", "We", "also", "granted", "Astellas", "Pharma", "Inc.", "<tag2>", "o", "ur", "g", "ross", "profit", "s.", "<tag3>"], "wordsA": ["We", "also", "granted", "Astellas", "Pharma", "Inc."], "wordsB": ["o", "ur", "g", "ross", "profit", "s."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p63_s2", "idA": "1095981_13_item7_p26_s4", "sentA": "We also granted Astellas Pharma Inc.", "sentB": "rp o r a t e goa l s.", "type": 1, "words": ["<tag1>", "We", "also", "granted", "Astellas", "Pharma", "Inc.", "<tag2>", "rp", "o", "r", "a", "t", "e", "goa", "l", "s.", "<tag3>"], "wordsA": ["We", "also", "granted", "Astellas", "Pharma", "Inc."], "wordsB": ["rp", "o", "r", "a", "t", "e", "goa", "l", "s."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p75_s3", "idA": "1095981_13_item7_p26_s6", "sentA": "The $10,000,000 in total proceeds we received exceeded the market value of our stock at the completion of the purchase agreement.", "sentB": "In addition, Lorem is required to pay us 30% of their gross profits in China, Hong Kong and Malaysia for the term of the agreement.", "type": 1, "words": ["<tag1>", "The", "$10,000,000", "in", "total", "proceeds", "we", "received", "exceeded", "the", "market", "value", "of", "our", "stock", "at", "the", "completion", "of", "the", "purchase", "agreement.", "<tag2>", "In", "addition,", "Lorem", "is", "required", "to", "pay", "us", "30%", "of", "their", "gross", "profits", "in", "China,", "Hong", "Kong", "and", "Malaysia", "for", "the", "term", "of", "the", "agreement.", "<tag3>"], "wordsA": ["The", "$10,000,000", "in", "total", "proceeds", "we", "received", "exceeded", "the", "market", "value", "of", "our", "stock", "at", "the", "completion", "of", "the", "purchase", "agreement."], "wordsB": ["In", "addition,", "Lorem", "is", "required", "to", "pay", "us", "30%", "of", "their", "gross", "profits", "in", "China,", "Hong", "Kong", "and", "Malaysia", "for", "the", "term", "of", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p5_s2", "idA": "1095981_13_item7_p27_s0", "sentA": "In the third quarter of 2012, we were awarded a contract to develop a new countermeasure for thermal burns valued at up to $106 million with U.S. Department of Health and Human Service s Biomedical Advanced Research and Development Authority (BARDA).", "sentB": "This trial, ATHENA II, will enroll 45 patients at up to 10 centers, including most of the centers in ATHENA I and will begin enrolling in the first quarter of 2014.", "type": 1, "words": ["<tag1>", "In", "the", "third", "quarter", "of", "2012,", "we", "were", "awarded", "a", "contract", "to", "develop", "a", "new", "countermeasure", "for", "thermal", "burns", "valued", "at", "up", "to", "$106", "million", "with", "U.S.", "Department", "of", "Health", "and", "Human", "Service", "s", "Biomedical", "Advanced", "Research", "and", "Development", "Authority", "(BARDA).", "<tag2>", "This", "trial,", "ATHENA", "II,", "will", "enroll", "45", "patients", "at", "up", "to", "10", "centers,", "including", "most", "of", "the", "centers", "in", "ATHENA", "I", "and", "will", "begin", "enrolling", "in", "the", "first", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["In", "the", "third", "quarter", "of", "2012,", "we", "were", "awarded", "a", "contract", "to", "develop", "a", "new", "countermeasure", "for", "thermal", "burns", "valued", "at", "up", "to", "$106", "million", "with", "U.S.", "Department", "of", "Health", "and", "Human", "Service", "s", "Biomedical", "Advanced", "Research", "and", "Development", "Authority", "(BARDA)."], "wordsB": ["This", "trial,", "ATHENA", "II,", "will", "enroll", "45", "patients", "at", "up", "to", "10", "centers,", "including", "most", "of", "the", "centers", "in", "ATHENA", "I", "and", "will", "begin", "enrolling", "in", "the", "first", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p76_s3", "idA": "1095981_13_item7_p29_s3", "sentA": "We elected to receive a cash grant and the funds were received during late 2010.", "sentB": "The Equity purchased was closed in two installments, the first in November 2013, and the second in January 2014.", "type": 1, "words": ["<tag1>", "We", "elected", "to", "receive", "a", "cash", "grant", "and", "the", "funds", "were", "received", "during", "late", "2010.", "<tag2>", "The", "Equity", "purchased", "was", "closed", "in", "two", "installments,", "the", "first", "in", "November", "2013,", "and", "the", "second", "in", "January", "2014.", "<tag3>"], "wordsA": ["We", "elected", "to", "receive", "a", "cash", "grant", "and", "the", "funds", "were", "received", "during", "late", "2010."], "wordsB": ["The", "Equity", "purchased", "was", "closed", "in", "two", "installments,", "the", "first", "in", "November", "2013,", "and", "the", "second", "in", "January", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p64_s0", "idA": "1095981_13_item7_p37_s0", "sentA": "The future : We expect research and development expenditures to increase in 2013 as we continue enrollment in our US trial ATHENA, limited enrollment in the ADVANCE cardiac trial, continue development work under our BARDA contract, and as we seek additional regulatory clearances and potentially seek to initiate additional trials or patient registries during 2013.", "sentB": "The Company continues to seek additional capital through product revenues, strategic transactions, including extension opportunities under the awarded BARDA contract, and from other financing alternatives.", "type": 1, "words": ["<tag1>", "The", "future", ":", "We", "expect", "research", "and", "development", "expenditures", "to", "increase", "in", "2013", "as", "we", "continue", "enrollment", "in", "our", "US", "trial", "ATHENA,", "limited", "enrollment", "in", "the", "ADVANCE", "cardiac", "trial,", "continue", "development", "work", "under", "our", "BARDA", "contract,", "and", "as", "we", "seek", "additional", "regulatory", "clearances", "and", "potentially", "seek", "to", "initiate", "additional", "trials", "or", "patient", "registries", "during", "2013.", "<tag2>", "The", "Company", "continues", "to", "seek", "additional", "capital", "through", "product", "revenues,", "strategic", "transactions,", "including", "extension", "opportunities", "under", "the", "awarded", "BARDA", "contract,", "and", "from", "other", "financing", "alternatives.", "<tag3>"], "wordsA": ["The", "future", ":", "We", "expect", "research", "and", "development", "expenditures", "to", "increase", "in", "2013", "as", "we", "continue", "enrollment", "in", "our", "US", "trial", "ATHENA,", "limited", "enrollment", "in", "the", "ADVANCE", "cardiac", "trial,", "continue", "development", "work", "under", "our", "BARDA", "contract,", "and", "as", "we", "seek", "additional", "regulatory", "clearances", "and", "potentially", "seek", "to", "initiate", "additional", "trials", "or", "patient", "registries", "during", "2013."], "wordsB": ["The", "Company", "continues", "to", "seek", "additional", "capital", "through", "product", "revenues,", "strategic", "transactions,", "including", "extension", "opportunities", "under", "the", "awarded", "BARDA", "contract,", "and", "from", "other", "financing", "alternatives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p72_s3", "idA": "1095981_13_item7_p53_s0", "sentA": "The future: Future changes in the fair value of the warrant liability will be recognized currently in earnings until such time as the warrants are exercised or expire in August 2013.", "sentB": "These warrants are immediately exercisable and will expire on June 28, 2020.", "type": 1, "words": ["<tag1>", "The", "future:", "Future", "changes", "in", "the", "fair", "value", "of", "the", "warrant", "liability", "will", "be", "recognized", "currently", "in", "earnings", "until", "such", "time", "as", "the", "warrants", "are", "exercised", "or", "expire", "in", "August", "2013.", "<tag2>", "These", "warrants", "are", "immediately", "exercisable", "and", "will", "expire", "on", "June", "28,", "2020.", "<tag3>"], "wordsA": ["The", "future:", "Future", "changes", "in", "the", "fair", "value", "of", "the", "warrant", "liability", "will", "be", "recognized", "currently", "in", "earnings", "until", "such", "time", "as", "the", "warrants", "are", "exercised", "or", "expire", "in", "August", "2013."], "wordsB": ["These", "warrants", "are", "immediately", "exercisable", "and", "will", "expire", "on", "June", "28,", "2020."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p72_s1", "idA": "1095981_13_item7_p69_s1", "sentA": "This price to the public in this offering was $4.50 per share and Jefferies agreed to purchase the shares from us at a price of $4.23 per share.", "sentB": "The Term Loan accrues interest at a fixed rate of 9.75% per annum.", "type": 1, "words": ["<tag1>", "This", "price", "to", "the", "public", "in", "this", "offering", "was", "$4.50", "per", "share", "and", "Jefferies", "agreed", "to", "purchase", "the", "shares", "from", "us", "at", "a", "price", "of", "$4.23", "per", "share.", "<tag2>", "The", "Term", "Loan", "accrues", "interest", "at", "a", "fixed", "rate", "of", "9.75%", "per", "annum.", "<tag3>"], "wordsA": ["This", "price", "to", "the", "public", "in", "this", "offering", "was", "$4.50", "per", "share", "and", "Jefferies", "agreed", "to", "purchase", "the", "shares", "from", "us", "at", "a", "price", "of", "$4.23", "per", "share."], "wordsB": ["The", "Term", "Loan", "accrues", "interest", "at", "a", "fixed", "rate", "of", "9.75%", "per", "annum."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p75_s0", "idA": "1095981_13_item7_p70_s0", "sentA": "In July 2011, we entered into a common stock purchase agreement with Seaside 88, LP relating to the offering and sale of a total of up to 6,326,262 shares of our common stock.", "sentB": "On October 29, 2013, we entered into a partnership with Lorem Vascular, to commercialize Cytori Cell Therapy for the cardiovascular, renal and diabetes markets, in China, Hong Kong, Malaysia, Singapore and Australia (License/Supply Agreement), and a Common Stock Purchase Agreement.", "type": 1, "words": ["<tag1>", "In", "July", "2011,", "we", "entered", "into", "a", "common", "stock", "purchase", "agreement", "with", "Seaside", "88,", "LP", "relating", "to", "the", "offering", "and", "sale", "of", "a", "total", "of", "up", "to", "6,326,262", "shares", "of", "our", "common", "stock.", "<tag2>", "On", "October", "29,", "2013,", "we", "entered", "into", "a", "partnership", "with", "Lorem", "Vascular,", "to", "commercialize", "Cytori", "Cell", "Therapy", "for", "the", "cardiovascular,", "renal", "and", "diabetes", "markets,", "in", "China,", "Hong", "Kong,", "Malaysia,", "Singapore", "and", "Australia", "(License/Supply", "Agreement),", "and", "a", "Common", "Stock", "Purchase", "Agreement.", "<tag3>"], "wordsA": ["In", "July", "2011,", "we", "entered", "into", "a", "common", "stock", "purchase", "agreement", "with", "Seaside", "88,", "LP", "relating", "to", "the", "offering", "and", "sale", "of", "a", "total", "of", "up", "to", "6,326,262", "shares", "of", "our", "common", "stock."], "wordsB": ["On", "October", "29,", "2013,", "we", "entered", "into", "a", "partnership", "with", "Lorem", "Vascular,", "to", "commercialize", "Cytori", "Cell", "Therapy", "for", "the", "cardiovascular,", "renal", "and", "diabetes", "markets,", "in", "China,", "Hong", "Kong,", "Malaysia,", "Singapore", "and", "Australia", "(License/Supply", "Agreement),", "and", "a", "Common", "Stock", "Purchase", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p73_s0", "idA": "1095981_13_item7_p71_s0", "sentA": "In September 2011, we entered into an Second Amendment to the Amended and Restated Loan and Security Agreement with the GECC, SVB, and Oxford Finance Corporation (Lenders), pursuant to which the Lenders increased the prior term loan made to the Company to a principal amount of $25.0 million.", "sentB": "In connection with the Loan Agreement, we prepaid all outstanding amounts under the prior loan agreement, at which time the Company s obligations under the prior loan agreement immediately terminated.", "type": 1, "words": ["<tag1>", "In", "September", "2011,", "we", "entered", "into", "an", "Second", "Amendment", "to", "the", "Amended", "and", "Restated", "Loan", "and", "Security", "Agreement", "with", "the", "GECC,", "SVB,", "and", "Oxford", "Finance", "Corporation", "(Lenders),", "pursuant", "to", "which", "the", "Lenders", "increased", "the", "prior", "term", "loan", "made", "to", "the", "Company", "to", "a", "principal", "amount", "of", "$25.0", "million.", "<tag2>", "In", "connection", "with", "the", "Loan", "Agreement,", "we", "prepaid", "all", "outstanding", "amounts", "under", "the", "prior", "loan", "agreement,", "at", "which", "time", "the", "Company", "s", "obligations", "under", "the", "prior", "loan", "agreement", "immediately", "terminated.", "<tag3>"], "wordsA": ["In", "September", "2011,", "we", "entered", "into", "an", "Second", "Amendment", "to", "the", "Amended", "and", "Restated", "Loan", "and", "Security", "Agreement", "with", "the", "GECC,", "SVB,", "and", "Oxford", "Finance", "Corporation", "(Lenders),", "pursuant", "to", "which", "the", "Lenders", "increased", "the", "prior", "term", "loan", "made", "to", "the", "Company", "to", "a", "principal", "amount", "of", "$25.0", "million."], "wordsB": ["In", "connection", "with", "the", "Loan", "Agreement,", "we", "prepaid", "all", "outstanding", "amounts", "under", "the", "prior", "loan", "agreement,", "at", "which", "time", "the", "Company", "s", "obligations", "under", "the", "prior", "loan", "agreement", "immediately", "terminated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p9_s4", "idA": "1095981_13_item7_p7_s0", "sentA": "We have also refined our corporate priorities to focus on what we believe represents the greatest near term value to our shareholders with our existing capital resources.", "sentB": "We have also received FDA approval in late 2013 to conduct a safety and feasibility clinical trial in patients with acute hamstring tears in order to evaluate the effect of Cytori Cell Therapy on healing in muscle injury.", "type": 1, "words": ["<tag1>", "We", "have", "also", "refined", "our", "corporate", "priorities", "to", "focus", "on", "what", "we", "believe", "represents", "the", "greatest", "near", "term", "value", "to", "our", "shareholders", "with", "our", "existing", "capital", "resources.", "<tag2>", "We", "have", "also", "received", "FDA", "approval", "in", "late", "2013", "to", "conduct", "a", "safety", "and", "feasibility", "clinical", "trial", "in", "patients", "with", "acute", "hamstring", "tears", "in", "order", "to", "evaluate", "the", "effect", "of", "Cytori", "Cell", "Therapy", "on", "healing", "in", "muscle", "injury.", "<tag3>"], "wordsA": ["We", "have", "also", "refined", "our", "corporate", "priorities", "to", "focus", "on", "what", "we", "believe", "represents", "the", "greatest", "near", "term", "value", "to", "our", "shareholders", "with", "our", "existing", "capital", "resources."], "wordsB": ["We", "have", "also", "received", "FDA", "approval", "in", "late", "2013", "to", "conduct", "a", "safety", "and", "feasibility", "clinical", "trial", "in", "patients", "with", "acute", "hamstring", "tears", "in", "order", "to", "evaluate", "the", "effect", "of", "Cytori", "Cell", "Therapy", "on", "healing", "in", "muscle", "injury."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item7_p75_s2", "idA": "1095981_13_item7_p87_s0", "sentA": "See Notes to Consolidated Condensed Financial Statements included elsewhere herein for disclosure and discussion of revenue recognition.", "sentB": "Under the Restated Agreement, Lorem Vascular committed to pay up to $500 million in license fees in the form of revenue milestones.", "type": 1, "words": ["<tag1>", "See", "Notes", "to", "Consolidated", "Condensed", "Financial", "Statements", "included", "elsewhere", "herein", "for", "disclosure", "and", "discussion", "of", "revenue", "recognition.", "<tag2>", "Under", "the", "Restated", "Agreement,", "Lorem", "Vascular", "committed", "to", "pay", "up", "to", "$500", "million", "in", "license", "fees", "in", "the", "form", "of", "revenue", "milestones.", "<tag3>"], "wordsA": ["See", "Notes", "to", "Consolidated", "Condensed", "Financial", "Statements", "included", "elsewhere", "herein", "for", "disclosure", "and", "discussion", "of", "revenue", "recognition."], "wordsB": ["Under", "the", "Restated", "Agreement,", "Lorem", "Vascular", "committed", "to", "pay", "up", "to", "$500", "million", "in", "license", "fees", "in", "the", "form", "of", "revenue", "milestones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p11_s3", "idA": "1095981_14_item7_p0_s1", "sentA": "In the U.S. our goal is to bring Cytori Cell Therapy to market for treatment of heart failure due to ischemic heart disease through Cytori-sponsored clinical development efforts and to develop a treatment for thermal burns combined with radiation injury under a contract from BARDA, a division of the U.S. Department of Health and Human Services.", "sentB": "Once the pilot trial is analyzed, the final phase would include research, regulatory, and clinical activities necessary to achieve regulatory clearances to optimize a treatment for combined injury involving thermal burn and radiation exposure.", "type": 1, "words": ["<tag1>", "In", "the", "U.S.", "our", "goal", "is", "to", "bring", "Cytori", "Cell", "Therapy", "to", "market", "for", "treatment", "of", "heart", "failure", "due", "to", "ischemic", "heart", "disease", "through", "Cytori-sponsored", "clinical", "development", "efforts", "and", "to", "develop", "a", "treatment", "for", "thermal", "burns", "combined", "with", "radiation", "injury", "under", "a", "contract", "from", "BARDA,", "a", "division", "of", "the", "U.S.", "Department", "of", "Health", "and", "Human", "Services.", "<tag2>", "Once", "the", "pilot", "trial", "is", "analyzed,", "the", "final", "phase", "would", "include", "research,", "regulatory,", "and", "clinical", "activities", "necessary", "to", "achieve", "regulatory", "clearances", "to", "optimize", "a", "treatment", "for", "combined", "injury", "involving", "thermal", "burn", "and", "radiation", "exposure.", "<tag3>"], "wordsA": ["In", "the", "U.S.", "our", "goal", "is", "to", "bring", "Cytori", "Cell", "Therapy", "to", "market", "for", "treatment", "of", "heart", "failure", "due", "to", "ischemic", "heart", "disease", "through", "Cytori-sponsored", "clinical", "development", "efforts", "and", "to", "develop", "a", "treatment", "for", "thermal", "burns", "combined", "with", "radiation", "injury", "under", "a", "contract", "from", "BARDA,", "a", "division", "of", "the", "U.S.", "Department", "of", "Health", "and", "Human", "Services."], "wordsB": ["Once", "the", "pilot", "trial", "is", "analyzed,", "the", "final", "phase", "would", "include", "research,", "regulatory,", "and", "clinical", "activities", "necessary", "to", "achieve", "regulatory", "clearances", "to", "optimize", "a", "treatment", "for", "combined", "injury", "involving", "thermal", "burn", "and", "radiation", "exposure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p94_s0", "idA": "1095981_14_item7_p10_s0", "sentA": "Product revenues consisted of revenues primarily from our Celution and StemSource Cell Banks.", "sentB": "For sales to customers who arrange for and manage the shipping process, we recognize revenue upon shipment from our facilities.", "type": 1, "words": ["<tag1>", "Product", "revenues", "consisted", "of", "revenues", "primarily", "from", "our", "Celution", "and", "StemSource", "Cell", "Banks.", "<tag2>", "For", "sales", "to", "customers", "who", "arrange", "for", "and", "manage", "the", "shipping", "process,", "we", "recognize", "revenue", "upon", "shipment", "from", "our", "facilities.", "<tag3>"], "wordsA": ["Product", "revenues", "consisted", "of", "revenues", "primarily", "from", "our", "Celution", "and", "StemSource", "Cell", "Banks."], "wordsB": ["For", "sales", "to", "customers", "who", "arrange", "for", "and", "manage", "the", "shipping", "process,", "we", "recognize", "revenue", "upon", "shipment", "from", "our", "facilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p86_s2", "idA": "1095981_14_item7_p12_s1", "sentA": "In September 2012 we obtained Class I Device Clearance for Celution and a number of our other products in Japan.", "sentB": "In September 2014, 4,032,389 warrants were exercised and we received proceeds of approximately $4,066,000.", "type": 1, "words": ["<tag1>", "In", "September", "2012", "we", "obtained", "Class", "I", "Device", "Clearance", "for", "Celution", "and", "a", "number", "of", "our", "other", "products", "in", "Japan.", "<tag2>", "In", "September", "2014,", "4,032,389", "warrants", "were", "exercised", "and", "we", "received", "proceeds", "of", "approximately", "$4,066,000.", "<tag3>"], "wordsA": ["In", "September", "2012", "we", "obtained", "Class", "I", "Device", "Clearance", "for", "Celution", "and", "a", "number", "of", "our", "other", "products", "in", "Japan."], "wordsB": ["In", "September", "2014,", "4,032,389", "warrants", "were", "exercised", "and", "we", "received", "proceeds", "of", "approximately", "$4,066,000."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p62_s0", "idA": "1095981_14_item7_p14_s1", "sentA": "We will sell the products to a diverse group of distributors and partners in Europe, Asia and the U.S., who may apply the products towards reconstructive surgery, soft tissue repair, research, aesthetics, and cell and tissue banking as approved in each country.", "sentB": "Specifically, we have prepared an operating plan that calls for us to reduce operations to focus almost entirely on one US clinical program and the supply of current products to existing or new distribution channels.", "type": 1, "words": ["<tag1>", "We", "will", "sell", "the", "products", "to", "a", "diverse", "group", "of", "distributors", "and", "partners", "in", "Europe,", "Asia", "and", "the", "U.S.,", "who", "may", "apply", "the", "products", "towards", "reconstructive", "surgery,", "soft", "tissue", "repair,", "research,", "aesthetics,", "and", "cell", "and", "tissue", "banking", "as", "approved", "in", "each", "country.", "<tag2>", "Specifically,", "we", "have", "prepared", "an", "operating", "plan", "that", "calls", "for", "us", "to", "reduce", "operations", "to", "focus", "almost", "entirely", "on", "one", "US", "clinical", "program", "and", "the", "supply", "of", "current", "products", "to", "existing", "or", "new", "distribution", "channels.", "<tag3>"], "wordsA": ["We", "will", "sell", "the", "products", "to", "a", "diverse", "group", "of", "distributors", "and", "partners", "in", "Europe,", "Asia", "and", "the", "U.S.,", "who", "may", "apply", "the", "products", "towards", "reconstructive", "surgery,", "soft", "tissue", "repair,", "research,", "aesthetics,", "and", "cell", "and", "tissue", "banking", "as", "approved", "in", "each", "country."], "wordsB": ["Specifically,", "we", "have", "prepared", "an", "operating", "plan", "that", "calls", "for", "us", "to", "reduce", "operations", "to", "focus", "almost", "entirely", "on", "one", "US", "clinical", "program", "and", "the", "supply", "of", "current", "products", "to", "existing", "or", "new", "distribution", "channels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p4_s0", "idA": "1095981_14_item7_p19_s1", "sentA": "During the year ended December 31, 2013, we recognized $638,000 of revenue associated with our arrangements with Olympus as a result of the United States Court of Appeals upholding the FDA s previous determination that our cell processing devices were not substantially equivalent to the cited predicate devices.", "sentB": "In January 2015, the FDA granted unrestricted IDE approval for a pivotal clinical trial, named the STAR trial, to evaluate Cytori Cell Therapy as a potential treatment for impaired hand function in scleroderma, a rare autoimmune disease affecting approximately 50,000 patients in the United States.", "type": 1, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2013,", "we", "recognized", "$638,000", "of", "revenue", "associated", "with", "our", "arrangements", "with", "Olympus", "as", "a", "result", "of", "the", "United", "States", "Court", "of", "Appeals", "upholding", "the", "FDA", "s", "previous", "determination", "that", "our", "cell", "processing", "devices", "were", "not", "substantially", "equivalent", "to", "the", "cited", "predicate", "devices.", "<tag2>", "In", "January", "2015,", "the", "FDA", "granted", "unrestricted", "IDE", "approval", "for", "a", "pivotal", "clinical", "trial,", "named", "the", "STAR", "trial,", "to", "evaluate", "Cytori", "Cell", "Therapy", "as", "a", "potential", "treatment", "for", "impaired", "hand", "function", "in", "scleroderma,", "a", "rare", "autoimmune", "disease", "affecting", "approximately", "50,000", "patients", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2013,", "we", "recognized", "$638,000", "of", "revenue", "associated", "with", "our", "arrangements", "with", "Olympus", "as", "a", "result", "of", "the", "United", "States", "Court", "of", "Appeals", "upholding", "the", "FDA", "s", "previous", "determination", "that", "our", "cell", "processing", "devices", "were", "not", "substantially", "equivalent", "to", "the", "cited", "predicate", "devices."], "wordsB": ["In", "January", "2015,", "the", "FDA", "granted", "unrestricted", "IDE", "approval", "for", "a", "pivotal", "clinical", "trial,", "named", "the", "STAR", "trial,", "to", "evaluate", "Cytori", "Cell", "Therapy", "as", "a", "potential", "treatment", "for", "impaired", "hand", "function", "in", "scleroderma,", "a", "rare", "autoimmune", "disease", "affecting", "approximately", "50,000", "patients", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p5_s1", "idA": "1095981_14_item7_p1_s0", "sentA": "Cytori Cell Therapy is a proprietary formulation of stem and regenerative cells derived from a patient s own adipose (fat) tissue (ADRCs).", "sentB": "The trial, called ACT-OA, is a 90 patient, randomized, double-blind, placebo control study involving two dose escalations of Cytori Cell Therapy, a low dose and a high dose conducted over 48 weeks.", "type": 1, "words": ["<tag1>", "Cytori", "Cell", "Therapy", "is", "a", "proprietary", "formulation", "of", "stem", "and", "regenerative", "cells", "derived", "from", "a", "patient", "s", "own", "adipose", "(fat)", "tissue", "(ADRCs).", "<tag2>", "The", "trial,", "called", "ACT-OA,", "is", "a", "90", "patient,", "randomized,", "double-blind,", "placebo", "control", "study", "involving", "two", "dose", "escalations", "of", "Cytori", "Cell", "Therapy,", "a", "low", "dose", "and", "a", "high", "dose", "conducted", "over", "48", "weeks.", "<tag3>"], "wordsA": ["Cytori", "Cell", "Therapy", "is", "a", "proprietary", "formulation", "of", "stem", "and", "regenerative", "cells", "derived", "from", "a", "patient", "s", "own", "adipose", "(fat)", "tissue", "(ADRCs)."], "wordsB": ["The", "trial,", "called", "ACT-OA,", "is", "a", "90", "patient,", "randomized,", "double-blind,", "placebo", "control", "study", "involving", "two", "dose", "escalations", "of", "Cytori", "Cell", "Therapy,", "a", "low", "dose", "and", "a", "high", "dose", "conducted", "over", "48", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p94_s2", "idA": "1095981_14_item7_p1_s2", "sentA": "To access these cells from a patient at the time of a surgical procedure, we have designed and developed a sophisticated tissue processing system, the Celution System, which automates the complex process of digesting fat tissue, releasing the ADRCs, and concentrating them into an optimized and proprietary formulation in a sterile environment.", "sentB": "The customer s obligation to pay and the payment terms are set at the time of delivery and are not dependent on the subsequent use or resale of our products.", "type": 1, "words": ["<tag1>", "To", "access", "these", "cells", "from", "a", "patient", "at", "the", "time", "of", "a", "surgical", "procedure,", "we", "have", "designed", "and", "developed", "a", "sophisticated", "tissue", "processing", "system,", "the", "Celution", "System,", "which", "automates", "the", "complex", "process", "of", "digesting", "fat", "tissue,", "releasing", "the", "ADRCs,", "and", "concentrating", "them", "into", "an", "optimized", "and", "proprietary", "formulation", "in", "a", "sterile", "environment.", "<tag2>", "The", "customer", "s", "obligation", "to", "pay", "and", "the", "payment", "terms", "are", "set", "at", "the", "time", "of", "delivery", "and", "are", "not", "dependent", "on", "the", "subsequent", "use", "or", "resale", "of", "our", "products.", "<tag3>"], "wordsA": ["To", "access", "these", "cells", "from", "a", "patient", "at", "the", "time", "of", "a", "surgical", "procedure,", "we", "have", "designed", "and", "developed", "a", "sophisticated", "tissue", "processing", "system,", "the", "Celution", "System,", "which", "automates", "the", "complex", "process", "of", "digesting", "fat", "tissue,", "releasing", "the", "ADRCs,", "and", "concentrating", "them", "into", "an", "optimized", "and", "proprietary", "formulation", "in", "a", "sterile", "environment."], "wordsB": ["The", "customer", "s", "obligation", "to", "pay", "and", "the", "payment", "terms", "are", "set", "at", "the", "time", "of", "delivery", "and", "are", "not", "dependent", "on", "the", "subsequent", "use", "or", "resale", "of", "our", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p96_s0", "idA": "1095981_14_item7_p1_s3", "sentA": "The system is comprised of a central device and single-use, per-procedure consumable cartridges.", "sentB": "Stem cell banks typically consist of a complex array of equipment, proprietary knowledge, license rights, and services, including one or more StemSource devices, a cryogenic freezer, measuring and monitoring equipment, and a database patient tracking system.", "type": 1, "words": ["<tag1>", "The", "system", "is", "comprised", "of", "a", "central", "device", "and", "single-use,", "per-procedure", "consumable", "cartridges.", "<tag2>", "Stem", "cell", "banks", "typically", "consist", "of", "a", "complex", "array", "of", "equipment,", "proprietary", "knowledge,", "license", "rights,", "and", "services,", "including", "one", "or", "more", "StemSource", "devices,", "a", "cryogenic", "freezer,", "measuring", "and", "monitoring", "equipment,", "and", "a", "database", "patient", "tracking", "system.", "<tag3>"], "wordsA": ["The", "system", "is", "comprised", "of", "a", "central", "device", "and", "single-use,", "per-procedure", "consumable", "cartridges."], "wordsB": ["Stem", "cell", "banks", "typically", "consist", "of", "a", "complex", "array", "of", "equipment,", "proprietary", "knowledge,", "license", "rights,", "and", "services,", "including", "one", "or", "more", "StemSource", "devices,", "a", "cryogenic", "freezer,", "measuring", "and", "monitoring", "equipment,", "and", "a", "database", "patient", "tracking", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p98_s0", "idA": "1095981_14_item7_p1_s3", "sentA": "The system is comprised of a central device and single-use, per-procedure consumable cartridges.", "sentB": "FASB authoritative guidance establishes a selling price hierarchy for determining the selling price of a deliverable, which is based on: (a) vendor-specific objective evidence ( VSOE (b) third-party evidence ( TPE or (c) management estimates.", "type": 1, "words": ["<tag1>", "The", "system", "is", "comprised", "of", "a", "central", "device", "and", "single-use,", "per-procedure", "consumable", "cartridges.", "<tag2>", "FASB", "authoritative", "guidance", "establishes", "a", "selling", "price", "hierarchy", "for", "determining", "the", "selling", "price", "of", "a", "deliverable,", "which", "is", "based", "on:", "(a)", "vendor-specific", "objective", "evidence", "(", "VSOE", "(b)", "third-party", "evidence", "(", "TPE", "or", "(c)", "management", "estimates.", "<tag3>"], "wordsA": ["The", "system", "is", "comprised", "of", "a", "central", "device", "and", "single-use,", "per-procedure", "consumable", "cartridges."], "wordsB": ["FASB", "authoritative", "guidance", "establishes", "a", "selling", "price", "hierarchy", "for", "determining", "the", "selling", "price", "of", "a", "deliverable,", "which", "is", "based", "on:", "(a)", "vendor-specific", "objective", "evidence", "(", "VSOE", "(b)", "third-party", "evidence", "(", "TPE", "or", "(c)", "management", "estimates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p7_s0", "idA": "1095981_14_item7_p1_s4", "sentA": "The business model is based on the sale of the device and generating recurring revenue from the cartridges that are utilized in each procedure.", "sentB": "Another therapeutic target under evaluation is stress urinary incontinence in men following radical prostatectomy, which is based on positive data reported in a peer reviewed journal.", "type": 1, "words": ["<tag1>", "The", "business", "model", "is", "based", "on", "the", "sale", "of", "the", "device", "and", "generating", "recurring", "revenue", "from", "the", "cartridges", "that", "are", "utilized", "in", "each", "procedure.", "<tag2>", "Another", "therapeutic", "target", "under", "evaluation", "is", "stress", "urinary", "incontinence", "in", "men", "following", "radical", "prostatectomy,", "which", "is", "based", "on", "positive", "data", "reported", "in", "a", "peer", "reviewed", "journal.", "<tag3>"], "wordsA": ["The", "business", "model", "is", "based", "on", "the", "sale", "of", "the", "device", "and", "generating", "recurring", "revenue", "from", "the", "cartridges", "that", "are", "utilized", "in", "each", "procedure."], "wordsB": ["Another", "therapeutic", "target", "under", "evaluation", "is", "stress", "urinary", "incontinence", "in", "men", "following", "radical", "prostatectomy,", "which", "is", "based", "on", "positive", "data", "reported", "in", "a", "peer", "reviewed", "journal."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p73_s1", "idA": "1095981_14_item7_p20_s1", "sentA": "As a result of this Termination Agreement, we are obligated to pay Senko $1,200,000 in six quarterly installment payments of $200,000 each through May 2014.", "sentB": "The waiver of principal payments continues from November 1, 2014 through April 1, 2015 and thereafter we are required to make payments of principal and accrued interest in equal monthly installments of $1.0 million, sufficient to amortize the Term Loans through the maturity date.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "this", "Termination", "Agreement,", "we", "are", "obligated", "to", "pay", "Senko", "$1,200,000", "in", "six", "quarterly", "installment", "payments", "of", "$200,000", "each", "through", "May", "2014.", "<tag2>", "The", "waiver", "of", "principal", "payments", "continues", "from", "November", "1,", "2014", "through", "April", "1,", "2015", "and", "thereafter", "we", "are", "required", "to", "make", "payments", "of", "principal", "and", "accrued", "interest", "in", "equal", "monthly", "installments", "of", "$1.0", "million,", "sufficient", "to", "amortize", "the", "Term", "Loans", "through", "the", "maturity", "date.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "this", "Termination", "Agreement,", "we", "are", "obligated", "to", "pay", "Senko", "$1,200,000", "in", "six", "quarterly", "installment", "payments", "of", "$200,000", "each", "through", "May", "2014."], "wordsB": ["The", "waiver", "of", "principal", "payments", "continues", "from", "November", "1,", "2014", "through", "April", "1,", "2015", "and", "thereafter", "we", "are", "required", "to", "make", "payments", "of", "principal", "and", "accrued", "interest", "in", "equal", "monthly", "installments", "of", "$1.0", "million,", "sufficient", "to", "amortize", "the", "Term", "Loans", "through", "the", "maturity", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p62_s4", "idA": "1095981_14_item7_p20_s3", "sentA": "At the time of the Termination Agreement, we accrued $1,200,000 of the termination fee, and recognized the remaining $1,179,000 in development revenues which reflects the Company s efforts towards commercialization under the agreement.", "sentB": "In aggregate, such reductions could result in eliminations of roles for the majority of the Company s current staff and the deferral or elimination of all ongoing development projects until such time that cash resources were available from operations or outside sources to re-establish development and growth plans.", "type": 1, "words": ["<tag1>", "At", "the", "time", "of", "the", "Termination", "Agreement,", "we", "accrued", "$1,200,000", "of", "the", "termination", "fee,", "and", "recognized", "the", "remaining", "$1,179,000", "in", "development", "revenues", "which", "reflects", "the", "Company", "s", "efforts", "towards", "commercialization", "under", "the", "agreement.", "<tag2>", "In", "aggregate,", "such", "reductions", "could", "result", "in", "eliminations", "of", "roles", "for", "the", "majority", "of", "the", "Company", "s", "current", "staff", "and", "the", "deferral", "or", "elimination", "of", "all", "ongoing", "development", "projects", "until", "such", "time", "that", "cash", "resources", "were", "available", "from", "operations", "or", "outside", "sources", "to", "re-establish", "development", "and", "growth", "plans.", "<tag3>"], "wordsA": ["At", "the", "time", "of", "the", "Termination", "Agreement,", "we", "accrued", "$1,200,000", "of", "the", "termination", "fee,", "and", "recognized", "the", "remaining", "$1,179,000", "in", "development", "revenues", "which", "reflects", "the", "Company", "s", "efforts", "towards", "commercialization", "under", "the", "agreement."], "wordsB": ["In", "aggregate,", "such", "reductions", "could", "result", "in", "eliminations", "of", "roles", "for", "the", "majority", "of", "the", "Company", "s", "current", "staff", "and", "the", "deferral", "or", "elimination", "of", "all", "ongoing", "development", "projects", "until", "such", "time", "that", "cash", "resources", "were", "available", "from", "operations", "or", "outside", "sources", "to", "re-establish", "development", "and", "growth", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p97_s0", "idA": "1095981_14_item7_p22_s6", "sentA": "There were no comparable revenues and expenditures for the year ended December 31, 2011.", "sentB": "Each cell bank is customized to provide the best solution for the customer.", "type": 1, "words": ["<tag1>", "There", "were", "no", "comparable", "revenues", "and", "expenditures", "for", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "Each", "cell", "bank", "is", "customized", "to", "provide", "the", "best", "solution", "for", "the", "customer.", "<tag3>"], "wordsA": ["There", "were", "no", "comparable", "revenues", "and", "expenditures", "for", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["Each", "cell", "bank", "is", "customized", "to", "provide", "the", "best", "solution", "for", "the", "customer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p5_s2", "idA": "1095981_14_item7_p24_s1", "sentA": "The following table summarizes the components of our research and development expenses for the years ended December 31, 2013, 2012 and 2011:", "sentB": "The randomization is 1:1:1 between the control, low dose and high dose groups.", "type": 1, "words": ["<tag1>", "The", "following", "table", "summarizes", "the", "components", "of", "our", "research", "and", "development", "expenses", "for", "the", "years", "ended", "December", "31,", "2013,", "2012", "and", "2011:", "<tag2>", "The", "randomization", "is", "1:1:1", "between", "the", "control,", "low", "dose", "and", "high", "dose", "groups.", "<tag3>"], "wordsA": ["The", "following", "table", "summarizes", "the", "components", "of", "our", "research", "and", "development", "expenses", "for", "the", "years", "ended", "December", "31,", "2013,", "2012", "and", "2011:"], "wordsB": ["The", "randomization", "is", "1:1:1", "between", "the", "control,", "low", "dose", "and", "high", "dose", "groups."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p31_s1", "idA": "1095981_14_item7_p30_s0", "sentA": "Sales and marketing expenses include costs of sales and marketing personnel, tradeshows, physician training, and promotional activities and materials.", "sentB": "These decreases are mostly attributable to the expense reduction initiatives implemented throughout 2014 in our Sales and Marketing organization.", "type": 1, "words": ["<tag1>", "Sales", "and", "marketing", "expenses", "include", "costs", "of", "sales", "and", "marketing", "personnel,", "tradeshows,", "physician", "training,", "and", "promotional", "activities", "and", "materials.", "<tag2>", "These", "decreases", "are", "mostly", "attributable", "to", "the", "expense", "reduction", "initiatives", "implemented", "throughout", "2014", "in", "our", "Sales", "and", "Marketing", "organization.", "<tag3>"], "wordsA": ["Sales", "and", "marketing", "expenses", "include", "costs", "of", "sales", "and", "marketing", "personnel,", "tradeshows,", "physician", "training,", "and", "promotional", "activities", "and", "materials."], "wordsB": ["These", "decreases", "are", "mostly", "attributable", "to", "the", "expense", "reduction", "initiatives", "implemented", "throughout", "2014", "in", "our", "Sales", "and", "Marketing", "organization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p24_s1", "idA": "1095981_14_item7_p33_s0", "sentA": "We expect sales and marketing expenditures to remain relatively stable in 2014.", "sentB": "We expect approximately half of the work associated with Option 1, as amended, to be completed by the end of 2015.", "type": 1, "words": ["<tag1>", "We", "expect", "sales", "and", "marketing", "expenditures", "to", "remain", "relatively", "stable", "in", "2014.", "<tag2>", "We", "expect", "approximately", "half", "of", "the", "work", "associated", "with", "Option", "1,", "as", "amended,", "to", "be", "completed", "by", "the", "end", "of", "2015.", "<tag3>"], "wordsA": ["We", "expect", "sales", "and", "marketing", "expenditures", "to", "remain", "relatively", "stable", "in", "2014."], "wordsB": ["We", "expect", "approximately", "half", "of", "the", "work", "associated", "with", "Option", "1,", "as", "amended,", "to", "be", "completed", "by", "the", "end", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p61_s6", "idA": "1095981_14_item7_p33_s0", "sentA": "We expect sales and marketing expenditures to remain relatively stable in 2014.", "sentB": "Without this additional capital, current working capital and cash generated from sales and containment of operating costs will not provide adequate funding for research, sales and marketing efforts, clinical and preclinical trials, and product development activities at their current levels.", "type": 1, "words": ["<tag1>", "We", "expect", "sales", "and", "marketing", "expenditures", "to", "remain", "relatively", "stable", "in", "2014.", "<tag2>", "Without", "this", "additional", "capital,", "current", "working", "capital", "and", "cash", "generated", "from", "sales", "and", "containment", "of", "operating", "costs", "will", "not", "provide", "adequate", "funding", "for", "research,", "sales", "and", "marketing", "efforts,", "clinical", "and", "preclinical", "trials,", "and", "product", "development", "activities", "at", "their", "current", "levels.", "<tag3>"], "wordsA": ["We", "expect", "sales", "and", "marketing", "expenditures", "to", "remain", "relatively", "stable", "in", "2014."], "wordsB": ["Without", "this", "additional", "capital,", "current", "working", "capital", "and", "cash", "generated", "from", "sales", "and", "containment", "of", "operating", "costs", "will", "not", "provide", "adequate", "funding", "for", "research,", "sales", "and", "marketing", "efforts,", "clinical", "and", "preclinical", "trials,", "and", "product", "development", "activities", "at", "their", "current", "levels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p94_s1", "idA": "1095981_14_item7_p38_s1", "sentA": "We measure stock-based compensation expense based on the grant-date fair value of any awards granted to our employees.", "sentB": "Shipping and handling costs that are billed to our customers are classified as revenue.", "type": 1, "words": ["<tag1>", "We", "measure", "stock-based", "compensation", "expense", "based", "on", "the", "grant-date", "fair", "value", "of", "any", "awards", "granted", "to", "our", "employees.", "<tag2>", "Shipping", "and", "handling", "costs", "that", "are", "billed", "to", "our", "customers", "are", "classified", "as", "revenue.", "<tag3>"], "wordsA": ["We", "measure", "stock-based", "compensation", "expense", "based", "on", "the", "grant-date", "fair", "value", "of", "any", "awards", "granted", "to", "our", "employees."], "wordsB": ["Shipping", "and", "handling", "costs", "that", "are", "billed", "to", "our", "customers", "are", "classified", "as", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p99_s0", "idA": "1095981_14_item7_p38_s1", "sentA": "We measure stock-based compensation expense based on the grant-date fair value of any awards granted to our employees.", "sentB": "For our cell bank sales, we establish relative selling prices for all deliverables based on vendor-specific quotes for comparable services when available.", "type": 1, "words": ["<tag1>", "We", "measure", "stock-based", "compensation", "expense", "based", "on", "the", "grant-date", "fair", "value", "of", "any", "awards", "granted", "to", "our", "employees.", "<tag2>", "For", "our", "cell", "bank", "sales,", "we", "establish", "relative", "selling", "prices", "for", "all", "deliverables", "based", "on", "vendor-specific", "quotes", "for", "comparable", "services", "when", "available.", "<tag3>"], "wordsA": ["We", "measure", "stock-based", "compensation", "expense", "based", "on", "the", "grant-date", "fair", "value", "of", "any", "awards", "granted", "to", "our", "employees."], "wordsB": ["For", "our", "cell", "bank", "sales,", "we", "establish", "relative", "selling", "prices", "for", "all", "deliverables", "based", "on", "vendor-specific", "quotes", "for", "comparable", "services", "when", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p93_s1", "idA": "1095981_14_item7_p38_s2", "sentA": "Such expense is recognized over the period of time that employees provide service to us and earn all rights to the awards.", "sentB": "If the other revenue recognition criteria are met, revenue for these product sales is recognized upon delivery to the customer, as all risks and rewards of ownership have been substantively transferred to the customer at that point.", "type": 1, "words": ["<tag1>", "Such", "expense", "is", "recognized", "over", "the", "period", "of", "time", "that", "employees", "provide", "service", "to", "us", "and", "earn", "all", "rights", "to", "the", "awards.", "<tag2>", "If", "the", "other", "revenue", "recognition", "criteria", "are", "met,", "revenue", "for", "these", "product", "sales", "is", "recognized", "upon", "delivery", "to", "the", "customer,", "as", "all", "risks", "and", "rewards", "of", "ownership", "have", "been", "substantively", "transferred", "to", "the", "customer", "at", "that", "point.", "<tag3>"], "wordsA": ["Such", "expense", "is", "recognized", "over", "the", "period", "of", "time", "that", "employees", "provide", "service", "to", "us", "and", "earn", "all", "rights", "to", "the", "awards."], "wordsB": ["If", "the", "other", "revenue", "recognition", "criteria", "are", "met,", "revenue", "for", "these", "product", "sales", "is", "recognized", "upon", "delivery", "to", "the", "customer,", "as", "all", "risks", "and", "rewards", "of", "ownership", "have", "been", "substantively", "transferred", "to", "the", "customer", "at", "that", "point."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p62_s1", "idA": "1095981_14_item7_p43_s1", "sentA": "In addition, previously-granted options will continue to vest in accordance with their original terms.", "sentB": "In addition, as part of this plan, there would be minimal expenditures for ongoing scientific research, product development or clinical research.", "type": 1, "words": ["<tag1>", "In", "addition,", "previously-granted", "options", "will", "continue", "to", "vest", "in", "accordance", "with", "their", "original", "terms.", "<tag2>", "In", "addition,", "as", "part", "of", "this", "plan,", "there", "would", "be", "minimal", "expenditures", "for", "ongoing", "scientific", "research,", "product", "development", "or", "clinical", "research.", "<tag3>"], "wordsA": ["In", "addition,", "previously-granted", "options", "will", "continue", "to", "vest", "in", "accordance", "with", "their", "original", "terms."], "wordsB": ["In", "addition,", "as", "part", "of", "this", "plan,", "there", "would", "be", "minimal", "expenditures", "for", "ongoing", "scientific", "research,", "product", "development", "or", "clinical", "research."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p102_s1", "idA": "1095981_14_item7_p43_s3", "sentA": "Of this amount, $4,725,000 is expected to be recognized as a result of vesting under service conditions over a weighted average period of 1.81 years.", "sentB": "Such long-lived assets are deemed to be impaired when the undiscounted cash flows expected to be generated by the asset (or asset group) are less than the asset s carrying amount.", "type": 1, "words": ["<tag1>", "Of", "this", "amount,", "$4,725,000", "is", "expected", "to", "be", "recognized", "as", "a", "result", "of", "vesting", "under", "service", "conditions", "over", "a", "weighted", "average", "period", "of", "1.81", "years.", "<tag2>", "Such", "long-lived", "assets", "are", "deemed", "to", "be", "impaired", "when", "the", "undiscounted", "cash", "flows", "expected", "to", "be", "generated", "by", "the", "asset", "(or", "asset", "group)", "are", "less", "than", "the", "asset", "s", "carrying", "amount.", "<tag3>"], "wordsA": ["Of", "this", "amount,", "$4,725,000", "is", "expected", "to", "be", "recognized", "as", "a", "result", "of", "vesting", "under", "service", "conditions", "over", "a", "weighted", "average", "period", "of", "1.81", "years."], "wordsB": ["Such", "long-lived", "assets", "are", "deemed", "to", "be", "impaired", "when", "the", "undiscounted", "cash", "flows", "expected", "to", "be", "generated", "by", "the", "asset", "(or", "asset", "group)", "are", "less", "than", "the", "asset", "s", "carrying", "amount."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p100_s1", "idA": "1095981_14_item7_p46_s0", "sentA": "The future: No future changes in the fair value of the warrant liability will be recognized as the warrants expired in August 2013.", "sentB": "Future services such as web hosting and ongoing maintenance are deferred and recognized into income as the services are provided, generally over one year following the installation of the equipment.", "type": 1, "words": ["<tag1>", "The", "future:", "No", "future", "changes", "in", "the", "fair", "value", "of", "the", "warrant", "liability", "will", "be", "recognized", "as", "the", "warrants", "expired", "in", "August", "2013.", "<tag2>", "Future", "services", "such", "as", "web", "hosting", "and", "ongoing", "maintenance", "are", "deferred", "and", "recognized", "into", "income", "as", "the", "services", "are", "provided,", "generally", "over", "one", "year", "following", "the", "installation", "of", "the", "equipment.", "<tag3>"], "wordsA": ["The", "future:", "No", "future", "changes", "in", "the", "fair", "value", "of", "the", "warrant", "liability", "will", "be", "recognized", "as", "the", "warrants", "expired", "in", "August", "2013."], "wordsB": ["Future", "services", "such", "as", "web", "hosting", "and", "ongoing", "maintenance", "are", "deferred", "and", "recognized", "into", "income", "as", "the", "services", "are", "provided,", "generally", "over", "one", "year", "following", "the", "installation", "of", "the", "equipment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p104_s1", "idA": "1095981_14_item7_p46_s0", "sentA": "The future: No future changes in the fair value of the warrant liability will be recognized as the warrants expired in August 2013.", "sentB": "Under the revised guidance, entities have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in Accounting Standards Codification Topic 350.", "type": 1, "words": ["<tag1>", "The", "future:", "No", "future", "changes", "in", "the", "fair", "value", "of", "the", "warrant", "liability", "will", "be", "recognized", "as", "the", "warrants", "expired", "in", "August", "2013.", "<tag2>", "Under", "the", "revised", "guidance,", "entities", "have", "the", "option", "to", "first", "assess", "qualitative", "factors", "to", "determine", "whether", "it", "is", "more", "likely", "than", "not", "that", "the", "fair", "value", "of", "a", "reporting", "unit", "is", "less", "than", "its", "carrying", "amount", "as", "a", "basis", "for", "determining", "whether", "it", "is", "necessary", "to", "perform", "the", "two-step", "goodwill", "impairment", "test", "described", "in", "Accounting", "Standards", "Codification", "Topic", "350.", "<tag3>"], "wordsA": ["The", "future:", "No", "future", "changes", "in", "the", "fair", "value", "of", "the", "warrant", "liability", "will", "be", "recognized", "as", "the", "warrants", "expired", "in", "August", "2013."], "wordsB": ["Under", "the", "revised", "guidance,", "entities", "have", "the", "option", "to", "first", "assess", "qualitative", "factors", "to", "determine", "whether", "it", "is", "more", "likely", "than", "not", "that", "the", "fair", "value", "of", "a", "reporting", "unit", "is", "less", "than", "its", "carrying", "amount", "as", "a", "basis", "for", "determining", "whether", "it", "is", "necessary", "to", "perform", "the", "two-step", "goodwill", "impairment", "test", "described", "in", "Accounting", "Standards", "Codification", "Topic", "350."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p108_s0", "idA": "1095981_14_item7_p46_s0", "sentA": "The future: No future changes in the fair value of the warrant liability will be recognized as the warrants expired in August 2013.", "sentB": "Warrants issued in connection with our preferred stock offering as well as our Letter Agreement with the Lenders do not trade in an active securities market, and as such, we estimate the fair value of these warrants using Black Scholes or Monte Carlo option pricing models.", "type": 1, "words": ["<tag1>", "The", "future:", "No", "future", "changes", "in", "the", "fair", "value", "of", "the", "warrant", "liability", "will", "be", "recognized", "as", "the", "warrants", "expired", "in", "August", "2013.", "<tag2>", "Warrants", "issued", "in", "connection", "with", "our", "preferred", "stock", "offering", "as", "well", "as", "our", "Letter", "Agreement", "with", "the", "Lenders", "do", "not", "trade", "in", "an", "active", "securities", "market,", "and", "as", "such,", "we", "estimate", "the", "fair", "value", "of", "these", "warrants", "using", "Black", "Scholes", "or", "Monte", "Carlo", "option", "pricing", "models.", "<tag3>"], "wordsA": ["The", "future:", "No", "future", "changes", "in", "the", "fair", "value", "of", "the", "warrant", "liability", "will", "be", "recognized", "as", "the", "warrants", "expired", "in", "August", "2013."], "wordsB": ["Warrants", "issued", "in", "connection", "with", "our", "preferred", "stock", "offering", "as", "well", "as", "our", "Letter", "Agreement", "with", "the", "Lenders", "do", "not", "trade", "in", "an", "active", "securities", "market,", "and", "as", "such,", "we", "estimate", "the", "fair", "value", "of", "these", "warrants", "using", "Black", "Scholes", "or", "Monte", "Carlo", "option", "pricing", "models."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p92_s0", "idA": "1095981_14_item7_p51_s0", "sentA": "In connection with the June 28, 2013 Loan and Security Agreement (Loan Agreement), a loss on debt extinguishment was recorded that relates to the payoff of the prior loan obligation.", "sentB": "In accordance with the Securities and Exchange Commission s guidance, we recognize revenue from product sales when the following fundamental criteria are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price to the customer is fixed or determinable and (iv) collection of the resulting accounts receivable is reasonably assured.", "type": 1, "words": ["<tag1>", "In", "connection", "with", "the", "June", "28,", "2013", "Loan", "and", "Security", "Agreement", "(Loan", "Agreement),", "a", "loss", "on", "debt", "extinguishment", "was", "recorded", "that", "relates", "to", "the", "payoff", "of", "the", "prior", "loan", "obligation.", "<tag2>", "In", "accordance", "with", "the", "Securities", "and", "Exchange", "Commission", "s", "guidance,", "we", "recognize", "revenue", "from", "product", "sales", "when", "the", "following", "fundamental", "criteria", "are", "met:", "(i)", "persuasive", "evidence", "of", "an", "arrangement", "exists,", "(ii)", "delivery", "has", "occurred,", "(iii)", "the", "price", "to", "the", "customer", "is", "fixed", "or", "determinable", "and", "(iv)", "collection", "of", "the", "resulting", "accounts", "receivable", "is", "reasonably", "assured.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "June", "28,", "2013", "Loan", "and", "Security", "Agreement", "(Loan", "Agreement),", "a", "loss", "on", "debt", "extinguishment", "was", "recorded", "that", "relates", "to", "the", "payoff", "of", "the", "prior", "loan", "obligation."], "wordsB": ["In", "accordance", "with", "the", "Securities", "and", "Exchange", "Commission", "s", "guidance,", "we", "recognize", "revenue", "from", "product", "sales", "when", "the", "following", "fundamental", "criteria", "are", "met:", "(i)", "persuasive", "evidence", "of", "an", "arrangement", "exists,", "(ii)", "delivery", "has", "occurred,", "(iii)", "the", "price", "to", "the", "customer", "is", "fixed", "or", "determinable", "and", "(iv)", "collection", "of", "the", "resulting", "accounts", "receivable", "is", "reasonably", "assured."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p104_s0", "idA": "1095981_14_item7_p53_s1", "sentA": "In September 2011, we entered into a second amendment to the Amended and Restated Loan and Security Agreement, pursuant to which the lenders funded an additional principal, increasing the total principal balance to $25.0 million.", "sentB": "In September 2011, the FASB issued revised guidance to simplify how entities test goodwill for impairment.", "type": 1, "words": ["<tag1>", "In", "September", "2011,", "we", "entered", "into", "a", "second", "amendment", "to", "the", "Amended", "and", "Restated", "Loan", "and", "Security", "Agreement,", "pursuant", "to", "which", "the", "lenders", "funded", "an", "additional", "principal,", "increasing", "the", "total", "principal", "balance", "to", "$25.0", "million.", "<tag2>", "In", "September", "2011,", "the", "FASB", "issued", "revised", "guidance", "to", "simplify", "how", "entities", "test", "goodwill", "for", "impairment.", "<tag3>"], "wordsA": ["In", "September", "2011,", "we", "entered", "into", "a", "second", "amendment", "to", "the", "Amended", "and", "Restated", "Loan", "and", "Security", "Agreement,", "pursuant", "to", "which", "the", "lenders", "funded", "an", "additional", "principal,", "increasing", "the", "total", "principal", "balance", "to", "$25.0", "million."], "wordsB": ["In", "September", "2011,", "the", "FASB", "issued", "revised", "guidance", "to", "simplify", "how", "entities", "test", "goodwill", "for", "impairment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p61_s2", "idA": "1095981_14_item7_p56_s1", "sentA": "Subject to our future financing activities, we expect interest expense in 2014 to increase slightly as we continue to pay interest on the $27.0 million term loan that was amended in June 2013.", "sentB": "Our efforts in 2014 to raise capital took longer than we initially anticipated.", "type": 1, "words": ["<tag1>", "Subject", "to", "our", "future", "financing", "activities,", "we", "expect", "interest", "expense", "in", "2014", "to", "increase", "slightly", "as", "we", "continue", "to", "pay", "interest", "on", "the", "$27.0", "million", "term", "loan", "that", "was", "amended", "in", "June", "2013.", "<tag2>", "Our", "efforts", "in", "2014", "to", "raise", "capital", "took", "longer", "than", "we", "initially", "anticipated.", "<tag3>"], "wordsA": ["Subject", "to", "our", "future", "financing", "activities,", "we", "expect", "interest", "expense", "in", "2014", "to", "increase", "slightly", "as", "we", "continue", "to", "pay", "interest", "on", "the", "$27.0", "million", "term", "loan", "that", "was", "amended", "in", "June", "2013."], "wordsB": ["Our", "efforts", "in", "2014", "to", "raise", "capital", "took", "longer", "than", "we", "initially", "anticipated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p95_s0", "idA": "1095981_14_item7_p58_s0", "sentA": "The losses relate entirely to our 50% equity interest in the Joint Venture, which we account for using the equity method of accounting.", "sentB": "For sales that include multiple deliverables, such as sales of our StemSource Cell Bank (cell bank), we account for products or services (deliverables) separately rather than as a combined unit.", "type": 1, "words": ["<tag1>", "The", "losses", "relate", "entirely", "to", "our", "50%", "equity", "interest", "in", "the", "Joint", "Venture,", "which", "we", "account", "for", "using", "the", "equity", "method", "of", "accounting.", "<tag2>", "For", "sales", "that", "include", "multiple", "deliverables,", "such", "as", "sales", "of", "our", "StemSource", "Cell", "Bank", "(cell", "bank),", "we", "account", "for", "products", "or", "services", "(deliverables)", "separately", "rather", "than", "as", "a", "combined", "unit.", "<tag3>"], "wordsA": ["The", "losses", "relate", "entirely", "to", "our", "50%", "equity", "interest", "in", "the", "Joint", "Venture,", "which", "we", "account", "for", "using", "the", "equity", "method", "of", "accounting."], "wordsB": ["For", "sales", "that", "include", "multiple", "deliverables,", "such", "as", "sales", "of", "our", "StemSource", "Cell", "Bank", "(cell", "bank),", "we", "account", "for", "products", "or", "services", "(deliverables)", "separately", "rather", "than", "as", "a", "combined", "unit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p99_s1", "idA": "1095981_14_item7_p5_s0", "sentA": "In the third quarter, the FDA approved expanding the ATHENA trial from six trial centers to a total of eight centers.", "sentB": "In the absence of VSOE, we use competitors products or services considered largely interchangeable with our own or management s best estimate.", "type": 1, "words": ["<tag1>", "In", "the", "third", "quarter,", "the", "FDA", "approved", "expanding", "the", "ATHENA", "trial", "from", "six", "trial", "centers", "to", "a", "total", "of", "eight", "centers.", "<tag2>", "In", "the", "absence", "of", "VSOE,", "we", "use", "competitors", "products", "or", "services", "considered", "largely", "interchangeable", "with", "our", "own", "or", "management", "s", "best", "estimate.", "<tag3>"], "wordsA": ["In", "the", "third", "quarter,", "the", "FDA", "approved", "expanding", "the", "ATHENA", "trial", "from", "six", "trial", "centers", "to", "a", "total", "of", "eight", "centers."], "wordsB": ["In", "the", "absence", "of", "VSOE,", "we", "use", "competitors", "products", "or", "services", "considered", "largely", "interchangeable", "with", "our", "own", "or", "management", "s", "best", "estimate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p102_s0", "idA": "1095981_14_item7_p60_s0", "sentA": "The following is a summary of our key liquidity measures at December 31, 2013 and 2012:", "sentB": "We assess certain of our long-lived assets, such as property and equipment and intangible assets other than goodwill, for potential impairment when there is a change in circumstances that indicates carrying values of assets may not be recoverable.", "type": 1, "words": ["<tag1>", "The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2013", "and", "2012:", "<tag2>", "We", "assess", "certain", "of", "our", "long-lived", "assets,", "such", "as", "property", "and", "equipment", "and", "intangible", "assets", "other", "than", "goodwill,", "for", "potential", "impairment", "when", "there", "is", "a", "change", "in", "circumstances", "that", "indicates", "carrying", "values", "of", "assets", "may", "not", "be", "recoverable.", "<tag3>"], "wordsA": ["The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2013", "and", "2012:"], "wordsB": ["We", "assess", "certain", "of", "our", "long-lived", "assets,", "such", "as", "property", "and", "equipment", "and", "intangible", "assets", "other", "than", "goodwill,", "for", "potential", "impairment", "when", "there", "is", "a", "change", "in", "circumstances", "that", "indicates", "carrying", "values", "of", "assets", "may", "not", "be", "recoverable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p101_s4", "idA": "1095981_14_item7_p61_s3", "sentA": "To date, these operating losses have been funded primarily from outside sources of invested capital and gross profits.", "sentB": "Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.", "type": 1, "words": ["<tag1>", "To", "date,", "these", "operating", "losses", "have", "been", "funded", "primarily", "from", "outside", "sources", "of", "invested", "capital", "and", "gross", "profits.", "<tag2>", "Account", "balances", "are", "charged", "off", "against", "the", "allowance", "after", "all", "means", "of", "collection", "have", "been", "exhausted", "and", "the", "potential", "for", "recovery", "is", "considered", "remote.", "<tag3>"], "wordsA": ["To", "date,", "these", "operating", "losses", "have", "been", "funded", "primarily", "from", "outside", "sources", "of", "invested", "capital", "and", "gross", "profits."], "wordsB": ["Account", "balances", "are", "charged", "off", "against", "the", "allowance", "after", "all", "means", "of", "collection", "have", "been", "exhausted", "and", "the", "potential", "for", "recovery", "is", "considered", "remote."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p101_s2", "idA": "1095981_14_item7_p64_s0", "sentA": "The Company continues to seek additional capital through product revenues, strategic transactions, including extension opportunities under the awarded BARDA contract, and from other financing alternatives.", "sentB": "The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio.", "type": 1, "words": ["<tag1>", "The", "Company", "continues", "to", "seek", "additional", "capital", "through", "product", "revenues,", "strategic", "transactions,", "including", "extension", "opportunities", "under", "the", "awarded", "BARDA", "contract,", "and", "from", "other", "financing", "alternatives.", "<tag2>", "The", "Company", "maintains", "an", "allowance", "for", "doubtful", "accounts", "for", "estimated", "losses", "inherent", "in", "its", "accounts", "receivable", "portfolio.", "<tag3>"], "wordsA": ["The", "Company", "continues", "to", "seek", "additional", "capital", "through", "product", "revenues,", "strategic", "transactions,", "including", "extension", "opportunities", "under", "the", "awarded", "BARDA", "contract,", "and", "from", "other", "financing", "alternatives."], "wordsB": ["The", "Company", "maintains", "an", "allowance", "for", "doubtful", "accounts", "for", "estimated", "losses", "inherent", "in", "its", "accounts", "receivable", "portfolio."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p101_s3", "idA": "1095981_14_item7_p66_s0", "sentA": "In June 2010, we entered into an Amended and Restated Loan and Security Agreement with the GECC, SVB, and Oxford Finance Corporation (Lenders), pursuant to which the Lenders funded a term loan in the amount of $20,000,000 on June 14, 2010, which refinanced the remaining balance of the term loan entered into with GECC and SVB on October 14, 2008.", "sentB": "In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and our customers financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns.", "type": 1, "words": ["<tag1>", "In", "June", "2010,", "we", "entered", "into", "an", "Amended", "and", "Restated", "Loan", "and", "Security", "Agreement", "with", "the", "GECC,", "SVB,", "and", "Oxford", "Finance", "Corporation", "(Lenders),", "pursuant", "to", "which", "the", "Lenders", "funded", "a", "term", "loan", "in", "the", "amount", "of", "$20,000,000", "on", "June", "14,", "2010,", "which", "refinanced", "the", "remaining", "balance", "of", "the", "term", "loan", "entered", "into", "with", "GECC", "and", "SVB", "on", "October", "14,", "2008.", "<tag2>", "In", "establishing", "the", "required", "allowance,", "management", "considers", "historical", "losses", "adjusted", "to", "take", "into", "account", "current", "market", "conditions", "and", "our", "customers", "financial", "condition,", "the", "amount", "of", "receivables", "in", "dispute,", "and", "the", "current", "receivables", "aging", "and", "current", "payment", "patterns.", "<tag3>"], "wordsA": ["In", "June", "2010,", "we", "entered", "into", "an", "Amended", "and", "Restated", "Loan", "and", "Security", "Agreement", "with", "the", "GECC,", "SVB,", "and", "Oxford", "Finance", "Corporation", "(Lenders),", "pursuant", "to", "which", "the", "Lenders", "funded", "a", "term", "loan", "in", "the", "amount", "of", "$20,000,000", "on", "June", "14,", "2010,", "which", "refinanced", "the", "remaining", "balance", "of", "the", "term", "loan", "entered", "into", "with", "GECC", "and", "SVB", "on", "October", "14,", "2008."], "wordsB": ["In", "establishing", "the", "required", "allowance,", "management", "considers", "historical", "losses", "adjusted", "to", "take", "into", "account", "current", "market", "conditions", "and", "our", "customers", "financial", "condition,", "the", "amount", "of", "receivables", "in", "dispute,", "and", "the", "current", "receivables", "aging", "and", "current", "payment", "patterns."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p104_s3", "idA": "1095981_14_item7_p66_s0", "sentA": "In June 2010, we entered into an Amended and Restated Loan and Security Agreement with the GECC, SVB, and Oxford Finance Corporation (Lenders), pursuant to which the Lenders funded a term loan in the amount of $20,000,000 on June 14, 2010, which refinanced the remaining balance of the term loan entered into with GECC and SVB on October 14, 2008.", "sentB": "If deemed necessary, a two-step test is used to identify the potential impairment and to measure the amount of goodwill impairment, if any.", "type": 1, "words": ["<tag1>", "In", "June", "2010,", "we", "entered", "into", "an", "Amended", "and", "Restated", "Loan", "and", "Security", "Agreement", "with", "the", "GECC,", "SVB,", "and", "Oxford", "Finance", "Corporation", "(Lenders),", "pursuant", "to", "which", "the", "Lenders", "funded", "a", "term", "loan", "in", "the", "amount", "of", "$20,000,000", "on", "June", "14,", "2010,", "which", "refinanced", "the", "remaining", "balance", "of", "the", "term", "loan", "entered", "into", "with", "GECC", "and", "SVB", "on", "October", "14,", "2008.", "<tag2>", "If", "deemed", "necessary,", "a", "two-step", "test", "is", "used", "to", "identify", "the", "potential", "impairment", "and", "to", "measure", "the", "amount", "of", "goodwill", "impairment,", "if", "any.", "<tag3>"], "wordsA": ["In", "June", "2010,", "we", "entered", "into", "an", "Amended", "and", "Restated", "Loan", "and", "Security", "Agreement", "with", "the", "GECC,", "SVB,", "and", "Oxford", "Finance", "Corporation", "(Lenders),", "pursuant", "to", "which", "the", "Lenders", "funded", "a", "term", "loan", "in", "the", "amount", "of", "$20,000,000", "on", "June", "14,", "2010,", "which", "refinanced", "the", "remaining", "balance", "of", "the", "term", "loan", "entered", "into", "with", "GECC", "and", "SVB", "on", "October", "14,", "2008."], "wordsB": ["If", "deemed", "necessary,", "a", "two-step", "test", "is", "used", "to", "identify", "the", "potential", "impairment", "and", "to", "measure", "the", "amount", "of", "goodwill", "impairment,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p72_s4", "idA": "1095981_14_item7_p67_s1", "sentA": "This price to the public in this offering was $4.50 per share and Jefferies agreed to purchase the shares from us at a price of $4.23 per share.", "sentB": "For those investors participating in the October 2014 issuance of Series A 3.6% Convertible Preferred Stock, we agreed to reduce the exercise price of 3,384,601 warrants from $2.00 per share to $0.5771 per share, conditioned upon shareholder approval which was obtained in January 2015.", "type": 1, "words": ["<tag1>", "This", "price", "to", "the", "public", "in", "this", "offering", "was", "$4.50", "per", "share", "and", "Jefferies", "agreed", "to", "purchase", "the", "shares", "from", "us", "at", "a", "price", "of", "$4.23", "per", "share.", "<tag2>", "For", "those", "investors", "participating", "in", "the", "October", "2014", "issuance", "of", "Series", "A", "3.6%", "Convertible", "Preferred", "Stock,", "we", "agreed", "to", "reduce", "the", "exercise", "price", "of", "3,384,601", "warrants", "from", "$2.00", "per", "share", "to", "$0.5771", "per", "share,", "conditioned", "upon", "shareholder", "approval", "which", "was", "obtained", "in", "January", "2015.", "<tag3>"], "wordsA": ["This", "price", "to", "the", "public", "in", "this", "offering", "was", "$4.50", "per", "share", "and", "Jefferies", "agreed", "to", "purchase", "the", "shares", "from", "us", "at", "a", "price", "of", "$4.23", "per", "share."], "wordsB": ["For", "those", "investors", "participating", "in", "the", "October", "2014", "issuance", "of", "Series", "A", "3.6%", "Convertible", "Preferred", "Stock,", "we", "agreed", "to", "reduce", "the", "exercise", "price", "of", "3,384,601", "warrants", "from", "$2.00", "per", "share", "to", "$0.5771", "per", "share,", "conditioned", "upon", "shareholder", "approval", "which", "was", "obtained", "in", "January", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p5_s3", "idA": "1095981_14_item7_p6_s2", "sentA": "All evidence to date supports the current, known safety profile for Cytori s Cell Therapy and the patients enrolled in the trial will continue to be followed according to the protocol.", "sentB": "The first patient was enrolled in February 2015.", "type": 1, "words": ["<tag1>", "All", "evidence", "to", "date", "supports", "the", "current,", "known", "safety", "profile", "for", "Cytori", "s", "Cell", "Therapy", "and", "the", "patients", "enrolled", "in", "the", "trial", "will", "continue", "to", "be", "followed", "according", "to", "the", "protocol.", "<tag2>", "The", "first", "patient", "was", "enrolled", "in", "February", "2015.", "<tag3>"], "wordsA": ["All", "evidence", "to", "date", "supports", "the", "current,", "known", "safety", "profile", "for", "Cytori", "s", "Cell", "Therapy", "and", "the", "patients", "enrolled", "in", "the", "trial", "will", "continue", "to", "be", "followed", "according", "to", "the", "protocol."], "wordsB": ["The", "first", "patient", "was", "enrolled", "in", "February", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p62_s3", "idA": "1095981_14_item7_p6_s3", "sentA": "The outcomes will be fully analyzed in conjunction with the existing safety and feasibility data from the APOLLO acute myocardial infarction trial.", "sentB": "In parallel, we would significantly reduce administrative staff and salaries consistent with the overall reduction in scope of operations.", "type": 1, "words": ["<tag1>", "The", "outcomes", "will", "be", "fully", "analyzed", "in", "conjunction", "with", "the", "existing", "safety", "and", "feasibility", "data", "from", "the", "APOLLO", "acute", "myocardial", "infarction", "trial.", "<tag2>", "In", "parallel,", "we", "would", "significantly", "reduce", "administrative", "staff", "and", "salaries", "consistent", "with", "the", "overall", "reduction", "in", "scope", "of", "operations.", "<tag3>"], "wordsA": ["The", "outcomes", "will", "be", "fully", "analyzed", "in", "conjunction", "with", "the", "existing", "safety", "and", "feasibility", "data", "from", "the", "APOLLO", "acute", "myocardial", "infarction", "trial."], "wordsB": ["In", "parallel,", "we", "would", "significantly", "reduce", "administrative", "staff", "and", "salaries", "consistent", "with", "the", "overall", "reduction", "in", "scope", "of", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p74_s1", "idA": "1095981_14_item7_p72_s2", "sentA": "In connection with the Term Loans, on June 28, 2013, we issued to the Lenders warrants to purchase up to an aggregate of 596,553 shares of our common stock at an exercise price of $2.26 per share.", "sentB": "Each warrant has an exercise price of $0.5771 per share, is exercisable six months after the date of issuance and expires five years from the date on which it is initially exercisable.", "type": 1, "words": ["<tag1>", "In", "connection", "with", "the", "Term", "Loans,", "on", "June", "28,", "2013,", "we", "issued", "to", "the", "Lenders", "warrants", "to", "purchase", "up", "to", "an", "aggregate", "of", "596,553", "shares", "of", "our", "common", "stock", "at", "an", "exercise", "price", "of", "$2.26", "per", "share.", "<tag2>", "Each", "warrant", "has", "an", "exercise", "price", "of", "$0.5771", "per", "share,", "is", "exercisable", "six", "months", "after", "the", "date", "of", "issuance", "and", "expires", "five", "years", "from", "the", "date", "on", "which", "it", "is", "initially", "exercisable.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "Term", "Loans,", "on", "June", "28,", "2013,", "we", "issued", "to", "the", "Lenders", "warrants", "to", "purchase", "up", "to", "an", "aggregate", "of", "596,553", "shares", "of", "our", "common", "stock", "at", "an", "exercise", "price", "of", "$2.26", "per", "share."], "wordsB": ["Each", "warrant", "has", "an", "exercise", "price", "of", "$0.5771", "per", "share,", "is", "exercisable", "six", "months", "after", "the", "date", "of", "issuance", "and", "expires", "five", "years", "from", "the", "date", "on", "which", "it", "is", "initially", "exercisable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p11_s0", "idA": "1095981_14_item7_p74_s1", "sentA": "The aggregate value of the consideration paid by Bimini at the execution of the agreement was $5.0 million.", "sentB": "In August and December, 2014, BARDA awarded to us contract options of $14 million.", "type": 1, "words": ["<tag1>", "The", "aggregate", "value", "of", "the", "consideration", "paid", "by", "Bimini", "at", "the", "execution", "of", "the", "agreement", "was", "$5.0", "million.", "<tag2>", "In", "August", "and", "December,", "2014,", "BARDA", "awarded", "to", "us", "contract", "options", "of", "$14", "million.", "<tag3>"], "wordsA": ["The", "aggregate", "value", "of", "the", "consideration", "paid", "by", "Bimini", "at", "the", "execution", "of", "the", "agreement", "was", "$5.0", "million."], "wordsB": ["In", "August", "and", "December,", "2014,", "BARDA", "awarded", "to", "us", "contract", "options", "of", "$14", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p11_s2", "idA": "1095981_14_item7_p74_s1", "sentA": "The aggregate value of the consideration paid by Bimini at the execution of the agreement was $5.0 million.", "sentB": "The award for conducting the pilot trial, approximately $8 million, would follow FDA approval of the trial protocol and associated documentation.", "type": 1, "words": ["<tag1>", "The", "aggregate", "value", "of", "the", "consideration", "paid", "by", "Bimini", "at", "the", "execution", "of", "the", "agreement", "was", "$5.0", "million.", "<tag2>", "The", "award", "for", "conducting", "the", "pilot", "trial,", "approximately", "$8", "million,", "would", "follow", "FDA", "approval", "of", "the", "trial", "protocol", "and", "associated", "documentation.", "<tag3>"], "wordsA": ["The", "aggregate", "value", "of", "the", "consideration", "paid", "by", "Bimini", "at", "the", "execution", "of", "the", "agreement", "was", "$5.0", "million."], "wordsB": ["The", "award", "for", "conducting", "the", "pilot", "trial,", "approximately", "$8", "million,", "would", "follow", "FDA", "approval", "of", "the", "trial", "protocol", "and", "associated", "documentation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p97_s1", "idA": "1095981_14_item7_p74_s1", "sentA": "The aggregate value of the consideration paid by Bimini at the execution of the agreement was $5.0 million.", "sentB": "Depending on customers needs, all or combination of the following units of accounting will apply to cell bank transactions:", "type": 1, "words": ["<tag1>", "The", "aggregate", "value", "of", "the", "consideration", "paid", "by", "Bimini", "at", "the", "execution", "of", "the", "agreement", "was", "$5.0", "million.", "<tag2>", "Depending", "on", "customers", "needs,", "all", "or", "combination", "of", "the", "following", "units", "of", "accounting", "will", "apply", "to", "cell", "bank", "transactions:", "<tag3>"], "wordsA": ["The", "aggregate", "value", "of", "the", "consideration", "paid", "by", "Bimini", "at", "the", "execution", "of", "the", "agreement", "was", "$5.0", "million."], "wordsB": ["Depending", "on", "customers", "needs,", "all", "or", "combination", "of", "the", "following", "units", "of", "accounting", "will", "apply", "to", "cell", "bank", "transactions:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p61_s5", "idA": "1095981_14_item7_p75_s2", "sentA": "Under the Restated Agreement, Lorem Vascular committed to pay up to $500 million in license fees in the form of revenue milestones.", "sentB": "Although there can be no assurance given, we hope to successfully complete one or more additional financing transactions and corporate partnerships in the near-term.", "type": 1, "words": ["<tag1>", "Under", "the", "Restated", "Agreement,", "Lorem", "Vascular", "committed", "to", "pay", "up", "to", "$500", "million", "in", "license", "fees", "in", "the", "form", "of", "revenue", "milestones.", "<tag2>", "Although", "there", "can", "be", "no", "assurance", "given,", "we", "hope", "to", "successfully", "complete", "one", "or", "more", "additional", "financing", "transactions", "and", "corporate", "partnerships", "in", "the", "near-term.", "<tag3>"], "wordsA": ["Under", "the", "Restated", "Agreement,", "Lorem", "Vascular", "committed", "to", "pay", "up", "to", "$500", "million", "in", "license", "fees", "in", "the", "form", "of", "revenue", "milestones."], "wordsB": ["Although", "there", "can", "be", "no", "assurance", "given,", "we", "hope", "to", "successfully", "complete", "one", "or", "more", "additional", "financing", "transactions", "and", "corporate", "partnerships", "in", "the", "near-term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p75_s0", "idA": "1095981_14_item7_p76_s3", "sentA": "The Equity purchased was closed in two installments, the first in November 2013, and the second in January 2014.", "sentB": "The preferred stock and the warrants were immediately separable and were issued separately.", "type": 1, "words": ["<tag1>", "The", "Equity", "purchased", "was", "closed", "in", "two", "installments,", "the", "first", "in", "November", "2013,", "and", "the", "second", "in", "January", "2014.", "<tag2>", "The", "preferred", "stock", "and", "the", "warrants", "were", "immediately", "separable", "and", "were", "issued", "separately.", "<tag3>"], "wordsA": ["The", "Equity", "purchased", "was", "closed", "in", "two", "installments,", "the", "first", "in", "November", "2013,", "and", "the", "second", "in", "January", "2014."], "wordsB": ["The", "preferred", "stock", "and", "the", "warrants", "were", "immediately", "separable", "and", "were", "issued", "separately."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p1_s3", "idA": "1095981_14_item7_p7_s1", "sentA": "We have reported long term, 18-month data from the PRECISE trial for chronic myocardial ischemia, which showed that Cytori s Cell Therapy demonstrated safety and sustained improvement in cardiac functional capacity as measured by VO 2 max.", "sentB": "An independent published study has demonstrated that Cytori s proprietary process results in higher nucleated cell viability, less residual enzyme activity, less processing time, and improved economics in terms of cell progenitor output compared to other semi-automated and automated processes available.", "type": 1, "words": ["<tag1>", "We", "have", "reported", "long", "term,", "18-month", "data", "from", "the", "PRECISE", "trial", "for", "chronic", "myocardial", "ischemia,", "which", "showed", "that", "Cytori", "s", "Cell", "Therapy", "demonstrated", "safety", "and", "sustained", "improvement", "in", "cardiac", "functional", "capacity", "as", "measured", "by", "VO", "2", "max.", "<tag2>", "An", "independent", "published", "study", "has", "demonstrated", "that", "Cytori", "s", "proprietary", "process", "results", "in", "higher", "nucleated", "cell", "viability,", "less", "residual", "enzyme", "activity,", "less", "processing", "time,", "and", "improved", "economics", "in", "terms", "of", "cell", "progenitor", "output", "compared", "to", "other", "semi-automated", "and", "automated", "processes", "available.", "<tag3>"], "wordsA": ["We", "have", "reported", "long", "term,", "18-month", "data", "from", "the", "PRECISE", "trial", "for", "chronic", "myocardial", "ischemia,", "which", "showed", "that", "Cytori", "s", "Cell", "Therapy", "demonstrated", "safety", "and", "sustained", "improvement", "in", "cardiac", "functional", "capacity", "as", "measured", "by", "VO", "2", "max."], "wordsB": ["An", "independent", "published", "study", "has", "demonstrated", "that", "Cytori", "s", "proprietary", "process", "results", "in", "higher", "nucleated", "cell", "viability,", "less", "residual", "enzyme", "activity,", "less", "processing", "time,", "and", "improved", "economics", "in", "terms", "of", "cell", "progenitor", "output", "compared", "to", "other", "semi-automated", "and", "automated", "processes", "available."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p93_s0", "idA": "1095981_14_item7_p84_s0", "sentA": "The net cash provided by financing activities for the year ended December 31, 2013 related primarily to a sale to Lorem Vascular of 4,000,000 shares for $12,000,000 in gross proceeds, as well as an additional $3,000,000 in gross proceeds (received in 2013) which related to the second closing of an additional 4,000,000 shares in January 2014.", "sentB": "For all sales, we use a binding purchase order or a signed agreement as evidence of an arrangement.", "type": 1, "words": ["<tag1>", "The", "net", "cash", "provided", "by", "financing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "related", "primarily", "to", "a", "sale", "to", "Lorem", "Vascular", "of", "4,000,000", "shares", "for", "$12,000,000", "in", "gross", "proceeds,", "as", "well", "as", "an", "additional", "$3,000,000", "in", "gross", "proceeds", "(received", "in", "2013)", "which", "related", "to", "the", "second", "closing", "of", "an", "additional", "4,000,000", "shares", "in", "January", "2014.", "<tag2>", "For", "all", "sales,", "we", "use", "a", "binding", "purchase", "order", "or", "a", "signed", "agreement", "as", "evidence", "of", "an", "arrangement.", "<tag3>"], "wordsA": ["The", "net", "cash", "provided", "by", "financing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "related", "primarily", "to", "a", "sale", "to", "Lorem", "Vascular", "of", "4,000,000", "shares", "for", "$12,000,000", "in", "gross", "proceeds,", "as", "well", "as", "an", "additional", "$3,000,000", "in", "gross", "proceeds", "(received", "in", "2013)", "which", "related", "to", "the", "second", "closing", "of", "an", "additional", "4,000,000", "shares", "in", "January", "2014."], "wordsB": ["For", "all", "sales,", "we", "use", "a", "binding", "purchase", "order", "or", "a", "signed", "agreement", "as", "evidence", "of", "an", "arrangement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p4_s3", "idA": "1095981_14_item7_p89_s0", "sentA": "We believe it is important for you to understand our most critical accounting policies.", "sentB": "Based on our internal analysis of the clinical and commercial chances of success, we have decided that scleroderma will be our most advanced clinical indication as it is a phase III pivotal study.", "type": 1, "words": ["<tag1>", "We", "believe", "it", "is", "important", "for", "you", "to", "understand", "our", "most", "critical", "accounting", "policies.", "<tag2>", "Based", "on", "our", "internal", "analysis", "of", "the", "clinical", "and", "commercial", "chances", "of", "success,", "we", "have", "decided", "that", "scleroderma", "will", "be", "our", "most", "advanced", "clinical", "indication", "as", "it", "is", "a", "phase", "III", "pivotal", "study.", "<tag3>"], "wordsA": ["We", "believe", "it", "is", "important", "for", "you", "to", "understand", "our", "most", "critical", "accounting", "policies."], "wordsB": ["Based", "on", "our", "internal", "analysis", "of", "the", "clinical", "and", "commercial", "chances", "of", "success,", "we", "have", "decided", "that", "scleroderma", "will", "be", "our", "most", "advanced", "clinical", "indication", "as", "it", "is", "a", "phase", "III", "pivotal", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p60_s2", "idA": "1095981_14_item7_p90_s0", "sentA": "See Notes to Consolidated Financial Statements included elsewhere herein for disclosure and discussion of our warrant liability and our put option liability.", "sentB": "However, our ability to raise capital was adversely affected once FDA put a hold on our Athena trials in mid-2014, which had an adverse impact to stock price performance and our corresponding ability to restructure our debt.", "type": 1, "words": ["<tag1>", "See", "Notes", "to", "Consolidated", "Financial", "Statements", "included", "elsewhere", "herein", "for", "disclosure", "and", "discussion", "of", "our", "warrant", "liability", "and", "our", "put", "option", "liability.", "<tag2>", "However,", "our", "ability", "to", "raise", "capital", "was", "adversely", "affected", "once", "FDA", "put", "a", "hold", "on", "our", "Athena", "trials", "in", "mid-2014,", "which", "had", "an", "adverse", "impact", "to", "stock", "price", "performance", "and", "our", "corresponding", "ability", "to", "restructure", "our", "debt.", "<tag3>"], "wordsA": ["See", "Notes", "to", "Consolidated", "Financial", "Statements", "included", "elsewhere", "herein", "for", "disclosure", "and", "discussion", "of", "our", "warrant", "liability", "and", "our", "put", "option", "liability."], "wordsB": ["However,", "our", "ability", "to", "raise", "capital", "was", "adversely", "affected", "once", "FDA", "put", "a", "hold", "on", "our", "Athena", "trials", "in", "mid-2014,", "which", "had", "an", "adverse", "impact", "to", "stock", "price", "performance", "and", "our", "corresponding", "ability", "to", "restructure", "our", "debt."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item7_p62_s6", "idA": "1095981_14_item7_p9_s4", "sentA": "We have also received FDA approval in late 2013 to conduct a safety and feasibility clinical trial in patients with acute hamstring tears in order to evaluate the effect of Cytori Cell Therapy on healing in muscle injury.", "sentB": "While management is actively pursuing it s near term financial and strategic alternatives it is also, in parallel, continuing to evaluate the timing of implementation of the alternative operating plan and the initiation of the identified reductions.", "type": 1, "words": ["<tag1>", "We", "have", "also", "received", "FDA", "approval", "in", "late", "2013", "to", "conduct", "a", "safety", "and", "feasibility", "clinical", "trial", "in", "patients", "with", "acute", "hamstring", "tears", "in", "order", "to", "evaluate", "the", "effect", "of", "Cytori", "Cell", "Therapy", "on", "healing", "in", "muscle", "injury.", "<tag2>", "While", "management", "is", "actively", "pursuing", "it", "s", "near", "term", "financial", "and", "strategic", "alternatives", "it", "is", "also,", "in", "parallel,", "continuing", "to", "evaluate", "the", "timing", "of", "implementation", "of", "the", "alternative", "operating", "plan", "and", "the", "initiation", "of", "the", "identified", "reductions.", "<tag3>"], "wordsA": ["We", "have", "also", "received", "FDA", "approval", "in", "late", "2013", "to", "conduct", "a", "safety", "and", "feasibility", "clinical", "trial", "in", "patients", "with", "acute", "hamstring", "tears", "in", "order", "to", "evaluate", "the", "effect", "of", "Cytori", "Cell", "Therapy", "on", "healing", "in", "muscle", "injury."], "wordsB": ["While", "management", "is", "actively", "pursuing", "it", "s", "near", "term", "financial", "and", "strategic", "alternatives", "it", "is", "also,", "in", "parallel,", "continuing", "to", "evaluate", "the", "timing", "of", "implementation", "of", "the", "alternative", "operating", "plan", "and", "the", "initiation", "of", "the", "identified", "reductions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p6_s2", "idA": "1095981_15_item7_p0_s0", "sentA": "We are a biotechnology company dedicated to the development of novel treatments and devices for a range of disorders using cells as a key part of the therapy.", "sentB": "The objective of the analysis was to determine whether early high level data could be useful in planning the anticipated phase III program or support ongoing R D activities that could accelerate the overall clinical development of the technology.", "type": 1, "words": ["<tag1>", "We", "are", "a", "biotechnology", "company", "dedicated", "to", "the", "development", "of", "novel", "treatments", "and", "devices", "for", "a", "range", "of", "disorders", "using", "cells", "as", "a", "key", "part", "of", "the", "therapy.", "<tag2>", "The", "objective", "of", "the", "analysis", "was", "to", "determine", "whether", "early", "high", "level", "data", "could", "be", "useful", "in", "planning", "the", "anticipated", "phase", "III", "program", "or", "support", "ongoing", "R", "D", "activities", "that", "could", "accelerate", "the", "overall", "clinical", "development", "of", "the", "technology.", "<tag3>"], "wordsA": ["We", "are", "a", "biotechnology", "company", "dedicated", "to", "the", "development", "of", "novel", "treatments", "and", "devices", "for", "a", "range", "of", "disorders", "using", "cells", "as", "a", "key", "part", "of", "the", "therapy."], "wordsB": ["The", "objective", "of", "the", "analysis", "was", "to", "determine", "whether", "early", "high", "level", "data", "could", "be", "useful", "in", "planning", "the", "anticipated", "phase", "III", "program", "or", "support", "ongoing", "R", "D", "activities", "that", "could", "accelerate", "the", "overall", "clinical", "development", "of", "the", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p78_s3", "idA": "1095981_15_item7_p101_s0", "sentA": "Accounts receivable are recorded at the invoiced amount and do not bear interest.", "sentB": "The purchase price for each unit sold at the initial closing was $0.77.", "type": 1, "words": ["<tag1>", "Accounts", "receivable", "are", "recorded", "at", "the", "invoiced", "amount", "and", "do", "not", "bear", "interest.", "<tag2>", "The", "purchase", "price", "for", "each", "unit", "sold", "at", "the", "initial", "closing", "was", "$0.77.", "<tag3>"], "wordsA": ["Accounts", "receivable", "are", "recorded", "at", "the", "invoiced", "amount", "and", "do", "not", "bear", "interest."], "wordsB": ["The", "purchase", "price", "for", "each", "unit", "sold", "at", "the", "initial", "closing", "was", "$0.77."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p88_s4", "idA": "1095981_15_item7_p101_s0", "sentA": "Accounts receivable are recorded at the invoiced amount and do not bear interest.", "sentB": "The purchase price for each unit sold at the initial closing was $0.77.", "type": 1, "words": ["<tag1>", "Accounts", "receivable", "are", "recorded", "at", "the", "invoiced", "amount", "and", "do", "not", "bear", "interest.", "<tag2>", "The", "purchase", "price", "for", "each", "unit", "sold", "at", "the", "initial", "closing", "was", "$0.77.", "<tag3>"], "wordsA": ["Accounts", "receivable", "are", "recorded", "at", "the", "invoiced", "amount", "and", "do", "not", "bear", "interest."], "wordsB": ["The", "purchase", "price", "for", "each", "unit", "sold", "at", "the", "initial", "closing", "was", "$0.77."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p19_s1", "idA": "1095981_15_item7_p16_s2", "sentA": "Additionally, as a result of Class I Device Clearance for Celution and a number of our other products in Japan, we anticipate selling these products to researchers at academic hospitals seeking to perform investigator-initiated and funded studies using Cytori s Cell Therapy.", "sentB": "In Japan and EMEA, researchers will use the Celution System to construct ongoing and new investigator-initiated and funded studies focused on, but not limited to, hand scleroderma, Crohn disease, peripheral artery disease, erectile dysfunction, and diabetic foot ulcer.", "type": 1, "words": ["<tag1>", "Additionally,", "as", "a", "result", "of", "Class", "I", "Device", "Clearance", "for", "Celution", "and", "a", "number", "of", "our", "other", "products", "in", "Japan,", "we", "anticipate", "selling", "these", "products", "to", "researchers", "at", "academic", "hospitals", "seeking", "to", "perform", "investigator-initiated", "and", "funded", "studies", "using", "Cytori", "s", "Cell", "Therapy.", "<tag2>", "In", "Japan", "and", "EMEA,", "researchers", "will", "use", "the", "Celution", "System", "to", "construct", "ongoing", "and", "new", "investigator-initiated", "and", "funded", "studies", "focused", "on,", "but", "not", "limited", "to,", "hand", "scleroderma,", "Crohn", "disease,", "peripheral", "artery", "disease,", "erectile", "dysfunction,", "and", "diabetic", "foot", "ulcer.", "<tag3>"], "wordsA": ["Additionally,", "as", "a", "result", "of", "Class", "I", "Device", "Clearance", "for", "Celution", "and", "a", "number", "of", "our", "other", "products", "in", "Japan,", "we", "anticipate", "selling", "these", "products", "to", "researchers", "at", "academic", "hospitals", "seeking", "to", "perform", "investigator-initiated", "and", "funded", "studies", "using", "Cytori", "s", "Cell", "Therapy."], "wordsB": ["In", "Japan", "and", "EMEA,", "researchers", "will", "use", "the", "Celution", "System", "to", "construct", "ongoing", "and", "new", "investigator-initiated", "and", "funded", "studies", "focused", "on,", "but", "not", "limited", "to,", "hand", "scleroderma,", "Crohn", "disease,", "peripheral", "artery", "disease,", "erectile", "dysfunction,", "and", "diabetic", "foot", "ulcer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p64_s3", "idA": "1095981_15_item7_p25_s0", "sentA": "Research and development expenses relate to the development of a technology platform that involves using adipose tissue as a source of autologous regenerative cells for therapeutic applications as well as the continued development efforts related to our Celution System.", "sentB": "More recently, a continued downward trend in our stock price resulting from general economic and industry conditions as well as the market s unfavorable view of our recent equity financings (which financings were priced at a discount to market and included 100% warrant coverage) and our Nasdaq listing deficiency, have made it more difficult to procure additional capital on terms reasonably acceptable to us.", "type": 1, "words": ["<tag1>", "Research", "and", "development", "expenses", "relate", "to", "the", "development", "of", "a", "technology", "platform", "that", "involves", "using", "adipose", "tissue", "as", "a", "source", "of", "autologous", "regenerative", "cells", "for", "therapeutic", "applications", "as", "well", "as", "the", "continued", "development", "efforts", "related", "to", "our", "Celution", "System.", "<tag2>", "More", "recently,", "a", "continued", "downward", "trend", "in", "our", "stock", "price", "resulting", "from", "general", "economic", "and", "industry", "conditions", "as", "well", "as", "the", "market", "s", "unfavorable", "view", "of", "our", "recent", "equity", "financings", "(which", "financings", "were", "priced", "at", "a", "discount", "to", "market", "and", "included", "100%", "warrant", "coverage)", "and", "our", "Nasdaq", "listing", "deficiency,", "have", "made", "it", "more", "difficult", "to", "procure", "additional", "capital", "on", "terms", "reasonably", "acceptable", "to", "us.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "relate", "to", "the", "development", "of", "a", "technology", "platform", "that", "involves", "using", "adipose", "tissue", "as", "a", "source", "of", "autologous", "regenerative", "cells", "for", "therapeutic", "applications", "as", "well", "as", "the", "continued", "development", "efforts", "related", "to", "our", "Celution", "System."], "wordsB": ["More", "recently,", "a", "continued", "downward", "trend", "in", "our", "stock", "price", "resulting", "from", "general", "economic", "and", "industry", "conditions", "as", "well", "as", "the", "market", "s", "unfavorable", "view", "of", "our", "recent", "equity", "financings", "(which", "financings", "were", "priced", "at", "a", "discount", "to", "market", "and", "included", "100%", "warrant", "coverage)", "and", "our", "Nasdaq", "listing", "deficiency,", "have", "made", "it", "more", "difficult", "to", "procure", "additional", "capital", "on", "terms", "reasonably", "acceptable", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p13_s1", "idA": "1095981_15_item7_p2_s1", "sentA": "The sales enhance the body of clinical feasibility data using our technology that could lead to new indications and intellectual property, contribute to near term marginal profit that partially offset our operating expenses and provide the basis for further partnerships and commercial experience that should facilitate future product revenue growth.", "sentB": "It also served to fund approximately two years of preclinical studies in other burn-related areas that could lead to broadening of the utility of Cytori technology to burn centers and in wound healing more generally.", "type": 1, "words": ["<tag1>", "The", "sales", "enhance", "the", "body", "of", "clinical", "feasibility", "data", "using", "our", "technology", "that", "could", "lead", "to", "new", "indications", "and", "intellectual", "property,", "contribute", "to", "near", "term", "marginal", "profit", "that", "partially", "offset", "our", "operating", "expenses", "and", "provide", "the", "basis", "for", "further", "partnerships", "and", "commercial", "experience", "that", "should", "facilitate", "future", "product", "revenue", "growth.", "<tag2>", "It", "also", "served", "to", "fund", "approximately", "two", "years", "of", "preclinical", "studies", "in", "other", "burn-related", "areas", "that", "could", "lead", "to", "broadening", "of", "the", "utility", "of", "Cytori", "technology", "to", "burn", "centers", "and", "in", "wound", "healing", "more", "generally.", "<tag3>"], "wordsA": ["The", "sales", "enhance", "the", "body", "of", "clinical", "feasibility", "data", "using", "our", "technology", "that", "could", "lead", "to", "new", "indications", "and", "intellectual", "property,", "contribute", "to", "near", "term", "marginal", "profit", "that", "partially", "offset", "our", "operating", "expenses", "and", "provide", "the", "basis", "for", "further", "partnerships", "and", "commercial", "experience", "that", "should", "facilitate", "future", "product", "revenue", "growth."], "wordsB": ["It", "also", "served", "to", "fund", "approximately", "two", "years", "of", "preclinical", "studies", "in", "other", "burn-related", "areas", "that", "could", "lead", "to", "broadening", "of", "the", "utility", "of", "Cytori", "technology", "to", "burn", "centers", "and", "in", "wound", "healing", "more", "generally."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p105_s0", "idA": "1095981_15_item7_p38_s0", "sentA": "Stock-based compensation expenses include charges related to options and restricted stock awards issued to employees, directors and non-employees along with charges related to the employee stock purchases under the Employee Stock Purchase Plan (ESPP).", "sentB": "Manufacturing costs resulting from lower than normal production levels are expensed as incurred.", "type": 1, "words": ["<tag1>", "Stock-based", "compensation", "expenses", "include", "charges", "related", "to", "options", "and", "restricted", "stock", "awards", "issued", "to", "employees,", "directors", "and", "non-employees", "along", "with", "charges", "related", "to", "the", "employee", "stock", "purchases", "under", "the", "Employee", "Stock", "Purchase", "Plan", "(ESPP).", "<tag2>", "Manufacturing", "costs", "resulting", "from", "lower", "than", "normal", "production", "levels", "are", "expensed", "as", "incurred.", "<tag3>"], "wordsA": ["Stock-based", "compensation", "expenses", "include", "charges", "related", "to", "options", "and", "restricted", "stock", "awards", "issued", "to", "employees,", "directors", "and", "non-employees", "along", "with", "charges", "related", "to", "the", "employee", "stock", "purchases", "under", "the", "Employee", "Stock", "Purchase", "Plan", "(ESPP)."], "wordsB": ["Manufacturing", "costs", "resulting", "from", "lower", "than", "normal", "production", "levels", "are", "expensed", "as", "incurred."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p6_s3", "idA": "1095981_15_item7_p62_s6", "sentA": "While management is actively pursuing it s near term financial and strategic alternatives it is also, in parallel, continuing to evaluate the timing of implementation of the alternative operating plan and the initiation of the identified reductions.", "sentB": "In the 3 rd quarter of 2016, following full un-blinding of the data, the Company will be able to more fully evaluate the data including 48 week follow up, patient subset analyses, and the effect on knee cartilage as measured by magnetic resonance imaging results changes between baseline and 48 weeks.", "type": 1, "words": ["<tag1>", "While", "management", "is", "actively", "pursuing", "it", "s", "near", "term", "financial", "and", "strategic", "alternatives", "it", "is", "also,", "in", "parallel,", "continuing", "to", "evaluate", "the", "timing", "of", "implementation", "of", "the", "alternative", "operating", "plan", "and", "the", "initiation", "of", "the", "identified", "reductions.", "<tag2>", "In", "the", "3", "rd", "quarter", "of", "2016,", "following", "full", "un-blinding", "of", "the", "data,", "the", "Company", "will", "be", "able", "to", "more", "fully", "evaluate", "the", "data", "including", "48", "week", "follow", "up,", "patient", "subset", "analyses,", "and", "the", "effect", "on", "knee", "cartilage", "as", "measured", "by", "magnetic", "resonance", "imaging", "results", "changes", "between", "baseline", "and", "48", "weeks.", "<tag3>"], "wordsA": ["While", "management", "is", "actively", "pursuing", "it", "s", "near", "term", "financial", "and", "strategic", "alternatives", "it", "is", "also,", "in", "parallel,", "continuing", "to", "evaluate", "the", "timing", "of", "implementation", "of", "the", "alternative", "operating", "plan", "and", "the", "initiation", "of", "the", "identified", "reductions."], "wordsB": ["In", "the", "3", "rd", "quarter", "of", "2016,", "following", "full", "un-blinding", "of", "the", "data,", "the", "Company", "will", "be", "able", "to", "more", "fully", "evaluate", "the", "data", "including", "48", "week", "follow", "up,", "patient", "subset", "analyses,", "and", "the", "effect", "on", "knee", "cartilage", "as", "measured", "by", "magnetic", "resonance", "imaging", "results", "changes", "between", "baseline", "and", "48", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p19_s2", "idA": "1095981_15_item7_p70_s1", "sentA": "In addition, Lorem Vascular agreed to purchase our Celution System and consumables under the Restated Agreement.", "sentB": "ECCS-50 therapy for hand scleroderma prepared with the Celution System will be accessible to patients and physicians through a Managed Access Program that launched in EMEA in early 2016.", "type": 1, "words": ["<tag1>", "In", "addition,", "Lorem", "Vascular", "agreed", "to", "purchase", "our", "Celution", "System", "and", "consumables", "under", "the", "Restated", "Agreement.", "<tag2>", "ECCS-50", "therapy", "for", "hand", "scleroderma", "prepared", "with", "the", "Celution", "System", "will", "be", "accessible", "to", "patients", "and", "physicians", "through", "a", "Managed", "Access", "Program", "that", "launched", "in", "EMEA", "in", "early", "2016.", "<tag3>"], "wordsA": ["In", "addition,", "Lorem", "Vascular", "agreed", "to", "purchase", "our", "Celution", "System", "and", "consumables", "under", "the", "Restated", "Agreement."], "wordsB": ["ECCS-50", "therapy", "for", "hand", "scleroderma", "prepared", "with", "the", "Celution", "System", "will", "be", "accessible", "to", "patients", "and", "physicians", "through", "a", "Managed", "Access", "Program", "that", "launched", "in", "EMEA", "in", "early", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p6_s1", "idA": "1095981_15_item7_p71_s2", "sentA": "The transaction was completed on June 4, 2014 raising approximately $10,000,000 in gross proceeds before deducting any offering expenses or fees payable by us.", "sentB": "A pre-specified partial unblinding and top-line analysis of 24 week data was completed in Q1 of 2016.", "type": 1, "words": ["<tag1>", "The", "transaction", "was", "completed", "on", "June", "4,", "2014", "raising", "approximately", "$10,000,000", "in", "gross", "proceeds", "before", "deducting", "any", "offering", "expenses", "or", "fees", "payable", "by", "us.", "<tag2>", "A", "pre-specified", "partial", "unblinding", "and", "top-line", "analysis", "of", "24", "week", "data", "was", "completed", "in", "Q1", "of", "2016.", "<tag3>"], "wordsA": ["The", "transaction", "was", "completed", "on", "June", "4,", "2014", "raising", "approximately", "$10,000,000", "in", "gross", "proceeds", "before", "deducting", "any", "offering", "expenses", "or", "fees", "payable", "by", "us."], "wordsB": ["A", "pre-specified", "partial", "unblinding", "and", "top-line", "analysis", "of", "24", "week", "data", "was", "completed", "in", "Q1", "of", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p104_s1", "idA": "1095981_15_item7_p75_s0", "sentA": "The preferred stock and the warrants were immediately separable and were issued separately.", "sentB": "We periodically evaluate our on-hand stock and make appropriate provisions for any stock deemed excess or obsolete.", "type": 1, "words": ["<tag1>", "The", "preferred", "stock", "and", "the", "warrants", "were", "immediately", "separable", "and", "were", "issued", "separately.", "<tag2>", "We", "periodically", "evaluate", "our", "on-hand", "stock", "and", "make", "appropriate", "provisions", "for", "any", "stock", "deemed", "excess", "or", "obsolete.", "<tag3>"], "wordsA": ["The", "preferred", "stock", "and", "the", "warrants", "were", "immediately", "separable", "and", "were", "issued", "separately."], "wordsB": ["We", "periodically", "evaluate", "our", "on-hand", "stock", "and", "make", "appropriate", "provisions", "for", "any", "stock", "deemed", "excess", "or", "obsolete."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p7_s1", "idA": "1095981_15_item7_p7_s0", "sentA": "Another therapeutic target under evaluation is stress urinary incontinence in men following radical prostatectomy, which is based on positive data reported in a peer reviewed journal.", "sentB": "In July 2015, a Company-supported male stress urinary incontinence (SUI) trial in Japan for male prostatectomy patients (after prostate surgery) received approval to being enrolled from the Japanese Ministry of Health, Labor and Welfare.", "type": 1, "words": ["<tag1>", "Another", "therapeutic", "target", "under", "evaluation", "is", "stress", "urinary", "incontinence", "in", "men", "following", "radical", "prostatectomy,", "which", "is", "based", "on", "positive", "data", "reported", "in", "a", "peer", "reviewed", "journal.", "<tag2>", "In", "July", "2015,", "a", "Company-supported", "male", "stress", "urinary", "incontinence", "(SUI)", "trial", "in", "Japan", "for", "male", "prostatectomy", "patients", "(after", "prostate", "surgery)", "received", "approval", "to", "being", "enrolled", "from", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare.", "<tag3>"], "wordsA": ["Another", "therapeutic", "target", "under", "evaluation", "is", "stress", "urinary", "incontinence", "in", "men", "following", "radical", "prostatectomy,", "which", "is", "based", "on", "positive", "data", "reported", "in", "a", "peer", "reviewed", "journal."], "wordsB": ["In", "July", "2015,", "a", "Company-supported", "male", "stress", "urinary", "incontinence", "(SUI)", "trial", "in", "Japan", "for", "male", "prostatectomy", "patients", "(after", "prostate", "surgery)", "received", "approval", "to", "being", "enrolled", "from", "the", "Japanese", "Ministry", "of", "Health,", "Labor", "and", "Welfare."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p78_s5", "idA": "1095981_15_item7_p84_s0", "sentA": "Net cash provided by investing activities for the year ended December 31, 2013 resulted from cash outflows for payment of a license termination fee of $800,000 and for purchases of property and equipment and cash inflows of $5,000,000 from the sale of the Puregraft product line.", "sentB": "The second closing of the purchase and sale of the units occurred on August 27, 2015 upon satisfaction of certain conditions, including, without limitation, stockholder vote, and the Company received approximately $2.2 million in net proceeds from the sale of 7,499,993 units of the 14,999,993 units available for sale at the second closing.", "type": 1, "words": ["<tag1>", "Net", "cash", "provided", "by", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "resulted", "from", "cash", "outflows", "for", "payment", "of", "a", "license", "termination", "fee", "of", "$800,000", "and", "for", "purchases", "of", "property", "and", "equipment", "and", "cash", "inflows", "of", "$5,000,000", "from", "the", "sale", "of", "the", "Puregraft", "product", "line.", "<tag2>", "The", "second", "closing", "of", "the", "purchase", "and", "sale", "of", "the", "units", "occurred", "on", "August", "27,", "2015", "upon", "satisfaction", "of", "certain", "conditions,", "including,", "without", "limitation,", "stockholder", "vote,", "and", "the", "Company", "received", "approximately", "$2.2", "million", "in", "net", "proceeds", "from", "the", "sale", "of", "7,499,993", "units", "of", "the", "14,999,993", "units", "available", "for", "sale", "at", "the", "second", "closing.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "by", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "resulted", "from", "cash", "outflows", "for", "payment", "of", "a", "license", "termination", "fee", "of", "$800,000", "and", "for", "purchases", "of", "property", "and", "equipment", "and", "cash", "inflows", "of", "$5,000,000", "from", "the", "sale", "of", "the", "Puregraft", "product", "line."], "wordsB": ["The", "second", "closing", "of", "the", "purchase", "and", "sale", "of", "the", "units", "occurred", "on", "August", "27,", "2015", "upon", "satisfaction", "of", "certain", "conditions,", "including,", "without", "limitation,", "stockholder", "vote,", "and", "the", "Company", "received", "approximately", "$2.2", "million", "in", "net", "proceeds", "from", "the", "sale", "of", "7,499,993", "units", "of", "the", "14,999,993", "units", "available", "for", "sale", "at", "the", "second", "closing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p88_s6", "idA": "1095981_15_item7_p84_s0", "sentA": "Net cash provided by investing activities for the year ended December 31, 2013 resulted from cash outflows for payment of a license termination fee of $800,000 and for purchases of property and equipment and cash inflows of $5,000,000 from the sale of the Puregraft product line.", "sentB": "The second closing of the purchase and sale of the units occurred on August 27, 2015 upon satisfaction of certain conditions, including, without limitation, stockholder vote, and the Company received approximately $2.1 million in net proceeds from the sale of 7,499,993 units of the 14,999,993 units available for sale at the second closing.", "type": 1, "words": ["<tag1>", "Net", "cash", "provided", "by", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "resulted", "from", "cash", "outflows", "for", "payment", "of", "a", "license", "termination", "fee", "of", "$800,000", "and", "for", "purchases", "of", "property", "and", "equipment", "and", "cash", "inflows", "of", "$5,000,000", "from", "the", "sale", "of", "the", "Puregraft", "product", "line.", "<tag2>", "The", "second", "closing", "of", "the", "purchase", "and", "sale", "of", "the", "units", "occurred", "on", "August", "27,", "2015", "upon", "satisfaction", "of", "certain", "conditions,", "including,", "without", "limitation,", "stockholder", "vote,", "and", "the", "Company", "received", "approximately", "$2.1", "million", "in", "net", "proceeds", "from", "the", "sale", "of", "7,499,993", "units", "of", "the", "14,999,993", "units", "available", "for", "sale", "at", "the", "second", "closing.", "<tag3>"], "wordsA": ["Net", "cash", "provided", "by", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "resulted", "from", "cash", "outflows", "for", "payment", "of", "a", "license", "termination", "fee", "of", "$800,000", "and", "for", "purchases", "of", "property", "and", "equipment", "and", "cash", "inflows", "of", "$5,000,000", "from", "the", "sale", "of", "the", "Puregraft", "product", "line."], "wordsB": ["The", "second", "closing", "of", "the", "purchase", "and", "sale", "of", "the", "units", "occurred", "on", "August", "27,", "2015", "upon", "satisfaction", "of", "certain", "conditions,", "including,", "without", "limitation,", "stockholder", "vote,", "and", "the", "Company", "received", "approximately", "$2.1", "million", "in", "net", "proceeds", "from", "the", "sale", "of", "7,499,993", "units", "of", "the", "14,999,993", "units", "available", "for", "sale", "at", "the", "second", "closing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item7_p57_s0", "idA": "1095981_15_item7_p85_s0", "sentA": "Net cash used in investing activities for the year ended December 31, 2012 resulted primarily from purchases of property and equipment, primarily for use in clinical trials and research.", "sentB": "The changes in other income (expense) in 2015, 2014 and 2013 resulted primarily from changes in exchange rates related to transactions in foreign currency.", "type": 1, "words": ["<tag1>", "Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "resulted", "primarily", "from", "purchases", "of", "property", "and", "equipment,", "primarily", "for", "use", "in", "clinical", "trials", "and", "research.", "<tag2>", "The", "changes", "in", "other", "income", "(expense)", "in", "2015,", "2014", "and", "2013", "resulted", "primarily", "from", "changes", "in", "exchange", "rates", "related", "to", "transactions", "in", "foreign", "currency.", "<tag3>"], "wordsA": ["Net", "cash", "used", "in", "investing", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "resulted", "primarily", "from", "purchases", "of", "property", "and", "equipment,", "primarily", "for", "use", "in", "clinical", "trials", "and", "research."], "wordsB": ["The", "changes", "in", "other", "income", "(expense)", "in", "2015,", "2014", "and", "2013", "resulted", "primarily", "from", "changes", "in", "exchange", "rates", "related", "to", "transactions", "in", "foreign", "currency."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s3", "idA": "1095981_16_item7_p100_s1", "sentA": "This guidance requires arrangement consideration to be allocated at the inception of the arrangement to all deliverables using the relative selling price method.", "sentB": "Patients perceived their health status to be improved as shown by a 45.2% and 42.4% decrease of the Scleroderma Health Assessment Questionnaire, or SHAQ, at month 2 (p=0.001) and at month 6 (p=0.001), respectively.", "type": 1, "words": ["<tag1>", "This", "guidance", "requires", "arrangement", "consideration", "to", "be", "allocated", "at", "the", "inception", "of", "the", "arrangement", "to", "all", "deliverables", "using", "the", "relative", "selling", "price", "method.", "<tag2>", "Patients", "perceived", "their", "health", "status", "to", "be", "improved", "as", "shown", "by", "a", "45.2%", "and", "42.4%", "decrease", "of", "the", "Scleroderma", "Health", "Assessment", "Questionnaire,", "or", "SHAQ,", "at", "month", "2", "(p=0.001)", "and", "at", "month", "6", "(p=0.001),", "respectively.", "<tag3>"], "wordsA": ["This", "guidance", "requires", "arrangement", "consideration", "to", "be", "allocated", "at", "the", "inception", "of", "the", "arrangement", "to", "all", "deliverables", "using", "the", "relative", "selling", "price", "method."], "wordsB": ["Patients", "perceived", "their", "health", "status", "to", "be", "improved", "as", "shown", "by", "a", "45.2%", "and", "42.4%", "decrease", "of", "the", "Scleroderma", "Health", "Assessment", "Questionnaire,", "or", "SHAQ,", "at", "month", "2", "(p=0.001)", "and", "at", "month", "6", "(p=0.001),", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s14", "idA": "1095981_16_item7_p103_s0", "sentA": "Accounts receivable are recorded at the invoiced amount and do not bear interest.", "sentB": "In February 2016, two-year follow up data in the SCLERADEC I trial was presented at the Systemic Sclerosis World Congress, which demonstrated sustained improvement in the following four key endpoints: Cochin Hand Function Score (CHFS), Scleroderma Health Assessment Questionnaire, Raynaud s Condition Score (which assesses severity of Raynaud s Phenomenon), and hand pain, as assessed by a standard visual analogue scale.", "type": 1, "words": ["<tag1>", "Accounts", "receivable", "are", "recorded", "at", "the", "invoiced", "amount", "and", "do", "not", "bear", "interest.", "<tag2>", "In", "February", "2016,", "two-year", "follow", "up", "data", "in", "the", "SCLERADEC", "I", "trial", "was", "presented", "at", "the", "Systemic", "Sclerosis", "World", "Congress,", "which", "demonstrated", "sustained", "improvement", "in", "the", "following", "four", "key", "endpoints:", "Cochin", "Hand", "Function", "Score", "(CHFS),", "Scleroderma", "Health", "Assessment", "Questionnaire,", "Raynaud", "s", "Condition", "Score", "(which", "assesses", "severity", "of", "Raynaud", "s", "Phenomenon),", "and", "hand", "pain,", "as", "assessed", "by", "a", "standard", "visual", "analogue", "scale.", "<tag3>"], "wordsA": ["Accounts", "receivable", "are", "recorded", "at", "the", "invoiced", "amount", "and", "do", "not", "bear", "interest."], "wordsB": ["In", "February", "2016,", "two-year", "follow", "up", "data", "in", "the", "SCLERADEC", "I", "trial", "was", "presented", "at", "the", "Systemic", "Sclerosis", "World", "Congress,", "which", "demonstrated", "sustained", "improvement", "in", "the", "following", "four", "key", "endpoints:", "Cochin", "Hand", "Function", "Score", "(CHFS),", "Scleroderma", "Health", "Assessment", "Questionnaire,", "Raynaud", "s", "Condition", "Score", "(which", "assesses", "severity", "of", "Raynaud", "s", "Phenomenon),", "and", "hand", "pain,", "as", "assessed", "by", "a", "standard", "visual", "analogue", "scale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p12_s0", "idA": "1095981_16_item7_p106_s2", "sentA": "Any required impairment loss would be measured as the amount by which the asset s carrying value exceeds its fair value, and would be recorded as a reduction in the carrying value of the related asset and a charge to operating expense.", "sentB": "Continued reduction in the number of ulcers from 15 at baseline to 9 at one year and 6 at two years.", "type": 1, "words": ["<tag1>", "Any", "required", "impairment", "loss", "would", "be", "measured", "as", "the", "amount", "by", "which", "the", "asset", "s", "carrying", "value", "exceeds", "its", "fair", "value,", "and", "would", "be", "recorded", "as", "a", "reduction", "in", "the", "carrying", "value", "of", "the", "related", "asset", "and", "a", "charge", "to", "operating", "expense.", "<tag2>", "Continued", "reduction", "in", "the", "number", "of", "ulcers", "from", "15", "at", "baseline", "to", "9", "at", "one", "year", "and", "6", "at", "two", "years.", "<tag3>"], "wordsA": ["Any", "required", "impairment", "loss", "would", "be", "measured", "as", "the", "amount", "by", "which", "the", "asset", "s", "carrying", "value", "exceeds", "its", "fair", "value,", "and", "would", "be", "recorded", "as", "a", "reduction", "in", "the", "carrying", "value", "of", "the", "related", "asset", "and", "a", "charge", "to", "operating", "expense."], "wordsB": ["Continued", "reduction", "in", "the", "number", "of", "ulcers", "from", "15", "at", "baseline", "to", "9", "at", "one", "year", "and", "6", "at", "two", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p75_s3", "idA": "1095981_16_item7_p106_s3", "sentA": "We recognized no impairment losses during any of the periods presented in these financial statements.", "sentB": "There was no indication of impairment of goodwill for all periods presented.", "type": 1, "words": ["<tag1>", "We", "recognized", "no", "impairment", "losses", "during", "any", "of", "the", "periods", "presented", "in", "these", "financial", "statements.", "<tag2>", "There", "was", "no", "indication", "of", "impairment", "of", "goodwill", "for", "all", "periods", "presented.", "<tag3>"], "wordsA": ["We", "recognized", "no", "impairment", "losses", "during", "any", "of", "the", "periods", "presented", "in", "these", "financial", "statements."], "wordsB": ["There", "was", "no", "indication", "of", "impairment", "of", "goodwill", "for", "all", "periods", "presented."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p21_s0", "idA": "1095981_16_item7_p10_s2", "sentA": "An In-Process Review Meeting in the first half of 2014 confirmed completion of the proof of concept phase.", "sentB": "Consistent trends observed in most secondary endpoints at 12, 24 and 48 weeks in the target knee of the treated group relative to placebo control group; 12-week primary endpoint of single pain on walking question did not achieve statistical significance.", "type": 1, "words": ["<tag1>", "An", "In-Process", "Review", "Meeting", "in", "the", "first", "half", "of", "2014", "confirmed", "completion", "of", "the", "proof", "of", "concept", "phase.", "<tag2>", "Consistent", "trends", "observed", "in", "most", "secondary", "endpoints", "at", "12,", "24", "and", "48", "weeks", "in", "the", "target", "knee", "of", "the", "treated", "group", "relative", "to", "placebo", "control", "group;", "12-week", "primary", "endpoint", "of", "single", "pain", "on", "walking", "question", "did", "not", "achieve", "statistical", "significance.", "<tag3>"], "wordsA": ["An", "In-Process", "Review", "Meeting", "in", "the", "first", "half", "of", "2014", "confirmed", "completion", "of", "the", "proof", "of", "concept", "phase."], "wordsB": ["Consistent", "trends", "observed", "in", "most", "secondary", "endpoints", "at", "12,", "24", "and", "48", "weeks", "in", "the", "target", "knee", "of", "the", "treated", "group", "relative", "to", "placebo", "control", "group;", "12-week", "primary", "endpoint", "of", "single", "pain", "on", "walking", "question", "did", "not", "achieve", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s10", "idA": "1095981_16_item7_p10_s2", "sentA": "An In-Process Review Meeting in the first half of 2014 confirmed completion of the proof of concept phase.", "sentB": "One year results were published in September 2015 in the journal Rheumatology.", "type": 1, "words": ["<tag1>", "An", "In-Process", "Review", "Meeting", "in", "the", "first", "half", "of", "2014", "confirmed", "completion", "of", "the", "proof", "of", "concept", "phase.", "<tag2>", "One", "year", "results", "were", "published", "in", "September", "2015", "in", "the", "journal", "Rheumatology.", "<tag3>"], "wordsA": ["An", "In-Process", "Review", "Meeting", "in", "the", "first", "half", "of", "2014", "confirmed", "completion", "of", "the", "proof", "of", "concept", "phase."], "wordsB": ["One", "year", "results", "were", "published", "in", "September", "2015", "in", "the", "journal", "Rheumatology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p16_s0", "idA": "1095981_16_item7_p111_s2", "sentA": "The expected volatility is based on the historical volatility of our common stock over the most recent period commensurate with the estimated expected term of the stock options.", "sentB": "It is the most common form of arthritis and affects an estimated 13.9% of US adults over the age of 25, and 33.6% of U.S. adults over the age of 65.", "type": 1, "words": ["<tag1>", "The", "expected", "volatility", "is", "based", "on", "the", "historical", "volatility", "of", "our", "common", "stock", "over", "the", "most", "recent", "period", "commensurate", "with", "the", "estimated", "expected", "term", "of", "the", "stock", "options.", "<tag2>", "It", "is", "the", "most", "common", "form", "of", "arthritis", "and", "affects", "an", "estimated", "13.9%", "of", "US", "adults", "over", "the", "age", "of", "25,", "and", "33.6%", "of", "U.S.", "adults", "over", "the", "age", "of", "65.", "<tag3>"], "wordsA": ["The", "expected", "volatility", "is", "based", "on", "the", "historical", "volatility", "of", "our", "common", "stock", "over", "the", "most", "recent", "period", "commensurate", "with", "the", "estimated", "expected", "term", "of", "the", "stock", "options."], "wordsB": ["It", "is", "the", "most", "common", "form", "of", "arthritis", "and", "affects", "an", "estimated", "13.9%", "of", "US", "adults", "over", "the", "age", "of", "25,", "and", "33.6%", "of", "U.S.", "adults", "over", "the", "age", "of", "65."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p17_s1", "idA": "1095981_16_item7_p111_s2", "sentA": "The expected volatility is based on the historical volatility of our common stock over the most recent period commensurate with the estimated expected term of the stock options.", "sentB": "A substantial medical need exists as present medications have limited efficacy and joint replacement is a relatively definitive treatment for those with the most advanced disease.", "type": 1, "words": ["<tag1>", "The", "expected", "volatility", "is", "based", "on", "the", "historical", "volatility", "of", "our", "common", "stock", "over", "the", "most", "recent", "period", "commensurate", "with", "the", "estimated", "expected", "term", "of", "the", "stock", "options.", "<tag2>", "A", "substantial", "medical", "need", "exists", "as", "present", "medications", "have", "limited", "efficacy", "and", "joint", "replacement", "is", "a", "relatively", "definitive", "treatment", "for", "those", "with", "the", "most", "advanced", "disease.", "<tag3>"], "wordsA": ["The", "expected", "volatility", "is", "based", "on", "the", "historical", "volatility", "of", "our", "common", "stock", "over", "the", "most", "recent", "period", "commensurate", "with", "the", "estimated", "expected", "term", "of", "the", "stock", "options."], "wordsB": ["A", "substantial", "medical", "need", "exists", "as", "present", "medications", "have", "limited", "efficacy", "and", "joint", "replacement", "is", "a", "relatively", "definitive", "treatment", "for", "those", "with", "the", "most", "advanced", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p62_s1", "idA": "1095981_16_item7_p111_s6", "sentA": "The fair value of restricted stock agreements granted is based on the market price of our common stock on the day of the grant.", "sentB": "There is no upper limit on the price per share that Lincoln Park must pay for common stock under a Regular Purchase or an accelerated purchase and in no event will shares be sold to Lincoln Park on a day our closing price is less than the floor price of $0.50 per share as set forth in the Lincoln Park Purchase Agreement.", "type": 1, "words": ["<tag1>", "The", "fair", "value", "of", "restricted", "stock", "agreements", "granted", "is", "based", "on", "the", "market", "price", "of", "our", "common", "stock", "on", "the", "day", "of", "the", "grant.", "<tag2>", "There", "is", "no", "upper", "limit", "on", "the", "price", "per", "share", "that", "Lincoln", "Park", "must", "pay", "for", "common", "stock", "under", "a", "Regular", "Purchase", "or", "an", "accelerated", "purchase", "and", "in", "no", "event", "will", "shares", "be", "sold", "to", "Lincoln", "Park", "on", "a", "day", "our", "closing", "price", "is", "less", "than", "the", "floor", "price", "of", "$0.50", "per", "share", "as", "set", "forth", "in", "the", "Lincoln", "Park", "Purchase", "Agreement.", "<tag3>"], "wordsA": ["The", "fair", "value", "of", "restricted", "stock", "agreements", "granted", "is", "based", "on", "the", "market", "price", "of", "our", "common", "stock", "on", "the", "day", "of", "the", "grant."], "wordsB": ["There", "is", "no", "upper", "limit", "on", "the", "price", "per", "share", "that", "Lincoln", "Park", "must", "pay", "for", "common", "stock", "under", "a", "Regular", "Purchase", "or", "an", "accelerated", "purchase", "and", "in", "no", "event", "will", "shares", "be", "sold", "to", "Lincoln", "Park", "on", "a", "day", "our", "closing", "price", "is", "less", "than", "the", "floor", "price", "of", "$0.50", "per", "share", "as", "set", "forth", "in", "the", "Lincoln", "Park", "Purchase", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p5_s0", "idA": "1095981_16_item7_p112_s2", "sentA": "If there is a modification to the warrants, the Company estimates the fair value of the warrants immediately before and after the modification using an option pricing model, with changes in the fair value included in operating expenses.", "sentB": "Lead Indication: Scleroderma Scleroderma is a rare and chronic autoimmune disorder associated with fibrosis of the skin, and destructive changes in blood vessels and multiple organ systems as the result of a generalized overproduction of collagen.", "type": 1, "words": ["<tag1>", "If", "there", "is", "a", "modification", "to", "the", "warrants,", "the", "Company", "estimates", "the", "fair", "value", "of", "the", "warrants", "immediately", "before", "and", "after", "the", "modification", "using", "an", "option", "pricing", "model,", "with", "changes", "in", "the", "fair", "value", "included", "in", "operating", "expenses.", "<tag2>", "Lead", "Indication:", "Scleroderma", "Scleroderma", "is", "a", "rare", "and", "chronic", "autoimmune", "disorder", "associated", "with", "fibrosis", "of", "the", "skin,", "and", "destructive", "changes", "in", "blood", "vessels", "and", "multiple", "organ", "systems", "as", "the", "result", "of", "a", "generalized", "overproduction", "of", "collagen.", "<tag3>"], "wordsA": ["If", "there", "is", "a", "modification", "to", "the", "warrants,", "the", "Company", "estimates", "the", "fair", "value", "of", "the", "warrants", "immediately", "before", "and", "after", "the", "modification", "using", "an", "option", "pricing", "model,", "with", "changes", "in", "the", "fair", "value", "included", "in", "operating", "expenses."], "wordsB": ["Lead", "Indication:", "Scleroderma", "Scleroderma", "is", "a", "rare", "and", "chronic", "autoimmune", "disorder", "associated", "with", "fibrosis", "of", "the", "skin,", "and", "destructive", "changes", "in", "blood", "vessels", "and", "multiple", "organ", "systems", "as", "the", "result", "of", "a", "generalized", "overproduction", "of", "collagen."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p7_s5", "idA": "1095981_16_item7_p12_s2", "sentA": "Upon investigational device exemption (IDE) approval by the FDA, we anticipate that BARDA would provide funding to cover costs associated with execution of the clinical trial, currently estimated at approximately $8.3 million, bringing the combined value to up to $20.4 million.", "sentB": "In February 2015, the FDA approved our request to increase the number of investigational sites from 12 to up to 20.", "type": 1, "words": ["<tag1>", "Upon", "investigational", "device", "exemption", "(IDE)", "approval", "by", "the", "FDA,", "we", "anticipate", "that", "BARDA", "would", "provide", "funding", "to", "cover", "costs", "associated", "with", "execution", "of", "the", "clinical", "trial,", "currently", "estimated", "at", "approximately", "$8.3", "million,", "bringing", "the", "combined", "value", "to", "up", "to", "$20.4", "million.", "<tag2>", "In", "February", "2015,", "the", "FDA", "approved", "our", "request", "to", "increase", "the", "number", "of", "investigational", "sites", "from", "12", "to", "up", "to", "20.", "<tag3>"], "wordsA": ["Upon", "investigational", "device", "exemption", "(IDE)", "approval", "by", "the", "FDA,", "we", "anticipate", "that", "BARDA", "would", "provide", "funding", "to", "cover", "costs", "associated", "with", "execution", "of", "the", "clinical", "trial,", "currently", "estimated", "at", "approximately", "$8.3", "million,", "bringing", "the", "combined", "value", "to", "up", "to", "$20.4", "million."], "wordsB": ["In", "February", "2015,", "the", "FDA", "approved", "our", "request", "to", "increase", "the", "number", "of", "investigational", "sites", "from", "12", "to", "up", "to", "20."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p7_s6", "idA": "1095981_16_item7_p13_s1", "sentA": "It also served to fund approximately two years of preclinical studies in other burn-related areas that could lead to broadening of the utility of Cytori technology to burn centers and in wound healing more generally.", "sentB": "The increased number of sites served to broaden the geographic coverage of the trial and facilitate trial enrollment.", "type": 1, "words": ["<tag1>", "It", "also", "served", "to", "fund", "approximately", "two", "years", "of", "preclinical", "studies", "in", "other", "burn-related", "areas", "that", "could", "lead", "to", "broadening", "of", "the", "utility", "of", "Cytori", "technology", "to", "burn", "centers", "and", "in", "wound", "healing", "more", "generally.", "<tag2>", "The", "increased", "number", "of", "sites", "served", "to", "broaden", "the", "geographic", "coverage", "of", "the", "trial", "and", "facilitate", "trial", "enrollment.", "<tag3>"], "wordsA": ["It", "also", "served", "to", "fund", "approximately", "two", "years", "of", "preclinical", "studies", "in", "other", "burn-related", "areas", "that", "could", "lead", "to", "broadening", "of", "the", "utility", "of", "Cytori", "technology", "to", "burn", "centers", "and", "in", "wound", "healing", "more", "generally."], "wordsB": ["The", "increased", "number", "of", "sites", "served", "to", "broaden", "the", "geographic", "coverage", "of", "the", "trial", "and", "facilitate", "trial", "enrollment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p22_s1", "idA": "1095981_16_item7_p21_s0", "sentA": "Cost of product revenues as a percentage of product revenues was 66%, 59% and 48% for the years ended December 31, 2015, 2014 and 2013, respectively.", "sentB": "The differences against placebo favored ADRCs specifically in the number of bone marrow lesions, the percentage of the bone marrow lesion that is not a cyst, the size of the bone marrow lesions as a percentage of the total sub-region volume, percentage of full thickness cartilage loss, cartilage loss as a percentage of cartilage surface area and the size of the largest osteophyte.", "type": 1, "words": ["<tag1>", "Cost", "of", "product", "revenues", "as", "a", "percentage", "of", "product", "revenues", "was", "66%,", "59%", "and", "48%", "for", "the", "years", "ended", "December", "31,", "2015,", "2014", "and", "2013,", "respectively.", "<tag2>", "The", "differences", "against", "placebo", "favored", "ADRCs", "specifically", "in", "the", "number", "of", "bone", "marrow", "lesions,", "the", "percentage", "of", "the", "bone", "marrow", "lesion", "that", "is", "not", "a", "cyst,", "the", "size", "of", "the", "bone", "marrow", "lesions", "as", "a", "percentage", "of", "the", "total", "sub-region", "volume,", "percentage", "of", "full", "thickness", "cartilage", "loss,", "cartilage", "loss", "as", "a", "percentage", "of", "cartilage", "surface", "area", "and", "the", "size", "of", "the", "largest", "osteophyte.", "<tag3>"], "wordsA": ["Cost", "of", "product", "revenues", "as", "a", "percentage", "of", "product", "revenues", "was", "66%,", "59%", "and", "48%", "for", "the", "years", "ended", "December", "31,", "2015,", "2014", "and", "2013,", "respectively."], "wordsB": ["The", "differences", "against", "placebo", "favored", "ADRCs", "specifically", "in", "the", "number", "of", "bone", "marrow", "lesions,", "the", "percentage", "of", "the", "bone", "marrow", "lesion", "that", "is", "not", "a", "cyst,", "the", "size", "of", "the", "bone", "marrow", "lesions", "as", "a", "percentage", "of", "the", "total", "sub-region", "volume,", "percentage", "of", "full", "thickness", "cartilage", "loss,", "cartilage", "loss", "as", "a", "percentage", "of", "cartilage", "surface", "area", "and", "the", "size", "of", "the", "largest", "osteophyte."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p20_s0", "idA": "1095981_16_item7_p28_s0", "sentA": "Research and development expenses relate to the development of a technology platform that involves using adipose tissue as a source of autologous regenerative cells for therapeutic applications as well as the continued development efforts related to our Celution System.", "sentB": "Intraarticular application of a single dose of ECCO-50 is feasible in an outpatient day-surgery setting; no serious adverse events were reported related to the fat harvest, cell injection or to the cell therapy.", "type": 1, "words": ["<tag1>", "Research", "and", "development", "expenses", "relate", "to", "the", "development", "of", "a", "technology", "platform", "that", "involves", "using", "adipose", "tissue", "as", "a", "source", "of", "autologous", "regenerative", "cells", "for", "therapeutic", "applications", "as", "well", "as", "the", "continued", "development", "efforts", "related", "to", "our", "Celution", "System.", "<tag2>", "Intraarticular", "application", "of", "a", "single", "dose", "of", "ECCO-50", "is", "feasible", "in", "an", "outpatient", "day-surgery", "setting;", "no", "serious", "adverse", "events", "were", "reported", "related", "to", "the", "fat", "harvest,", "cell", "injection", "or", "to", "the", "cell", "therapy.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "relate", "to", "the", "development", "of", "a", "technology", "platform", "that", "involves", "using", "adipose", "tissue", "as", "a", "source", "of", "autologous", "regenerative", "cells", "for", "therapeutic", "applications", "as", "well", "as", "the", "continued", "development", "efforts", "related", "to", "our", "Celution", "System."], "wordsB": ["Intraarticular", "application", "of", "a", "single", "dose", "of", "ECCO-50", "is", "feasible", "in", "an", "outpatient", "day-surgery", "setting;", "no", "serious", "adverse", "events", "were", "reported", "related", "to", "the", "fat", "harvest,", "cell", "injection", "or", "to", "the", "cell", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p14_s1", "idA": "1095981_16_item7_p32_s0", "sentA": "The future : We expect research and development expenditures to slightly decrease as we completed enrollment of the U.S. ACT-OA clinical trial in 2015, but continue to sponsor the U.S. STAR clinical trial, a trial for treatment of impaired hand function in scleroderma, and support two physician initiated non-U.S. trials, ADRESU, a Japanese trial for treatment of men with urinary incontinence and SCLERADEC II, a European trial for the treatment of impaired hand function in scleroderma.", "sentB": "In November 2016, the US FDA Office of Orphan Products Development (OOPD) granted Cytori an orphan drug designation for cryopreserved or centrally processed ECCS-50 (HABEO) for scleroderma.", "type": 1, "words": ["<tag1>", "The", "future", ":", "We", "expect", "research", "and", "development", "expenditures", "to", "slightly", "decrease", "as", "we", "completed", "enrollment", "of", "the", "U.S.", "ACT-OA", "clinical", "trial", "in", "2015,", "but", "continue", "to", "sponsor", "the", "U.S.", "STAR", "clinical", "trial,", "a", "trial", "for", "treatment", "of", "impaired", "hand", "function", "in", "scleroderma,", "and", "support", "two", "physician", "initiated", "non-U.S.", "trials,", "ADRESU,", "a", "Japanese", "trial", "for", "treatment", "of", "men", "with", "urinary", "incontinence", "and", "SCLERADEC", "II,", "a", "European", "trial", "for", "the", "treatment", "of", "impaired", "hand", "function", "in", "scleroderma.", "<tag2>", "In", "November", "2016,", "the", "US", "FDA", "Office", "of", "Orphan", "Products", "Development", "(OOPD)", "granted", "Cytori", "an", "orphan", "drug", "designation", "for", "cryopreserved", "or", "centrally", "processed", "ECCS-50", "(HABEO)", "for", "scleroderma.", "<tag3>"], "wordsA": ["The", "future", ":", "We", "expect", "research", "and", "development", "expenditures", "to", "slightly", "decrease", "as", "we", "completed", "enrollment", "of", "the", "U.S.", "ACT-OA", "clinical", "trial", "in", "2015,", "but", "continue", "to", "sponsor", "the", "U.S.", "STAR", "clinical", "trial,", "a", "trial", "for", "treatment", "of", "impaired", "hand", "function", "in", "scleroderma,", "and", "support", "two", "physician", "initiated", "non-U.S.", "trials,", "ADRESU,", "a", "Japanese", "trial", "for", "treatment", "of", "men", "with", "urinary", "incontinence", "and", "SCLERADEC", "II,", "a", "European", "trial", "for", "the", "treatment", "of", "impaired", "hand", "function", "in", "scleroderma."], "wordsB": ["In", "November", "2016,", "the", "US", "FDA", "Office", "of", "Orphan", "Products", "Development", "(OOPD)", "granted", "Cytori", "an", "orphan", "drug", "designation", "for", "cryopreserved", "or", "centrally", "processed", "ECCS-50", "(HABEO)", "for", "scleroderma."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p23_s1", "idA": "1095981_16_item7_p37_s0", "sentA": "General and administrative expenses include costs for administrative personnel, legal and other professional expenses, and general corporate expenses.", "sentB": "The accumulated data and experienced gained will be critical in considering designs of further clinical trials in osteoarthritis and other potential indications.", "type": 1, "words": ["<tag1>", "General", "and", "administrative", "expenses", "include", "costs", "for", "administrative", "personnel,", "legal", "and", "other", "professional", "expenses,", "and", "general", "corporate", "expenses.", "<tag2>", "The", "accumulated", "data", "and", "experienced", "gained", "will", "be", "critical", "in", "considering", "designs", "of", "further", "clinical", "trials", "in", "osteoarthritis", "and", "other", "potential", "indications.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "include", "costs", "for", "administrative", "personnel,", "legal", "and", "other", "professional", "expenses,", "and", "general", "corporate", "expenses."], "wordsB": ["The", "accumulated", "data", "and", "experienced", "gained", "will", "be", "critical", "in", "considering", "designs", "of", "further", "clinical", "trials", "in", "osteoarthritis", "and", "other", "potential", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p6_s2", "idA": "1095981_16_item7_p37_s0", "sentA": "General and administrative expenses include costs for administrative personnel, legal and other professional expenses, and general corporate expenses.", "sentB": "When the disease is advanced, immunosuppressive and other medications may be used but are often accompanied by significant side effects.", "type": 1, "words": ["<tag1>", "General", "and", "administrative", "expenses", "include", "costs", "for", "administrative", "personnel,", "legal", "and", "other", "professional", "expenses,", "and", "general", "corporate", "expenses.", "<tag2>", "When", "the", "disease", "is", "advanced,", "immunosuppressive", "and", "other", "medications", "may", "be", "used", "but", "are", "often", "accompanied", "by", "significant", "side", "effects.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "include", "costs", "for", "administrative", "personnel,", "legal", "and", "other", "professional", "expenses,", "and", "general", "corporate", "expenses."], "wordsB": ["When", "the", "disease", "is", "advanced,", "immunosuppressive", "and", "other", "medications", "may", "be", "used", "but", "are", "often", "accompanied", "by", "significant", "side", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s9", "idA": "1095981_16_item7_p39_s1", "sentA": "However, within general and administrative expenses we had a decrease in salary and related benefits expense (excluding share-based compensation) of $0.7 million related to a decrease of headcount of 13 full-time equivalent employees, partially offset by an increase in professional services (which includes legal and consulting services) of $0.7 million.", "sentB": "Hand pain showed a significant decrease of 63.6% at month 2 (p=0.001) and 70% at month 6 (p 0.001).", "type": 1, "words": ["<tag1>", "However,", "within", "general", "and", "administrative", "expenses", "we", "had", "a", "decrease", "in", "salary", "and", "related", "benefits", "expense", "(excluding", "share-based", "compensation)", "of", "$0.7", "million", "related", "to", "a", "decrease", "of", "headcount", "of", "13", "full-time", "equivalent", "employees,", "partially", "offset", "by", "an", "increase", "in", "professional", "services", "(which", "includes", "legal", "and", "consulting", "services)", "of", "$0.7", "million.", "<tag2>", "Hand", "pain", "showed", "a", "significant", "decrease", "of", "63.6%", "at", "month", "2", "(p=0.001)", "and", "70%", "at", "month", "6", "(p", "0.001).", "<tag3>"], "wordsA": ["However,", "within", "general", "and", "administrative", "expenses", "we", "had", "a", "decrease", "in", "salary", "and", "related", "benefits", "expense", "(excluding", "share-based", "compensation)", "of", "$0.7", "million", "related", "to", "a", "decrease", "of", "headcount", "of", "13", "full-time", "equivalent", "employees,", "partially", "offset", "by", "an", "increase", "in", "professional", "services", "(which", "includes", "legal", "and", "consulting", "services)", "of", "$0.7", "million."], "wordsB": ["Hand", "pain", "showed", "a", "significant", "decrease", "of", "63.6%", "at", "month", "2", "(p=0.001)", "and", "70%", "at", "month", "6", "(p", "0.001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p15_s1", "idA": "1095981_16_item7_p45_s0", "sentA": "The decrease in share-based compensation for the year ended December 31, 2014 as compared to the same period in 2013 is primarily due to the decrease in headcount of 37 full-time equivalent employees, the stock price decrease experienced in 2014 and share-based compensation expense reversals due to option cancellations.", "sentB": "The breakdown of tissue leads to pain, joint stiffness and reduced function.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations.", "<tag2>", "The", "breakdown", "of", "tissue", "leads", "to", "pain,", "joint", "stiffness", "and", "reduced", "function.", "<tag3>"], "wordsA": ["The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations."], "wordsB": ["The", "breakdown", "of", "tissue", "leads", "to", "pain,", "joint", "stiffness", "and", "reduced", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p17_s0", "idA": "1095981_16_item7_p45_s0", "sentA": "The decrease in share-based compensation for the year ended December 31, 2014 as compared to the same period in 2013 is primarily due to the decrease in headcount of 37 full-time equivalent employees, the stock price decrease experienced in 2014 and share-based compensation expense reversals due to option cancellations.", "sentB": "Current treatments include physical therapy, non-steroidal anti-inflammatory medications, viscosupplement injections, and total knee replacement.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations.", "<tag2>", "Current", "treatments", "include", "physical", "therapy,", "non-steroidal", "anti-inflammatory", "medications,", "viscosupplement", "injections,", "and", "total", "knee", "replacement.", "<tag3>"], "wordsA": ["The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations."], "wordsB": ["Current", "treatments", "include", "physical", "therapy,", "non-steroidal", "anti-inflammatory", "medications,", "viscosupplement", "injections,", "and", "total", "knee", "replacement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p25_s0", "idA": "1095981_16_item7_p45_s0", "sentA": "The decrease in share-based compensation for the year ended December 31, 2014 as compared to the same period in 2013 is primarily due to the decrease in headcount of 37 full-time equivalent employees, the stock price decrease experienced in 2014 and share-based compensation expense reversals due to option cancellations.", "sentB": "Associate Professor De partment of Urology at University of Nagoya Graduate School of Medicine.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations.", "<tag2>", "Associate", "Professor", "De", "partment", "of", "Urology", "at", "University", "of", "Nagoya", "Graduate", "School", "of", "Medicine.", "<tag3>"], "wordsA": ["The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations."], "wordsB": ["Associate", "Professor", "De", "partment", "of", "Urology", "at", "University", "of", "Nagoya", "Graduate", "School", "of", "Medicine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p6_s0", "idA": "1095981_16_item7_p45_s0", "sentA": "The decrease in share-based compensation for the year ended December 31, 2014 as compared to the same period in 2013 is primarily due to the decrease in headcount of 37 full-time equivalent employees, the stock price decrease experienced in 2014 and share-based compensation expense reversals due to option cancellations.", "sentB": "The limited availability of treatments for scleroderma may provide some benefit but do little to modify disease progression or substantially improve symptoms.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations.", "<tag2>", "The", "limited", "availability", "of", "treatments", "for", "scleroderma", "may", "provide", "some", "benefit", "but", "do", "little", "to", "modify", "disease", "progression", "or", "substantially", "improve", "symptoms.", "<tag3>"], "wordsA": ["The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations."], "wordsB": ["The", "limited", "availability", "of", "treatments", "for", "scleroderma", "may", "provide", "some", "benefit", "but", "do", "little", "to", "modify", "disease", "progression", "or", "substantially", "improve", "symptoms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s1", "idA": "1095981_16_item7_p45_s0", "sentA": "The decrease in share-based compensation for the year ended December 31, 2014 as compared to the same period in 2013 is primarily due to the decrease in headcount of 37 full-time equivalent employees, the stock price decrease experienced in 2014 and share-based compensation expense reversals due to option cancellations.", "sentB": "The SCLERADEC I trial received partial support from Cytori.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations.", "<tag2>", "The", "SCLERADEC", "I", "trial", "received", "partial", "support", "from", "Cytori.", "<tag3>"], "wordsA": ["The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations."], "wordsB": ["The", "SCLERADEC", "I", "trial", "received", "partial", "support", "from", "Cytori."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s12", "idA": "1095981_16_item7_p45_s0", "sentA": "The decrease in share-based compensation for the year ended December 31, 2014 as compared to the same period in 2013 is primarily due to the decrease in headcount of 37 full-time equivalent employees, the stock price decrease experienced in 2014 and share-based compensation expense reversals due to option cancellations.", "sentB": "The Raynaud s score improved by 63.2% from baseline (p 0.001).", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations.", "<tag2>", "The", "Raynaud", "s", "score", "improved", "by", "63.2%", "from", "baseline", "(p", "0.001).", "<tag3>"], "wordsA": ["The", "decrease", "in", "share-based", "compensation", "for", "the", "year", "ended", "December", "31,", "2014", "as", "compared", "to", "the", "same", "period", "in", "2013", "is", "primarily", "due", "to", "the", "decrease", "in", "headcount", "of", "37", "full-time", "equivalent", "employees,", "the", "stock", "price", "decrease", "experienced", "in", "2014", "and", "share-based", "compensation", "expense", "reversals", "due", "to", "option", "cancellations."], "wordsB": ["The", "Raynaud", "s", "score", "improved", "by", "63.2%", "from", "baseline", "(p", "0.001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p23_s0", "idA": "1095981_16_item7_p4_s0", "sentA": "In January 2015, the FDA granted unrestricted IDE approval for a pivotal clinical trial, named the STAR trial, to evaluate Cytori Cell Therapy as a potential treatment for impaired hand function in scleroderma, a rare autoimmune disease affecting approximately 50,000 patients in the United States.", "sentB": "In summary, the ACT-OA Phase II trial demonstrated feasibility of same day fat harvesting, cell processing and intraarticular administration of autologous ADRCs (ECCO-50) with a potential for a cell benefit effect.", "type": 1, "words": ["<tag1>", "In", "January", "2015,", "the", "FDA", "granted", "unrestricted", "IDE", "approval", "for", "a", "pivotal", "clinical", "trial,", "named", "the", "STAR", "trial,", "to", "evaluate", "Cytori", "Cell", "Therapy", "as", "a", "potential", "treatment", "for", "impaired", "hand", "function", "in", "scleroderma,", "a", "rare", "autoimmune", "disease", "affecting", "approximately", "50,000", "patients", "in", "the", "United", "States.", "<tag2>", "In", "summary,", "the", "ACT-OA", "Phase", "II", "trial", "demonstrated", "feasibility", "of", "same", "day", "fat", "harvesting,", "cell", "processing", "and", "intraarticular", "administration", "of", "autologous", "ADRCs", "(ECCO-50)", "with", "a", "potential", "for", "a", "cell", "benefit", "effect.", "<tag3>"], "wordsA": ["In", "January", "2015,", "the", "FDA", "granted", "unrestricted", "IDE", "approval", "for", "a", "pivotal", "clinical", "trial,", "named", "the", "STAR", "trial,", "to", "evaluate", "Cytori", "Cell", "Therapy", "as", "a", "potential", "treatment", "for", "impaired", "hand", "function", "in", "scleroderma,", "a", "rare", "autoimmune", "disease", "affecting", "approximately", "50,000", "patients", "in", "the", "United", "States."], "wordsB": ["In", "summary,", "the", "ACT-OA", "Phase", "II", "trial", "demonstrated", "feasibility", "of", "same", "day", "fat", "harvesting,", "cell", "processing", "and", "intraarticular", "administration", "of", "autologous", "ADRCs", "(ECCO-50)", "with", "a", "potential", "for", "a", "cell", "benefit", "effect."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p19_s0", "idA": "1095981_16_item7_p4_s2", "sentA": "The trial evaluates the safety and efficacy of a single administration of Cytori Cell Therapy in scleroderma patients affecting the hands and fingers.", "sentB": "The primary objective of this prospective, randomized, placebo controlled study was to evaluate the safety and feasibility of intraarticular injection of Celution prepared adipose-derived regenerative cells injected into knees of patients with chronic knee pain due to osteoarthritis.", "type": 1, "words": ["<tag1>", "The", "trial", "evaluates", "the", "safety", "and", "efficacy", "of", "a", "single", "administration", "of", "Cytori", "Cell", "Therapy", "in", "scleroderma", "patients", "affecting", "the", "hands", "and", "fingers.", "<tag2>", "The", "primary", "objective", "of", "this", "prospective,", "randomized,", "placebo", "controlled", "study", "was", "to", "evaluate", "the", "safety", "and", "feasibility", "of", "intraarticular", "injection", "of", "Celution", "prepared", "adipose-derived", "regenerative", "cells", "injected", "into", "knees", "of", "patients", "with", "chronic", "knee", "pain", "due", "to", "osteoarthritis.", "<tag3>"], "wordsA": ["The", "trial", "evaluates", "the", "safety", "and", "efficacy", "of", "a", "single", "administration", "of", "Cytori", "Cell", "Therapy", "in", "scleroderma", "patients", "affecting", "the", "hands", "and", "fingers."], "wordsB": ["The", "primary", "objective", "of", "this", "prospective,", "randomized,", "placebo", "controlled", "study", "was", "to", "evaluate", "the", "safety", "and", "feasibility", "of", "intraarticular", "injection", "of", "Celution", "prepared", "adipose-derived", "regenerative", "cells", "injected", "into", "knees", "of", "patients", "with", "chronic", "knee", "pain", "due", "to", "osteoarthritis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p15_s0", "idA": "1095981_16_item7_p4_s3", "sentA": "Based on our internal analysis of the clinical and commercial chances of success, we have decided that scleroderma is our most advanced clinical indication as it is a phase III pivotal study.", "sentB": "Osteoarthritis Osteoarthritis is a disease of the entire joint involving the cartilage, joint lining, ligaments and underlying bone.", "type": 1, "words": ["<tag1>", "Based", "on", "our", "internal", "analysis", "of", "the", "clinical", "and", "commercial", "chances", "of", "success,", "we", "have", "decided", "that", "scleroderma", "is", "our", "most", "advanced", "clinical", "indication", "as", "it", "is", "a", "phase", "III", "pivotal", "study.", "<tag2>", "Osteoarthritis", "Osteoarthritis", "is", "a", "disease", "of", "the", "entire", "joint", "involving", "the", "cartilage,", "joint", "lining,", "ligaments", "and", "underlying", "bone.", "<tag3>"], "wordsA": ["Based", "on", "our", "internal", "analysis", "of", "the", "clinical", "and", "commercial", "chances", "of", "success,", "we", "have", "decided", "that", "scleroderma", "is", "our", "most", "advanced", "clinical", "indication", "as", "it", "is", "a", "phase", "III", "pivotal", "study."], "wordsB": ["Osteoarthritis", "Osteoarthritis", "is", "a", "disease", "of", "the", "entire", "joint", "involving", "the", "cartilage,", "joint", "lining,", "ligaments", "and", "underlying", "bone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p28_s11", "idA": "1095981_16_item7_p55_s0", "sentA": "Interest expense decreased for the year ended December 31, 2015 as compared to 2014, due to pay down and refinance of principal loan balance.", "sentB": "Other Clinical Indications Heart failure due to ischemic heart disease does not represent a current clinical target for us at this time.", "type": 1, "words": ["<tag1>", "Interest", "expense", "decreased", "for", "the", "year", "ended", "December", "31,", "2015", "as", "compared", "to", "2014,", "due", "to", "pay", "down", "and", "refinance", "of", "principal", "loan", "balance.", "<tag2>", "Other", "Clinical", "Indications", "Heart", "failure", "due", "to", "ischemic", "heart", "disease", "does", "not", "represent", "a", "current", "clinical", "target", "for", "us", "at", "this", "time.", "<tag3>"], "wordsA": ["Interest", "expense", "decreased", "for", "the", "year", "ended", "December", "31,", "2015", "as", "compared", "to", "2014,", "due", "to", "pay", "down", "and", "refinance", "of", "principal", "loan", "balance."], "wordsB": ["Other", "Clinical", "Indications", "Heart", "failure", "due", "to", "ischemic", "heart", "disease", "does", "not", "represent", "a", "current", "clinical", "target", "for", "us", "at", "this", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s2", "idA": "1095981_16_item7_p5_s0", "sentA": "In the later part of 2014, we received approval by the FDA to begin a U.S. IDE pilot (phase IIa/b) trial of Cytori Cell Therapy in patients with osteoarthritis of the knee.", "sentB": "The six-month results were published in the Annals of the Rheumatic Diseases in May 2014 and demonstrated approximately a 50 percent improvement at six months across four important and validated endpoints used to assess the clinical status in patients with scleroderma with impaired hand function.", "type": 1, "words": ["<tag1>", "In", "the", "later", "part", "of", "2014,", "we", "received", "approval", "by", "the", "FDA", "to", "begin", "a", "U.S.", "IDE", "pilot", "(phase", "IIa/b)", "trial", "of", "Cytori", "Cell", "Therapy", "in", "patients", "with", "osteoarthritis", "of", "the", "knee.", "<tag2>", "The", "six-month", "results", "were", "published", "in", "the", "Annals", "of", "the", "Rheumatic", "Diseases", "in", "May", "2014", "and", "demonstrated", "approximately", "a", "50", "percent", "improvement", "at", "six", "months", "across", "four", "important", "and", "validated", "endpoints", "used", "to", "assess", "the", "clinical", "status", "in", "patients", "with", "scleroderma", "with", "impaired", "hand", "function.", "<tag3>"], "wordsA": ["In", "the", "later", "part", "of", "2014,", "we", "received", "approval", "by", "the", "FDA", "to", "begin", "a", "U.S.", "IDE", "pilot", "(phase", "IIa/b)", "trial", "of", "Cytori", "Cell", "Therapy", "in", "patients", "with", "osteoarthritis", "of", "the", "knee."], "wordsB": ["The", "six-month", "results", "were", "published", "in", "the", "Annals", "of", "the", "Rheumatic", "Diseases", "in", "May", "2014", "and", "demonstrated", "approximately", "a", "50", "percent", "improvement", "at", "six", "months", "across", "four", "important", "and", "validated", "endpoints", "used", "to", "assess", "the", "clinical", "status", "in", "patients", "with", "scleroderma", "with", "impaired", "hand", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p13_s0", "idA": "1095981_16_item7_p5_s1", "sentA": "The trial, called ACT-OA, is a 94 patient, randomized, double-blind, placebo control study involving two dose escalations of Cytori Cell Therapy, a low dose and a high dose conducted over 48 weeks.", "sentB": "Guy Magalon and Brigitte Granel, under the sponsorship of the Assistance Publique - H pitaux de Marseille, submitted a study for review for a follow-up Phase III randomized, double-blind, placebo-controlled trial in F rance using Cytori Cell Therapy, to be supported by Cytori.", "type": 1, "words": ["<tag1>", "The", "trial,", "called", "ACT-OA,", "is", "a", "94", "patient,", "randomized,", "double-blind,", "placebo", "control", "study", "involving", "two", "dose", "escalations", "of", "Cytori", "Cell", "Therapy,", "a", "low", "dose", "and", "a", "high", "dose", "conducted", "over", "48", "weeks.", "<tag2>", "Guy", "Magalon", "and", "Brigitte", "Granel,", "under", "the", "sponsorship", "of", "the", "Assistance", "Publique", "-", "H", "pitaux", "de", "Marseille,", "submitted", "a", "study", "for", "review", "for", "a", "follow-up", "Phase", "III", "randomized,", "double-blind,", "placebo-controlled", "trial", "in", "F", "rance", "using", "Cytori", "Cell", "Therapy,", "to", "be", "supported", "by", "Cytori.", "<tag3>"], "wordsA": ["The", "trial,", "called", "ACT-OA,", "is", "a", "94", "patient,", "randomized,", "double-blind,", "placebo", "control", "study", "involving", "two", "dose", "escalations", "of", "Cytori", "Cell", "Therapy,", "a", "low", "dose", "and", "a", "high", "dose", "conducted", "over", "48", "weeks."], "wordsB": ["Guy", "Magalon", "and", "Brigitte", "Granel,", "under", "the", "sponsorship", "of", "the", "Assistance", "Publique", "-", "H", "pitaux", "de", "Marseille,", "submitted", "a", "study", "for", "review", "for", "a", "follow-up", "Phase", "III", "randomized,", "double-blind,", "placebo-controlled", "trial", "in", "F", "rance", "using", "Cytori", "Cell", "Therapy,", "to", "be", "supported", "by", "Cytori."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p22_s0", "idA": "1095981_16_item7_p5_s1", "sentA": "The trial, called ACT-OA, is a 94 patient, randomized, double-blind, placebo control study involving two dose escalations of Cytori Cell Therapy, a low dose and a high dose conducted over 48 weeks.", "sentB": "Consistent trends observed in all 6 pre-specified MRI Osteoarthritis Knee Score (MOAKS) classification scores suggesting decrease in target knee joint pathologic features at 48 weeks for the treated group relative to placebo control group.", "type": 1, "words": ["<tag1>", "The", "trial,", "called", "ACT-OA,", "is", "a", "94", "patient,", "randomized,", "double-blind,", "placebo", "control", "study", "involving", "two", "dose", "escalations", "of", "Cytori", "Cell", "Therapy,", "a", "low", "dose", "and", "a", "high", "dose", "conducted", "over", "48", "weeks.", "<tag2>", "Consistent", "trends", "observed", "in", "all", "6", "pre-specified", "MRI", "Osteoarthritis", "Knee", "Score", "(MOAKS)", "classification", "scores", "suggesting", "decrease", "in", "target", "knee", "joint", "pathologic", "features", "at", "48", "weeks", "for", "the", "treated", "group", "relative", "to", "placebo", "control", "group.", "<tag3>"], "wordsA": ["The", "trial,", "called", "ACT-OA,", "is", "a", "94", "patient,", "randomized,", "double-blind,", "placebo", "control", "study", "involving", "two", "dose", "escalations", "of", "Cytori", "Cell", "Therapy,", "a", "low", "dose", "and", "a", "high", "dose", "conducted", "over", "48", "weeks."], "wordsB": ["Consistent", "trends", "observed", "in", "all", "6", "pre-specified", "MRI", "Osteoarthritis", "Knee", "Score", "(MOAKS)", "classification", "scores", "suggesting", "decrease", "in", "target", "knee", "joint", "pathologic", "features", "at", "48", "weeks", "for", "the", "treated", "group", "relative", "to", "placebo", "control", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s13", "idA": "1095981_16_item7_p5_s1", "sentA": "The trial, called ACT-OA, is a 94 patient, randomized, double-blind, placebo control study involving two dose escalations of Cytori Cell Therapy, a low dose and a high dose conducted over 48 weeks.", "sentB": "Other findings at one-year included a 30.5% improvement in grip strength (p=0.002) and a 34.5% improvement in hand pain (p=0.052).", "type": 1, "words": ["<tag1>", "The", "trial,", "called", "ACT-OA,", "is", "a", "94", "patient,", "randomized,", "double-blind,", "placebo", "control", "study", "involving", "two", "dose", "escalations", "of", "Cytori", "Cell", "Therapy,", "a", "low", "dose", "and", "a", "high", "dose", "conducted", "over", "48", "weeks.", "<tag2>", "Other", "findings", "at", "one-year", "included", "a", "30.5%", "improvement", "in", "grip", "strength", "(p=0.002)", "and", "a", "34.5%", "improvement", "in", "hand", "pain", "(p=0.052).", "<tag3>"], "wordsA": ["The", "trial,", "called", "ACT-OA,", "is", "a", "94", "patient,", "randomized,", "double-blind,", "placebo", "control", "study", "involving", "two", "dose", "escalations", "of", "Cytori", "Cell", "Therapy,", "a", "low", "dose", "and", "a", "high", "dose", "conducted", "over", "48", "weeks."], "wordsB": ["Other", "findings", "at", "one-year", "included", "a", "30.5%", "improvement", "in", "grip", "strength", "(p=0.002)", "and", "a", "34.5%", "improvement", "in", "hand", "pain", "(p=0.052)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p13_s2", "idA": "1095981_16_item7_p62_s0", "sentA": "The following is a summary of our key liquidity measures at December 31, 2015 and 2014:", "sentB": "Enrollment of this trial commenced in October 2015 and is ongoing.", "type": 1, "words": ["<tag1>", "The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2015", "and", "2014:", "<tag2>", "Enrollment", "of", "this", "trial", "commenced", "in", "October", "2015", "and", "is", "ongoing.", "<tag3>"], "wordsA": ["The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2015", "and", "2014:"], "wordsB": ["Enrollment", "of", "this", "trial", "commenced", "in", "October", "2015", "and", "is", "ongoing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p28_s13", "idA": "1095981_16_item7_p64_s4", "sentA": "If we are unsuccessful in our efforts to raise outside capital in the near term, we will be required to significantly reduce our research, development, and administrative operations, including reduction of our employee base, in order to offset the lack of available funding.", "sentB": "While the safety data from these trial programs will be used for regulatory support for our other indications and also for publication in peer reviewed forums, we are not actively pursuing indications related to these trials.", "type": 1, "words": ["<tag1>", "If", "we", "are", "unsuccessful", "in", "our", "efforts", "to", "raise", "outside", "capital", "in", "the", "near", "term,", "we", "will", "be", "required", "to", "significantly", "reduce", "our", "research,", "development,", "and", "administrative", "operations,", "including", "reduction", "of", "our", "employee", "base,", "in", "order", "to", "offset", "the", "lack", "of", "available", "funding.", "<tag2>", "While", "the", "safety", "data", "from", "these", "trial", "programs", "will", "be", "used", "for", "regulatory", "support", "for", "our", "other", "indications", "and", "also", "for", "publication", "in", "peer", "reviewed", "forums,", "we", "are", "not", "actively", "pursuing", "indications", "related", "to", "these", "trials.", "<tag3>"], "wordsA": ["If", "we", "are", "unsuccessful", "in", "our", "efforts", "to", "raise", "outside", "capital", "in", "the", "near", "term,", "we", "will", "be", "required", "to", "significantly", "reduce", "our", "research,", "development,", "and", "administrative", "operations,", "including", "reduction", "of", "our", "employee", "base,", "in", "order", "to", "offset", "the", "lack", "of", "available", "funding."], "wordsB": ["While", "the", "safety", "data", "from", "these", "trial", "programs", "will", "be", "used", "for", "regulatory", "support", "for", "our", "other", "indications", "and", "also", "for", "publication", "in", "peer", "reviewed", "forums,", "we", "are", "not", "actively", "pursuing", "indications", "related", "to", "these", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p9_s0", "idA": "1095981_16_item7_p66_s3", "sentA": "In parallel, we would significantly reduce administrative staff and salaries consistent with the overall reduction in scope of operations.", "sentB": "Hand dysfunction assessed by the CHFS, showed a 62% reduction in hand dysfunction at two years (p 0.001).", "type": 1, "words": ["<tag1>", "In", "parallel,", "we", "would", "significantly", "reduce", "administrative", "staff", "and", "salaries", "consistent", "with", "the", "overall", "reduction", "in", "scope", "of", "operations.", "<tag2>", "Hand", "dysfunction", "assessed", "by", "the", "CHFS,", "showed", "a", "62%", "reduction", "in", "hand", "dysfunction", "at", "two", "years", "(p", "0.001).", "<tag3>"], "wordsA": ["In", "parallel,", "we", "would", "significantly", "reduce", "administrative", "staff", "and", "salaries", "consistent", "with", "the", "overall", "reduction", "in", "scope", "of", "operations."], "wordsB": ["Hand", "dysfunction", "assessed", "by", "the", "CHFS,", "showed", "a", "62%", "reduction", "in", "hand", "dysfunction", "at", "two", "years", "(p", "0.001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p28_s12", "idA": "1095981_16_item7_p67_s0", "sentA": "From January 1, 2013 to December 31, 2015, we have financed our operations primarily by:", "sentB": "Our ATHENA and ATHENA II trials related to that indication were truncated and we have minimized expenses related to initiatives in this area.", "type": 1, "words": ["<tag1>", "From", "January", "1,", "2013", "to", "December", "31,", "2015,", "we", "have", "financed", "our", "operations", "primarily", "by:", "<tag2>", "Our", "ATHENA", "and", "ATHENA", "II", "trials", "related", "to", "that", "indication", "were", "truncated", "and", "we", "have", "minimized", "expenses", "related", "to", "initiatives", "in", "this", "area.", "<tag3>"], "wordsA": ["From", "January", "1,", "2013", "to", "December", "31,", "2015,", "we", "have", "financed", "our", "operations", "primarily", "by:"], "wordsB": ["Our", "ATHENA", "and", "ATHENA", "II", "trials", "related", "to", "that", "indication", "were", "truncated", "and", "we", "have", "minimized", "expenses", "related", "to", "initiatives", "in", "this", "area."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p26_s0", "idA": "1095981_16_item7_p6_s0", "sentA": "The first patient was enrolled in February 2015, and enrollment was completed in June 2015.", "sentB": "Trial enrollment began trial in September 2015, and in December 2016, the trial was 50% enrolled.", "type": 1, "words": ["<tag1>", "The", "first", "patient", "was", "enrolled", "in", "February", "2015,", "and", "enrollment", "was", "completed", "in", "June", "2015.", "<tag2>", "Trial", "enrollment", "began", "trial", "in", "September", "2015,", "and", "in", "December", "2016,", "the", "trial", "was", "50%", "enrolled.", "<tag3>"], "wordsA": ["The", "first", "patient", "was", "enrolled", "in", "February", "2015,", "and", "enrollment", "was", "completed", "in", "June", "2015."], "wordsB": ["Trial", "enrollment", "began", "trial", "in", "September", "2015,", "and", "in", "December", "2016,", "the", "trial", "was", "50%", "enrolled."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p28_s14", "idA": "1095981_16_item7_p6_s1", "sentA": "A pre-specified partial unblinding and top-line analysis of 24 week data was completed in Q1 of 2016.", "sentB": "The 12 month results of the ATHENA Trials were presented by the investigators at the Society of Cardiac Angiography and Interventions Annual Scientific Meeting on May 5, 2016 and data was published in the Catheterization and Cardiovascular Interventions journal in June 2016.", "type": 1, "words": ["<tag1>", "A", "pre-specified", "partial", "unblinding", "and", "top-line", "analysis", "of", "24", "week", "data", "was", "completed", "in", "Q1", "of", "2016.", "<tag2>", "The", "12", "month", "results", "of", "the", "ATHENA", "Trials", "were", "presented", "by", "the", "investigators", "at", "the", "Society", "of", "Cardiac", "Angiography", "and", "Interventions", "Annual", "Scientific", "Meeting", "on", "May", "5,", "2016", "and", "data", "was", "published", "in", "the", "Catheterization", "and", "Cardiovascular", "Interventions", "journal", "in", "June", "2016.", "<tag3>"], "wordsA": ["A", "pre-specified", "partial", "unblinding", "and", "top-line", "analysis", "of", "24", "week", "data", "was", "completed", "in", "Q1", "of", "2016."], "wordsB": ["The", "12", "month", "results", "of", "the", "ATHENA", "Trials", "were", "presented", "by", "the", "investigators", "at", "the", "Society", "of", "Cardiac", "Angiography", "and", "Interventions", "Annual", "Scientific", "Meeting", "on", "May", "5,", "2016", "and", "data", "was", "published", "in", "the", "Catheterization", "and", "Cardiovascular", "Interventions", "journal", "in", "June", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p59_s5", "idA": "1095981_16_item7_p6_s1", "sentA": "A pre-specified partial unblinding and top-line analysis of 24 week data was completed in Q1 of 2016.", "sentB": "On June 15, 2016, we closed the Rights Offering originally filed under a Form S-1 registration statement in April 2016.", "type": 1, "words": ["<tag1>", "A", "pre-specified", "partial", "unblinding", "and", "top-line", "analysis", "of", "24", "week", "data", "was", "completed", "in", "Q1", "of", "2016.", "<tag2>", "On", "June", "15,", "2016,", "we", "closed", "the", "Rights", "Offering", "originally", "filed", "under", "a", "Form", "S-1", "registration", "statement", "in", "April", "2016.", "<tag3>"], "wordsA": ["A", "pre-specified", "partial", "unblinding", "and", "top-line", "analysis", "of", "24", "week", "data", "was", "completed", "in", "Q1", "of", "2016."], "wordsB": ["On", "June", "15,", "2016,", "we", "closed", "the", "Rights", "Offering", "originally", "filed", "under", "a", "Form", "S-1", "registration", "statement", "in", "April", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p11_s0", "idA": "1095981_16_item7_p6_s3", "sentA": "In the 3 rd quarter of 2016, following full un-blinding of the data, the Company will be able to more fully evaluate the data including 48 week follow up, patient subset analyses, and the effect on knee cartilage as measured by magnetic resonance imaging results changes between baseline and 48 weeks.", "sentB": "Hand pain, as measured by a 100 mm Visual Analogue Scale, and the Scleroderma Health Assessment Questionnaire (SHAQ) score at two years both showed improvement of 50% over baseline (p=0.01 and p 0.001, respectively).", "type": 1, "words": ["<tag1>", "In", "the", "3", "rd", "quarter", "of", "2016,", "following", "full", "un-blinding", "of", "the", "data,", "the", "Company", "will", "be", "able", "to", "more", "fully", "evaluate", "the", "data", "including", "48", "week", "follow", "up,", "patient", "subset", "analyses,", "and", "the", "effect", "on", "knee", "cartilage", "as", "measured", "by", "magnetic", "resonance", "imaging", "results", "changes", "between", "baseline", "and", "48", "weeks.", "<tag2>", "Hand", "pain,", "as", "measured", "by", "a", "100", "mm", "Visual", "Analogue", "Scale,", "and", "the", "Scleroderma", "Health", "Assessment", "Questionnaire", "(SHAQ)", "score", "at", "two", "years", "both", "showed", "improvement", "of", "50%", "over", "baseline", "(p=0.01", "and", "p", "0.001,", "respectively).", "<tag3>"], "wordsA": ["In", "the", "3", "rd", "quarter", "of", "2016,", "following", "full", "un-blinding", "of", "the", "data,", "the", "Company", "will", "be", "able", "to", "more", "fully", "evaluate", "the", "data", "including", "48", "week", "follow", "up,", "patient", "subset", "analyses,", "and", "the", "effect", "on", "knee", "cartilage", "as", "measured", "by", "magnetic", "resonance", "imaging", "results", "changes", "between", "baseline", "and", "48", "weeks."], "wordsB": ["Hand", "pain,", "as", "measured", "by", "a", "100", "mm", "Visual", "Analogue", "Scale,", "and", "the", "Scleroderma", "Health", "Assessment", "Questionnaire", "(SHAQ)", "score", "at", "two", "years", "both", "showed", "improvement", "of", "50%", "over", "baseline", "(p=0.01", "and", "p", "0.001,", "respectively)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s4", "idA": "1095981_16_item7_p75_s1", "sentA": "We received proceeds of approximately $4.1 million from the exercise of the warrants.", "sentB": "A 47% and 56% decrease of the CHFS at month 2 and month 6 in comparison to baseline was observed (p 0.001 for both).", "type": 1, "words": ["<tag1>", "We", "received", "proceeds", "of", "approximately", "$4.1", "million", "from", "the", "exercise", "of", "the", "warrants.", "<tag2>", "A", "47%", "and", "56%", "decrease", "of", "the", "CHFS", "at", "month", "2", "and", "month", "6", "in", "comparison", "to", "baseline", "was", "observed", "(p", "0.001", "for", "both).", "<tag3>"], "wordsA": ["We", "received", "proceeds", "of", "approximately", "$4.1", "million", "from", "the", "exercise", "of", "the", "warrants."], "wordsB": ["A", "47%", "and", "56%", "decrease", "of", "the", "CHFS", "at", "month", "2", "and", "month", "6", "in", "comparison", "to", "baseline", "was", "observed", "(p", "0.001", "for", "both)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s7", "idA": "1095981_16_item7_p75_s2", "sentA": "In addition, pursuant to the terms of the amendment, upon each holder s exercise of all warrants for cash prior to the amended expiration date, we issued additional warrants for the same number of common shares to the holders.", "sentB": "Among subjects having at least one digital ulcer, or DU, at inclusion, total number of DU decreased, from 15 DUs at baseline, 10 at month 2 and 7 at month 6.", "type": 1, "words": ["<tag1>", "In", "addition,", "pursuant", "to", "the", "terms", "of", "the", "amendment,", "upon", "each", "holder", "s", "exercise", "of", "all", "warrants", "for", "cash", "prior", "to", "the", "amended", "expiration", "date,", "we", "issued", "additional", "warrants", "for", "the", "same", "number", "of", "common", "shares", "to", "the", "holders.", "<tag2>", "Among", "subjects", "having", "at", "least", "one", "digital", "ulcer,", "or", "DU,", "at", "inclusion,", "total", "number", "of", "DU", "decreased,", "from", "15", "DUs", "at", "baseline,", "10", "at", "month", "2", "and", "7", "at", "month", "6.", "<tag3>"], "wordsA": ["In", "addition,", "pursuant", "to", "the", "terms", "of", "the", "amendment,", "upon", "each", "holder", "s", "exercise", "of", "all", "warrants", "for", "cash", "prior", "to", "the", "amended", "expiration", "date,", "we", "issued", "additional", "warrants", "for", "the", "same", "number", "of", "common", "shares", "to", "the", "holders."], "wordsB": ["Among", "subjects", "having", "at", "least", "one", "digital", "ulcer,", "or", "DU,", "at", "inclusion,", "total", "number", "of", "DU", "decreased,", "from", "15", "DUs", "at", "baseline,", "10", "at", "month", "2", "and", "7", "at", "month", "6."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p62_s4", "idA": "1095981_16_item7_p77_s0", "sentA": "In October, 2014, we entered into a Securities Purchase Agreement with certain institutional investors pursuant to which we sold a total of 13,500 units for a purchase price of $1,000 per unit, with each unit consisting of one share of our Series A 3.6% Convertible Preferred Stock, which was convertible into shares of our common stock with a conversion price of $0.52, and warrants to purchase up to a number of shares of common stock equal to 100% of the conversion shares under the shares of preferred stock, in a registered direct offering.", "sentB": "To date, we sold no shares under the Lincoln Park Purchase Agreement to Lincoln Park.", "type": 1, "words": ["<tag1>", "In", "October,", "2014,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors", "pursuant", "to", "which", "we", "sold", "a", "total", "of", "13,500", "units", "for", "a", "purchase", "price", "of", "$1,000", "per", "unit,", "with", "each", "unit", "consisting", "of", "one", "share", "of", "our", "Series", "A", "3.6%", "Convertible", "Preferred", "Stock,", "which", "was", "convertible", "into", "shares", "of", "our", "common", "stock", "with", "a", "conversion", "price", "of", "$0.52,", "and", "warrants", "to", "purchase", "up", "to", "a", "number", "of", "shares", "of", "common", "stock", "equal", "to", "100%", "of", "the", "conversion", "shares", "under", "the", "shares", "of", "preferred", "stock,", "in", "a", "registered", "direct", "offering.", "<tag2>", "To", "date,", "we", "sold", "no", "shares", "under", "the", "Lincoln", "Park", "Purchase", "Agreement", "to", "Lincoln", "Park.", "<tag3>"], "wordsA": ["In", "October,", "2014,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors", "pursuant", "to", "which", "we", "sold", "a", "total", "of", "13,500", "units", "for", "a", "purchase", "price", "of", "$1,000", "per", "unit,", "with", "each", "unit", "consisting", "of", "one", "share", "of", "our", "Series", "A", "3.6%", "Convertible", "Preferred", "Stock,", "which", "was", "convertible", "into", "shares", "of", "our", "common", "stock", "with", "a", "conversion", "price", "of", "$0.52,", "and", "warrants", "to", "purchase", "up", "to", "a", "number", "of", "shares", "of", "common", "stock", "equal", "to", "100%", "of", "the", "conversion", "shares", "under", "the", "shares", "of", "preferred", "stock,", "in", "a", "registered", "direct", "offering."], "wordsB": ["To", "date,", "we", "sold", "no", "shares", "under", "the", "Lincoln", "Park", "Purchase", "Agreement", "to", "Lincoln", "Park."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s11", "idA": "1095981_16_item7_p77_s2", "sentA": "The preferred stock and the warrants were immediately separable and were issued separately.", "sentB": "Relative to baseline, the CHFS and the SHAQ improved by 51.3% and 46.8%, respectively (p 0.001 for both).", "type": 1, "words": ["<tag1>", "The", "preferred", "stock", "and", "the", "warrants", "were", "immediately", "separable", "and", "were", "issued", "separately.", "<tag2>", "Relative", "to", "baseline,", "the", "CHFS", "and", "the", "SHAQ", "improved", "by", "51.3%", "and", "46.8%,", "respectively", "(p", "0.001", "for", "both).", "<tag3>"], "wordsA": ["The", "preferred", "stock", "and", "the", "warrants", "were", "immediately", "separable", "and", "were", "issued", "separately."], "wordsB": ["Relative", "to", "baseline,", "the", "CHFS", "and", "the", "SHAQ", "improved", "by", "51.3%", "and", "46.8%,", "respectively", "(p", "0.001", "for", "both)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p3_s1", "idA": "1095981_16_item7_p7_s2", "sentA": "The goal of this investigator-initiated trial is to gain regulatory approval in Japan of our Cytori Cell Therapy for this indication.", "sentB": "Partial funding of this study is granted by AMED (Japan Agency for Medical Research and Development).", "type": 1, "words": ["<tag1>", "The", "goal", "of", "this", "investigator-initiated", "trial", "is", "to", "gain", "regulatory", "approval", "in", "Japan", "of", "our", "Cytori", "Cell", "Therapy", "for", "this", "indication.", "<tag2>", "Partial", "funding", "of", "this", "study", "is", "granted", "by", "AMED", "(Japan", "Agency", "for", "Medical", "Research", "and", "Development).", "<tag3>"], "wordsA": ["The", "goal", "of", "this", "investigator-initiated", "trial", "is", "to", "gain", "regulatory", "approval", "in", "Japan", "of", "our", "Cytori", "Cell", "Therapy", "for", "this", "indication."], "wordsB": ["Partial", "funding", "of", "this", "study", "is", "granted", "by", "AMED", "(Japan", "Agency", "for", "Medical", "Research", "and", "Development)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p5_s2", "idA": "1095981_16_item7_p80_s0", "sentA": "* We have various payment options which could result in the acceleration or deferral of the Joint Venture purchase obligation.", "sentB": "More than 90 percent of scleroderma patients have hand involvement that is typically progressive and can result in chronic pain, blood flow changes and severe dysfunction.", "type": 1, "words": ["<tag1>", "*", "We", "have", "various", "payment", "options", "which", "could", "result", "in", "the", "acceleration", "or", "deferral", "of", "the", "Joint", "Venture", "purchase", "obligation.", "<tag2>", "More", "than", "90", "percent", "of", "scleroderma", "patients", "have", "hand", "involvement", "that", "is", "typically", "progressive", "and", "can", "result", "in", "chronic", "pain,", "blood", "flow", "changes", "and", "severe", "dysfunction.", "<tag3>"], "wordsA": ["*", "We", "have", "various", "payment", "options", "which", "could", "result", "in", "the", "acceleration", "or", "deferral", "of", "the", "Joint", "Venture", "purchase", "obligation."], "wordsB": ["More", "than", "90", "percent", "of", "scleroderma", "patients", "have", "hand", "involvement", "that", "is", "typically", "progressive", "and", "can", "result", "in", "chronic", "pain,", "blood", "flow", "changes", "and", "severe", "dysfunction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s6", "idA": "1095981_16_item7_p83_s2", "sentA": "Overall, our operational cash use decreased as compared to the same period in 2013, due primarily to an increase in cash collections from accounts receivable, offset by an increase in payments of accounts payable and accrued liabilities.", "sentB": "Similarly, an increase in pinch strength at month 6 was noted with a mean improvement of +1.0 1.1 kg for the dominant hand (p=0.009) and +0.8 1.2 kg for the non-dominant hand (p=0.050).", "type": 1, "words": ["<tag1>", "Overall,", "our", "operational", "cash", "use", "decreased", "as", "compared", "to", "the", "same", "period", "in", "2013,", "due", "primarily", "to", "an", "increase", "in", "cash", "collections", "from", "accounts", "receivable,", "offset", "by", "an", "increase", "in", "payments", "of", "accounts", "payable", "and", "accrued", "liabilities.", "<tag2>", "Similarly,", "an", "increase", "in", "pinch", "strength", "at", "month", "6", "was", "noted", "with", "a", "mean", "improvement", "of", "+1.0", "1.1", "kg", "for", "the", "dominant", "hand", "(p=0.009)", "and", "+0.8", "1.2", "kg", "for", "the", "non-dominant", "hand", "(p=0.050).", "<tag3>"], "wordsA": ["Overall,", "our", "operational", "cash", "use", "decreased", "as", "compared", "to", "the", "same", "period", "in", "2013,", "due", "primarily", "to", "an", "increase", "in", "cash", "collections", "from", "accounts", "receivable,", "offset", "by", "an", "increase", "in", "payments", "of", "accounts", "payable", "and", "accrued", "liabilities."], "wordsB": ["Similarly,", "an", "increase", "in", "pinch", "strength", "at", "month", "6", "was", "noted", "with", "a", "mean", "improvement", "of", "+1.0", "1.1", "kg", "for", "the", "dominant", "hand", "(p=0.009)", "and", "+0.8", "1.2", "kg", "for", "the", "non-dominant", "hand", "(p=0.050)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s8", "idA": "1095981_16_item7_p88_s2", "sentA": "The purchase and sale of the units is took place in two separate closings.", "sentB": "The average reduction of the Raynaud s Condition Score from baseline was 53.7% at month 2 (p 0.001) and 67.5% at month 6 (p 0.001).", "type": 1, "words": ["<tag1>", "The", "purchase", "and", "sale", "of", "the", "units", "is", "took", "place", "in", "two", "separate", "closings.", "<tag2>", "The", "average", "reduction", "of", "the", "Raynaud", "s", "Condition", "Score", "from", "baseline", "was", "53.7%", "at", "month", "2", "(p", "0.001)", "and", "67.5%", "at", "month", "6", "(p", "0.001).", "<tag3>"], "wordsA": ["The", "purchase", "and", "sale", "of", "the", "units", "is", "took", "place", "in", "two", "separate", "closings."], "wordsB": ["The", "average", "reduction", "of", "the", "Raynaud", "s", "Condition", "Score", "from", "baseline", "was", "53.7%", "at", "month", "2", "(p", "0.001)", "and", "67.5%", "at", "month", "6", "(p", "0.001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p65_s0", "idA": "1095981_16_item7_p92_s1", "sentA": "If results differ materially from our estimates, we will make adjustments to our financial statements prospectively as we become aware of the necessity for an adjustment.", "sentB": "We do not have any off-balance sheet arrangements (as defined by applicable regulations of the SEC) that are reasonably likely to have a current or future material effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.", "type": 1, "words": ["<tag1>", "If", "results", "differ", "materially", "from", "our", "estimates,", "we", "will", "make", "adjustments", "to", "our", "financial", "statements", "prospectively", "as", "we", "become", "aware", "of", "the", "necessity", "for", "an", "adjustment.", "<tag2>", "We", "do", "not", "have", "any", "off-balance", "sheet", "arrangements", "(as", "defined", "by", "applicable", "regulations", "of", "the", "SEC)", "that", "are", "reasonably", "likely", "to", "have", "a", "current", "or", "future", "material", "effect", "on", "our", "financial", "condition,", "results", "of", "operations,", "liquidity,", "capital", "expenditures", "or", "capital", "resources.", "<tag3>"], "wordsA": ["If", "results", "differ", "materially", "from", "our", "estimates,", "we", "will", "make", "adjustments", "to", "our", "financial", "statements", "prospectively", "as", "we", "become", "aware", "of", "the", "necessity", "for", "an", "adjustment."], "wordsB": ["We", "do", "not", "have", "any", "off-balance", "sheet", "arrangements", "(as", "defined", "by", "applicable", "regulations", "of", "the", "SEC)", "that", "are", "reasonably", "likely", "to", "have", "a", "current", "or", "future", "material", "effect", "on", "our", "financial", "condition,", "results", "of", "operations,", "liquidity,", "capital", "expenditures", "or", "capital", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p76_s0", "idA": "1095981_16_item7_p94_s1", "sentA": "For customers that have not developed a sufficient payment history with us or for whom a letter of credit is not in place at the time of the transaction, we defer revenues until collectability is reasonably assured.", "sentB": "Separable intangible assets that have finite useful lives are amortized over their respective useful lives.", "type": 1, "words": ["<tag1>", "For", "customers", "that", "have", "not", "developed", "a", "sufficient", "payment", "history", "with", "us", "or", "for", "whom", "a", "letter", "of", "credit", "is", "not", "in", "place", "at", "the", "time", "of", "the", "transaction,", "we", "defer", "revenues", "until", "collectability", "is", "reasonably", "assured.", "<tag2>", "Separable", "intangible", "assets", "that", "have", "finite", "useful", "lives", "are", "amortized", "over", "their", "respective", "useful", "lives.", "<tag3>"], "wordsA": ["For", "customers", "that", "have", "not", "developed", "a", "sufficient", "payment", "history", "with", "us", "or", "for", "whom", "a", "letter", "of", "credit", "is", "not", "in", "place", "at", "the", "time", "of", "the", "transaction,", "we", "defer", "revenues", "until", "collectability", "is", "reasonably", "assured."], "wordsB": ["Separable", "intangible", "assets", "that", "have", "finite", "useful", "lives", "are", "amortized", "over", "their", "respective", "useful", "lives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p0_s0", "idA": "1095981_16_item7_p96_s3", "sentA": "For sales where all revenue recognition criteria are not met, revenue is deferred and related inventory remains on our books.", "sentB": "We develop cellular therapeutics uniquely formulated and optimized for specific diseases and medical conditions and related products.", "type": 1, "words": ["<tag1>", "For", "sales", "where", "all", "revenue", "recognition", "criteria", "are", "not", "met,", "revenue", "is", "deferred", "and", "related", "inventory", "remains", "on", "our", "books.", "<tag2>", "We", "develop", "cellular", "therapeutics", "uniquely", "formulated", "and", "optimized", "for", "specific", "diseases", "and", "medical", "conditions", "and", "related", "products.", "<tag3>"], "wordsA": ["For", "sales", "where", "all", "revenue", "recognition", "criteria", "are", "not", "met,", "revenue", "is", "deferred", "and", "related", "inventory", "remains", "on", "our", "books."], "wordsB": ["We", "develop", "cellular", "therapeutics", "uniquely", "formulated", "and", "optimized", "for", "specific", "diseases", "and", "medical", "conditions", "and", "related", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p13_s3", "idA": "1095981_16_item7_p98_s2", "sentA": "Web hosting, technical support and maintenance services are generally provided for a period of up to one year subsequent to the date of sale.", "sentB": "Patients will be followed for a 6-month p ost-procedure.", "type": 1, "words": ["<tag1>", "Web", "hosting,", "technical", "support", "and", "maintenance", "services", "are", "generally", "provided", "for", "a", "period", "of", "up", "to", "one", "year", "subsequent", "to", "the", "date", "of", "sale.", "<tag2>", "Patients", "will", "be", "followed", "for", "a", "6-month", "p", "ost-procedure.", "<tag3>"], "wordsA": ["Web", "hosting,", "technical", "support", "and", "maintenance", "services", "are", "generally", "provided", "for", "a", "period", "of", "up", "to", "one", "year", "subsequent", "to", "the", "date", "of", "sale."], "wordsB": ["Patients", "will", "be", "followed", "for", "a", "6-month", "p", "ost-procedure."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p8_s5", "idA": "1095981_16_item7_p99_s0", "sentA": "Each cell bank is customized to provide the best solution for the customer.", "sentB": "Grip strength increased at month 6 with a mean improvement of +4.8 6.4 kg for the dominant hand (p=0.033) and +4.0 3.5 kg for the non-dominant hand (p=0.002).", "type": 1, "words": ["<tag1>", "Each", "cell", "bank", "is", "customized", "to", "provide", "the", "best", "solution", "for", "the", "customer.", "<tag2>", "Grip", "strength", "increased", "at", "month", "6", "with", "a", "mean", "improvement", "of", "+4.8", "6.4", "kg", "for", "the", "dominant", "hand", "(p=0.033)", "and", "+4.0", "3.5", "kg", "for", "the", "non-dominant", "hand", "(p=0.002).", "<tag3>"], "wordsA": ["Each", "cell", "bank", "is", "customized", "to", "provide", "the", "best", "solution", "for", "the", "customer."], "wordsB": ["Grip", "strength", "increased", "at", "month", "6", "with", "a", "mean", "improvement", "of", "+4.8", "6.4", "kg", "for", "the", "dominant", "hand", "(p=0.033)", "and", "+4.0", "3.5", "kg", "for", "the", "non-dominant", "hand", "(p=0.002)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item7_p10_s0", "idA": "1095981_16_item7_p9_s1", "sentA": "The initial base period included $4.7 million over two years and covered preclinical research and continued development of Cytori s Celution System to improve cell processing.", "sentB": "Raynaud s Condition Score decreased by an average of 89% over baseline at two years (p 0.001).", "type": 1, "words": ["<tag1>", "The", "initial", "base", "period", "included", "$4.7", "million", "over", "two", "years", "and", "covered", "preclinical", "research", "and", "continued", "development", "of", "Cytori", "s", "Celution", "System", "to", "improve", "cell", "processing.", "<tag2>", "Raynaud", "s", "Condition", "Score", "decreased", "by", "an", "average", "of", "89%", "over", "baseline", "at", "two", "years", "(p", "0.001).", "<tag3>"], "wordsA": ["The", "initial", "base", "period", "included", "$4.7", "million", "over", "two", "years", "and", "covered", "preclinical", "research", "and", "continued", "development", "of", "Cytori", "s", "Celution", "System", "to", "improve", "cell", "processing."], "wordsB": ["Raynaud", "s", "Condition", "Score", "decreased", "by", "an", "average", "of", "89%", "over", "baseline", "at", "two", "years", "(p", "0.001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p1_s1", "idA": "1095981_17_item7_p1_s1", "sentA": "These cellular therapeutics are extracted from an adult patient s own adipose (fat) tissue using our fully automated Celution System, which includes a device, proprietary enzymes, and sterile consumable sets utilized at the point-of-therapeutic application or potentially at an off-site processing center.", "sentB": "To bring this promise to health providers and their patients, we are developing novel therapies prepared and administered at the patient s bedside with proprietary technologies that include therapy-specific reusable, automated, standardized Celution devices, single-use Celution consumable sets, Celase reagent, and Intravase reagent.", "type": 1, "words": ["<tag1>", "These", "cellular", "therapeutics", "are", "extracted", "from", "an", "adult", "patient", "s", "own", "adipose", "(fat)", "tissue", "using", "our", "fully", "automated", "Celution", "System,", "which", "includes", "a", "device,", "proprietary", "enzymes,", "and", "sterile", "consumable", "sets", "utilized", "at", "the", "point-of-therapeutic", "application", "or", "potentially", "at", "an", "off-site", "processing", "center.", "<tag2>", "To", "bring", "this", "promise", "to", "health", "providers", "and", "their", "patients,", "we", "are", "developing", "novel", "therapies", "prepared", "and", "administered", "at", "the", "patient", "s", "bedside", "with", "proprietary", "technologies", "that", "include", "therapy-specific", "reusable,", "automated,", "standardized", "Celution", "devices,", "single-use", "Celution", "consumable", "sets,", "Celase", "reagent,", "and", "Intravase", "reagent.", "<tag3>"], "wordsA": ["These", "cellular", "therapeutics", "are", "extracted", "from", "an", "adult", "patient", "s", "own", "adipose", "(fat)", "tissue", "using", "our", "fully", "automated", "Celution", "System,", "which", "includes", "a", "device,", "proprietary", "enzymes,", "and", "sterile", "consumable", "sets", "utilized", "at", "the", "point-of-therapeutic", "application", "or", "potentially", "at", "an", "off-site", "processing", "center."], "wordsB": ["To", "bring", "this", "promise", "to", "health", "providers", "and", "their", "patients,", "we", "are", "developing", "novel", "therapies", "prepared", "and", "administered", "at", "the", "patient", "s", "bedside", "with", "proprietary", "technologies", "that", "include", "therapy-specific", "reusable,", "automated,", "standardized", "Celution", "devices,", "single-use", "Celution", "consumable", "sets,", "Celase", "reagent,", "and", "Intravase", "reagent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p3_s3", "idA": "1095981_17_item7_p28_s1", "sentA": "The initial base period included $4.7 million over two years and covered preclinical research and continued development of Cytori s Celution System to improve cell processing.", "sentB": "We are exploring contract manufacturing organization options for the Celution System to reduce overhead and product costs of goods sold.", "type": 1, "words": ["<tag1>", "The", "initial", "base", "period", "included", "$4.7", "million", "over", "two", "years", "and", "covered", "preclinical", "research", "and", "continued", "development", "of", "Cytori", "s", "Celution", "System", "to", "improve", "cell", "processing.", "<tag2>", "We", "are", "exploring", "contract", "manufacturing", "organization", "options", "for", "the", "Celution", "System", "to", "reduce", "overhead", "and", "product", "costs", "of", "goods", "sold.", "<tag3>"], "wordsA": ["The", "initial", "base", "period", "included", "$4.7", "million", "over", "two", "years", "and", "covered", "preclinical", "research", "and", "continued", "development", "of", "Cytori", "s", "Celution", "System", "to", "improve", "cell", "processing."], "wordsB": ["We", "are", "exploring", "contract", "manufacturing", "organization", "options", "for", "the", "Celution", "System", "to", "reduce", "overhead", "and", "product", "costs", "of", "goods", "sold."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p0_s1", "idA": "1095981_17_item7_p28_s12", "sentA": "Our ATHENA and ATHENA II trials related to that indication were truncated and we have minimized expenses related to initiatives in this area.", "sentB": "To meet this objective, we have acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value.", "type": 1, "words": ["<tag1>", "Our", "ATHENA", "and", "ATHENA", "II", "trials", "related", "to", "that", "indication", "were", "truncated", "and", "we", "have", "minimized", "expenses", "related", "to", "initiatives", "in", "this", "area.", "<tag2>", "To", "meet", "this", "objective,", "we", "have", "acquired", "and", "are", "developing", "two", "technology", "platforms", "that", "hold", "promise", "for", "treating", "millions", "of", "patients", "and", "represent", "significant", "potential", "for", "increasing", "shareholder", "value.", "<tag3>"], "wordsA": ["Our", "ATHENA", "and", "ATHENA", "II", "trials", "related", "to", "that", "indication", "were", "truncated", "and", "we", "have", "minimized", "expenses", "related", "to", "initiatives", "in", "this", "area."], "wordsB": ["To", "meet", "this", "objective,", "we", "have", "acquired", "and", "are", "developing", "two", "technology", "platforms", "that", "hold", "promise", "for", "treating", "millions", "of", "patients", "and", "represent", "significant", "potential", "for", "increasing", "shareholder", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p3_s5", "idA": "1095981_17_item7_p28_s12", "sentA": "Our ATHENA and ATHENA II trials related to that indication were truncated and we have minimized expenses related to initiatives in this area.", "sentB": "In those markets, we have been able to further develop and improve our core technologies, gain expanded clinical and product experience and data, and generate sales.", "type": 1, "words": ["<tag1>", "Our", "ATHENA", "and", "ATHENA", "II", "trials", "related", "to", "that", "indication", "were", "truncated", "and", "we", "have", "minimized", "expenses", "related", "to", "initiatives", "in", "this", "area.", "<tag2>", "In", "those", "markets,", "we", "have", "been", "able", "to", "further", "develop", "and", "improve", "our", "core", "technologies,", "gain", "expanded", "clinical", "and", "product", "experience", "and", "data,", "and", "generate", "sales.", "<tag3>"], "wordsA": ["Our", "ATHENA", "and", "ATHENA", "II", "trials", "related", "to", "that", "indication", "were", "truncated", "and", "we", "have", "minimized", "expenses", "related", "to", "initiatives", "in", "this", "area."], "wordsB": ["In", "those", "markets,", "we", "have", "been", "able", "to", "further", "develop", "and", "improve", "our", "core", "technologies,", "gain", "expanded", "clinical", "and", "product", "experience", "and", "data,", "and", "generate", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p34_s3", "idA": "1095981_17_item7_p29_s0", "sentA": "Results of Operations Product revenues Product revenues consisted of revenues primarily from the sale of our Cytori Cell Therapy-related products.", "sentB": "The net proceeds to us from the offering were approximately $8.7 million, after deducting underwriting discounts and commissions and offering expenses incurred by us.", "type": 1, "words": ["<tag1>", "Results", "of", "Operations", "Product", "revenues", "Product", "revenues", "consisted", "of", "revenues", "primarily", "from", "the", "sale", "of", "our", "Cytori", "Cell", "Therapy-related", "products.", "<tag2>", "The", "net", "proceeds", "to", "us", "from", "the", "offering", "were", "approximately", "$8.7", "million,", "after", "deducting", "underwriting", "discounts", "and", "commissions", "and", "offering", "expenses", "incurred", "by", "us.", "<tag3>"], "wordsA": ["Results", "of", "Operations", "Product", "revenues", "Product", "revenues", "consisted", "of", "revenues", "primarily", "from", "the", "sale", "of", "our", "Cytori", "Cell", "Therapy-related", "products."], "wordsB": ["The", "net", "proceeds", "to", "us", "from", "the", "offering", "were", "approximately", "$8.7", "million,", "after", "deducting", "underwriting", "discounts", "and", "commissions", "and", "offering", "expenses", "incurred", "by", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p25_s0", "idA": "1095981_17_item7_p37_s4", "sentA": "The decrease in revenues for the years ended December 31, 2016 as compared to the same periods in 2015 is primarily due to slight decreases in research and development activities related to our contact with BARDA.", "sentB": "In process research and development acquired from Azaya Therapeutics In February 2017, we entered into an agreement to acquire assets, including in process research and development, or IPR D, related to two oncology drug product candidates, from Azaya Therapeutics.", "type": 1, "words": ["<tag1>", "The", "decrease", "in", "revenues", "for", "the", "years", "ended", "December", "31,", "2016", "as", "compared", "to", "the", "same", "periods", "in", "2015", "is", "primarily", "due", "to", "slight", "decreases", "in", "research", "and", "development", "activities", "related", "to", "our", "contact", "with", "BARDA.", "<tag2>", "In", "process", "research", "and", "development", "acquired", "from", "Azaya", "Therapeutics", "In", "February", "2017,", "we", "entered", "into", "an", "agreement", "to", "acquire", "assets,", "including", "in", "process", "research", "and", "development,", "or", "IPR", "D,", "related", "to", "two", "oncology", "drug", "product", "candidates,", "from", "Azaya", "Therapeutics.", "<tag3>"], "wordsA": ["The", "decrease", "in", "revenues", "for", "the", "years", "ended", "December", "31,", "2016", "as", "compared", "to", "the", "same", "periods", "in", "2015", "is", "primarily", "due", "to", "slight", "decreases", "in", "research", "and", "development", "activities", "related", "to", "our", "contact", "with", "BARDA."], "wordsB": ["In", "process", "research", "and", "development", "acquired", "from", "Azaya", "Therapeutics", "In", "February", "2017,", "we", "entered", "into", "an", "agreement", "to", "acquire", "assets,", "including", "in", "process", "research", "and", "development,", "or", "IPR", "D,", "related", "to", "two", "oncology", "drug", "product", "candidates,", "from", "Azaya", "Therapeutics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p1_s3", "idA": "1095981_17_item7_p38_s0", "sentA": "The future: Our current contract with BARDA expires in April 2017.", "sentB": "On July 24, 2017, we announced top-line, preliminary data and presented the full data analysis on October 18, 2017.", "type": 1, "words": ["<tag1>", "The", "future:", "Our", "current", "contract", "with", "BARDA", "expires", "in", "April", "2017.", "<tag2>", "On", "July", "24,", "2017,", "we", "announced", "top-line,", "preliminary", "data", "and", "presented", "the", "full", "data", "analysis", "on", "October", "18,", "2017.", "<tag3>"], "wordsA": ["The", "future:", "Our", "current", "contract", "with", "BARDA", "expires", "in", "April", "2017."], "wordsB": ["On", "July", "24,", "2017,", "we", "announced", "top-line,", "preliminary", "data", "and", "presented", "the", "full", "data", "analysis", "on", "October", "18,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p3_s1", "idA": "1095981_17_item7_p38_s0", "sentA": "The future: Our current contract with BARDA expires in April 2017.", "sentB": "Further, our CCT platform is the subject of investigator-initiated trials conducted by our partners, licensees and other third parties, some of which are supported by us and/or funded by government agencies and other funding sources, detailed in an announcement on November 13, 2017.", "type": 1, "words": ["<tag1>", "The", "future:", "Our", "current", "contract", "with", "BARDA", "expires", "in", "April", "2017.", "<tag2>", "Further,", "our", "CCT", "platform", "is", "the", "subject", "of", "investigator-initiated", "trials", "conducted", "by", "our", "partners,", "licensees", "and", "other", "third", "parties,", "some", "of", "which", "are", "supported", "by", "us", "and/or", "funded", "by", "government", "agencies", "and", "other", "funding", "sources,", "detailed", "in", "an", "announcement", "on", "November", "13,", "2017.", "<tag3>"], "wordsA": ["The", "future:", "Our", "current", "contract", "with", "BARDA", "expires", "in", "April", "2017."], "wordsB": ["Further,", "our", "CCT", "platform", "is", "the", "subject", "of", "investigator-initiated", "trials", "conducted", "by", "our", "partners,", "licensees", "and", "other", "third", "parties,", "some", "of", "which", "are", "supported", "by", "us", "and/or", "funded", "by", "government", "agencies", "and", "other", "funding", "sources,", "detailed", "in", "an", "announcement", "on", "November", "13,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p3_s0", "idA": "1095981_17_item7_p38_s1", "sentA": "We are in the process of negotiating an extension of the current contract option (which will expire in mid-April) for initiation of a pilot clinical trial of DCCT-10 in thermal burn injury.", "sentB": "Additional CCT treatments are in various stages of development in the areas of urology, wounds, and orthopedics.", "type": 1, "words": ["<tag1>", "We", "are", "in", "the", "process", "of", "negotiating", "an", "extension", "of", "the", "current", "contract", "option", "(which", "will", "expire", "in", "mid-April)", "for", "initiation", "of", "a", "pilot", "clinical", "trial", "of", "DCCT-10", "in", "thermal", "burn", "injury.", "<tag2>", "Additional", "CCT", "treatments", "are", "in", "various", "stages", "of", "development", "in", "the", "areas", "of", "urology,", "wounds,", "and", "orthopedics.", "<tag3>"], "wordsA": ["We", "are", "in", "the", "process", "of", "negotiating", "an", "extension", "of", "the", "current", "contract", "option", "(which", "will", "expire", "in", "mid-April)", "for", "initiation", "of", "a", "pilot", "clinical", "trial", "of", "DCCT-10", "in", "thermal", "burn", "injury."], "wordsB": ["Additional", "CCT", "treatments", "are", "in", "various", "stages", "of", "development", "in", "the", "areas", "of", "urology,", "wounds,", "and", "orthopedics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p4_s0", "idA": "1095981_17_item7_p39_s0", "sentA": "Research and development expenses Research and development expenses relate to the development of a technology platform that involves using adipose tissue as a source of autologous regenerative cells for therapeutic applications as well as the continued development efforts related to our clinical trials.", "sentB": "The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into early/late stage clinical trials.", "type": 1, "words": ["<tag1>", "Research", "and", "development", "expenses", "Research", "and", "development", "expenses", "relate", "to", "the", "development", "of", "a", "technology", "platform", "that", "involves", "using", "adipose", "tissue", "as", "a", "source", "of", "autologous", "regenerative", "cells", "for", "therapeutic", "applications", "as", "well", "as", "the", "continued", "development", "efforts", "related", "to", "our", "clinical", "trials.", "<tag2>", "The", "Cytori", "Nanomedicine", "platform", "features", "a", "versatile", "liposomal", "nanoparticle", "technology", "for", "drug", "encapsulation", "that", "has", "thus", "far", "provided", "the", "foundation", "to", "bring", "two", "promising", "drugs", "into", "early/late", "stage", "clinical", "trials.", "<tag3>"], "wordsA": ["Research", "and", "development", "expenses", "Research", "and", "development", "expenses", "relate", "to", "the", "development", "of", "a", "technology", "platform", "that", "involves", "using", "adipose", "tissue", "as", "a", "source", "of", "autologous", "regenerative", "cells", "for", "therapeutic", "applications", "as", "well", "as", "the", "continued", "development", "efforts", "related", "to", "our", "clinical", "trials."], "wordsB": ["The", "Cytori", "Nanomedicine", "platform", "features", "a", "versatile", "liposomal", "nanoparticle", "technology", "for", "drug", "encapsulation", "that", "has", "thus", "far", "provided", "the", "foundation", "to", "bring", "two", "promising", "drugs", "into", "early/late", "stage", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p25_s3", "idA": "1095981_17_item7_p49_s0", "sentA": "We measure stock-based compensation expense based on the grant-date fair value of any awards granted to our employees.", "sentB": "Additional research, pre-clinical studies, and regulatory approvals must be successfully completed prior to commercialization of any product.", "type": 1, "words": ["<tag1>", "We", "measure", "stock-based", "compensation", "expense", "based", "on", "the", "grant-date", "fair", "value", "of", "any", "awards", "granted", "to", "our", "employees.", "<tag2>", "Additional", "research,", "pre-clinical", "studies,", "and", "regulatory", "approvals", "must", "be", "successfully", "completed", "prior", "to", "commercialization", "of", "any", "product.", "<tag3>"], "wordsA": ["We", "measure", "stock-based", "compensation", "expense", "based", "on", "the", "grant-date", "fair", "value", "of", "any", "awards", "granted", "to", "our", "employees."], "wordsB": ["Additional", "research,", "pre-clinical", "studies,", "and", "regulatory", "approvals", "must", "be", "successfully", "completed", "prior", "to", "commercialization", "of", "any", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p6_s0", "idA": "1095981_17_item7_p58_s0", "sentA": "The following is a summary of our key liquidity measures at December 31, 2016 and 2015 (in thousands):", "sentB": "Our lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin.", "type": 1, "words": ["<tag1>", "The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2016", "and", "2015", "(in", "thousands):", "<tag2>", "Our", "lead", "drug", "candidate,", "ATI-0918", "is", "a", "generic", "version", "of", "pegylated", "liposomal", "encapsulated", "doxorubicin.", "<tag3>"], "wordsA": ["The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2016", "and", "2015", "(in", "thousands):"], "wordsB": ["Our", "lead", "drug", "candidate,", "ATI-0918", "is", "a", "generic", "version", "of", "pegylated", "liposomal", "encapsulated", "doxorubicin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p7_s0", "idA": "1095981_17_item7_p58_s0", "sentA": "The following is a summary of our key liquidity measures at December 31, 2016 and 2015 (in thousands):", "sentB": "Pegylated liposomal encapsulated doxorubicin is a heavily relied upon chemotherapeutic used in many cancer types on a global basis.", "type": 1, "words": ["<tag1>", "The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2016", "and", "2015", "(in", "thousands):", "<tag2>", "Pegylated", "liposomal", "encapsulated", "doxorubicin", "is", "a", "heavily", "relied", "upon", "chemotherapeutic", "used", "in", "many", "cancer", "types", "on", "a", "global", "basis.", "<tag3>"], "wordsA": ["The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2016", "and", "2015", "(in", "thousands):"], "wordsB": ["Pegylated", "liposomal", "encapsulated", "doxorubicin", "is", "a", "heavily", "relied", "upon", "chemotherapeutic", "used", "in", "many", "cancer", "types", "on", "a", "global", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p7_s4", "idA": "1095981_17_item7_p58_s0", "sentA": "The following is a summary of our key liquidity measures at December 31, 2016 and 2015 (in thousands):", "sentB": "Our second nanomedicine drug candidate is ATI-1123, a novel and new chemical entity which is a nanoparticle-encapsulated form of docetaxel, also a workhorse chemotherapeutic drug used for many cancers.", "type": 1, "words": ["<tag1>", "The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2016", "and", "2015", "(in", "thousands):", "<tag2>", "Our", "second", "nanomedicine", "drug", "candidate", "is", "ATI-1123,", "a", "novel", "and", "new", "chemical", "entity", "which", "is", "a", "nanoparticle-encapsulated", "form", "of", "docetaxel,", "also", "a", "workhorse", "chemotherapeutic", "drug", "used", "for", "many", "cancers.", "<tag3>"], "wordsA": ["The", "following", "is", "a", "summary", "of", "our", "key", "liquidity", "measures", "at", "December", "31,", "2016", "and", "2015", "(in", "thousands):"], "wordsB": ["Our", "second", "nanomedicine", "drug", "candidate", "is", "ATI-1123,", "a", "novel", "and", "new", "chemical", "entity", "which", "is", "a", "nanoparticle-encapsulated", "form", "of", "docetaxel,", "also", "a", "workhorse", "chemotherapeutic", "drug", "used", "for", "many", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p34_s7", "idA": "1095981_17_item7_p60_s0", "sentA": "During 2016, we sold 1,840,982 shares of our common stock under our ATM offering program, receiving total net proceeds of approximately $4.4 million.", "sentB": "The net proceeds to us were $0.8 million, after deducting underwriting costs and offering expenses incurred by us.", "type": 1, "words": ["<tag1>", "During", "2016,", "we", "sold", "1,840,982", "shares", "of", "our", "common", "stock", "under", "our", "ATM", "offering", "program,", "receiving", "total", "net", "proceeds", "of", "approximately", "$4.4", "million.", "<tag2>", "The", "net", "proceeds", "to", "us", "were", "$0.8", "million,", "after", "deducting", "underwriting", "costs", "and", "offering", "expenses", "incurred", "by", "us.", "<tag3>"], "wordsA": ["During", "2016,", "we", "sold", "1,840,982", "shares", "of", "our", "common", "stock", "under", "our", "ATM", "offering", "program,", "receiving", "total", "net", "proceeds", "of", "approximately", "$4.4", "million."], "wordsB": ["The", "net", "proceeds", "to", "us", "were", "$0.8", "million,", "after", "deducting", "underwriting", "costs", "and", "offering", "expenses", "incurred", "by", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p34_s2", "idA": "1095981_17_item7_p61_s2", "sentA": "The purchase price of shares of common stock related to the Regular Purchases will be based on the prevailing market prices of such shares at the time of sales.", "sentB": "Maxim agreed to purchase the shares from us pursuant to the Underwriting Agreement at a price of $1.0395 per share.", "type": 1, "words": ["<tag1>", "The", "purchase", "price", "of", "shares", "of", "common", "stock", "related", "to", "the", "Regular", "Purchases", "will", "be", "based", "on", "the", "prevailing", "market", "prices", "of", "such", "shares", "at", "the", "time", "of", "sales.", "<tag2>", "Maxim", "agreed", "to", "purchase", "the", "shares", "from", "us", "pursuant", "to", "the", "Underwriting", "Agreement", "at", "a", "price", "of", "$1.0395", "per", "share.", "<tag3>"], "wordsA": ["The", "purchase", "price", "of", "shares", "of", "common", "stock", "related", "to", "the", "Regular", "Purchases", "will", "be", "based", "on", "the", "prevailing", "market", "prices", "of", "such", "shares", "at", "the", "time", "of", "sales."], "wordsB": ["Maxim", "agreed", "to", "purchase", "the", "shares", "from", "us", "pursuant", "to", "the", "Underwriting", "Agreement", "at", "a", "price", "of", "$1.0395", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p34_s6", "idA": "1095981_17_item7_p61_s2", "sentA": "The purchase price of shares of common stock related to the Regular Purchases will be based on the prevailing market prices of such shares at the time of sales.", "sentB": "On May 31, 2017, Maxim exercised its option and purchased 849,000 shares at $1.10 per share.", "type": 1, "words": ["<tag1>", "The", "purchase", "price", "of", "shares", "of", "common", "stock", "related", "to", "the", "Regular", "Purchases", "will", "be", "based", "on", "the", "prevailing", "market", "prices", "of", "such", "shares", "at", "the", "time", "of", "sales.", "<tag2>", "On", "May", "31,", "2017,", "Maxim", "exercised", "its", "option", "and", "purchased", "849,000", "shares", "at", "$1.10", "per", "share.", "<tag3>"], "wordsA": ["The", "purchase", "price", "of", "shares", "of", "common", "stock", "related", "to", "the", "Regular", "Purchases", "will", "be", "based", "on", "the", "prevailing", "market", "prices", "of", "such", "shares", "at", "the", "time", "of", "sales."], "wordsB": ["On", "May", "31,", "2017,", "Maxim", "exercised", "its", "option", "and", "purchased", "849,000", "shares", "at", "$1.10", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p30_s5", "idA": "1095981_17_item7_p62_s8", "sentA": "Therefore, there exists substantial doubt about our ability to continue as a going concern.", "sentB": "On September 1, 2017, we announced a substantial corporate restructuring intended to significantly reduce expenses while maintaining its ability to execute on its BARDA-sponsored cell therapy program, Japanese business and oncology program.", "type": 1, "words": ["<tag1>", "Therefore,", "there", "exists", "substantial", "doubt", "about", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag2>", "On", "September", "1,", "2017,", "we", "announced", "a", "substantial", "corporate", "restructuring", "intended", "to", "significantly", "reduce", "expenses", "while", "maintaining", "its", "ability", "to", "execute", "on", "its", "BARDA-sponsored", "cell", "therapy", "program,", "Japanese", "business", "and", "oncology", "program.", "<tag3>"], "wordsA": ["Therefore,", "there", "exists", "substantial", "doubt", "about", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "wordsB": ["On", "September", "1,", "2017,", "we", "announced", "a", "substantial", "corporate", "restructuring", "intended", "to", "significantly", "reduce", "expenses", "while", "maintaining", "its", "ability", "to", "execute", "on", "its", "BARDA-sponsored", "cell", "therapy", "program,", "Japanese", "business", "and", "oncology", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p30_s6", "idA": "1095981_17_item7_p64_s1", "sentA": "Overall, our operational cash use decreased during the year ended December 31, 2016 as compared to the same period in 2015 due primarily to a decrease in losses from operations (when adjusted for non-cash items) of $3.3 million offset by working capital givebacks of approximately $2.1 million.", "sentB": "The restructuring reduced our workforce by approximately 50% and significantly reduced our operational cash burn.", "type": 1, "words": ["<tag1>", "Overall,", "our", "operational", "cash", "use", "decreased", "during", "the", "year", "ended", "December", "31,", "2016", "as", "compared", "to", "the", "same", "period", "in", "2015", "due", "primarily", "to", "a", "decrease", "in", "losses", "from", "operations", "(when", "adjusted", "for", "non-cash", "items)", "of", "$3.3", "million", "offset", "by", "working", "capital", "givebacks", "of", "approximately", "$2.1", "million.", "<tag2>", "The", "restructuring", "reduced", "our", "workforce", "by", "approximately", "50%", "and", "significantly", "reduced", "our", "operational", "cash", "burn.", "<tag3>"], "wordsA": ["Overall,", "our", "operational", "cash", "use", "decreased", "during", "the", "year", "ended", "December", "31,", "2016", "as", "compared", "to", "the", "same", "period", "in", "2015", "due", "primarily", "to", "a", "decrease", "in", "losses", "from", "operations", "(when", "adjusted", "for", "non-cash", "items)", "of", "$3.3", "million", "offset", "by", "working", "capital", "givebacks", "of", "approximately", "$2.1", "million."], "wordsB": ["The", "restructuring", "reduced", "our", "workforce", "by", "approximately", "50%", "and", "significantly", "reduced", "our", "operational", "cash", "burn."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p7_s1", "idA": "1095981_17_item7_p66_s3", "sentA": "We believe it is important for you to understand our most critical accounting policies.", "sentB": "We believe that data from a 60-patient European study of ATI-0918 has met the statistical criteria for bioequivalence to Janssen s Caelyx , the current reference listed drug in Eur ope.", "type": 1, "words": ["<tag1>", "We", "believe", "it", "is", "important", "for", "you", "to", "understand", "our", "most", "critical", "accounting", "policies.", "<tag2>", "We", "believe", "that", "data", "from", "a", "60-patient", "European", "study", "of", "ATI-0918", "has", "met", "the", "statistical", "criteria", "for", "bioequivalence", "to", "Janssen", "s", "Caelyx", ",", "the", "current", "reference", "listed", "drug", "in", "Eur", "ope.", "<tag3>"], "wordsA": ["We", "believe", "it", "is", "important", "for", "you", "to", "understand", "our", "most", "critical", "accounting", "policies."], "wordsB": ["We", "believe", "that", "data", "from", "a", "60-patient", "European", "study", "of", "ATI-0918", "has", "met", "the", "statistical", "criteria", "for", "bioequivalence", "to", "Janssen", "s", "Caelyx", ",", "the", "current", "reference", "listed", "drug", "in", "Eur", "ope."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p5_s0", "idA": "1095981_17_item7_p68_s2", "sentA": "The customer s obligation to pay and the payment terms are set at the time of delivery and are not dependent on the subsequent use or resale of our products.", "sentB": "because it can help improve the delivery and metabo lism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits.", "type": 1, "words": ["<tag1>", "The", "customer", "s", "obligation", "to", "pay", "and", "the", "payment", "terms", "are", "set", "at", "the", "time", "of", "delivery", "and", "are", "not", "dependent", "on", "the", "subsequent", "use", "or", "resale", "of", "our", "products.", "<tag2>", "because", "it", "can", "help", "improve", "the", "delivery", "and", "metabo", "lism", "of", "many", "drugs,", "thus", "potentially", "enhancing", "the", "therapeutic", "profile", "and", "patient", "benefits.", "<tag3>"], "wordsA": ["The", "customer", "s", "obligation", "to", "pay", "and", "the", "payment", "terms", "are", "set", "at", "the", "time", "of", "delivery", "and", "are", "not", "dependent", "on", "the", "subsequent", "use", "or", "resale", "of", "our", "products."], "wordsB": ["because", "it", "can", "help", "improve", "the", "delivery", "and", "metabo", "lism", "of", "many", "drugs,", "thus", "potentially", "enhancing", "the", "therapeutic", "profile", "and", "patient", "benefits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p0_s0", "idA": "1095981_17_item7_p75_s0", "sentA": "The first step is to compare the fair value of the reporting unit with its carrying amount, including goodwill.", "sentB": "Our objective is to build a profitable and growing specialty therapeutics company.", "type": 1, "words": ["<tag1>", "The", "first", "step", "is", "to", "compare", "the", "fair", "value", "of", "the", "reporting", "unit", "with", "its", "carrying", "amount,", "including", "goodwill.", "<tag2>", "Our", "objective", "is", "to", "build", "a", "profitable", "and", "growing", "specialty", "therapeutics", "company.", "<tag3>"], "wordsA": ["The", "first", "step", "is", "to", "compare", "the", "fair", "value", "of", "the", "reporting", "unit", "with", "its", "carrying", "amount,", "including", "goodwill."], "wordsB": ["Our", "objective", "is", "to", "build", "a", "profitable", "and", "growing", "specialty", "therapeutics", "company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p32_s1", "idA": "1095981_17_item7_p78_s1", "sentA": "The determination of the fair value of share-based payment awards utilizing the Black-Scholes model is affected by our stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends.", "sentB": "These warrants only become exercisable upon approval of the increase in authorized shares by our stockholder s .", "type": 1, "words": ["<tag1>", "The", "determination", "of", "the", "fair", "value", "of", "share-based", "payment", "awards", "utilizing", "the", "Black-Scholes", "model", "is", "affected", "by", "our", "stock", "price", "and", "a", "number", "of", "assumptions,", "including", "expected", "volatility,", "expected", "life,", "risk-free", "interest", "rate", "and", "expected", "dividends.", "<tag2>", "These", "warrants", "only", "become", "exercisable", "upon", "approval", "of", "the", "increase", "in", "authorized", "shares", "by", "our", "stockholder", "s", ".", "<tag3>"], "wordsA": ["The", "determination", "of", "the", "fair", "value", "of", "share-based", "payment", "awards", "utilizing", "the", "Black-Scholes", "model", "is", "affected", "by", "our", "stock", "price", "and", "a", "number", "of", "assumptions,", "including", "expected", "volatility,", "expected", "life,", "risk-free", "interest", "rate", "and", "expected", "dividends."], "wordsB": ["These", "warrants", "only", "become", "exercisable", "upon", "approval", "of", "the", "increase", "in", "authorized", "shares", "by", "our", "stockholder", "s", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p13_s6", "idA": "1095981_17_item7_p78_s2", "sentA": "The expected volatility is based on the historical volatility of our common stock over the most recent period commensurate with the estimated expected term of the stock options.", "sentB": "The amendment extends the term of the BARDA Agreement and the period of performance of Option 2 of the BARDA Agreement to November 30, 2020 .", "type": 1, "words": ["<tag1>", "The", "expected", "volatility", "is", "based", "on", "the", "historical", "volatility", "of", "our", "common", "stock", "over", "the", "most", "recent", "period", "commensurate", "with", "the", "estimated", "expected", "term", "of", "the", "stock", "options.", "<tag2>", "The", "amendment", "extends", "the", "term", "of", "the", "BARDA", "Agreement", "and", "the", "period", "of", "performance", "of", "Option", "2", "of", "the", "BARDA", "Agreement", "to", "November", "30,", "2020", ".", "<tag3>"], "wordsA": ["The", "expected", "volatility", "is", "based", "on", "the", "historical", "volatility", "of", "our", "common", "stock", "over", "the", "most", "recent", "period", "commensurate", "with", "the", "estimated", "expected", "term", "of", "the", "stock", "options."], "wordsB": ["The", "amendment", "extends", "the", "term", "of", "the", "BARDA", "Agreement", "and", "the", "period", "of", "performance", "of", "Option", "2", "of", "the", "BARDA", "Agreement", "to", "November", "30,", "2020", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p7_s6", "idA": "1095981_17_item7_p78_s6", "sentA": "The fair value of restricted stock agreements granted is based on the market price of our common stock on the day of the grant.", "sentB": "Finally, in connection with our acquisition of the ATI-0918 and ATI-1123 drug candidates, we hav e acquired know-how (including proprietary processes and techniques) and a scalable nanoparticle manufacturing plant in San Antonio, Texas from which we intend to test, validate and eventually manufacture commercial quantities of our nanoparticle drugs.", "type": 1, "words": ["<tag1>", "The", "fair", "value", "of", "restricted", "stock", "agreements", "granted", "is", "based", "on", "the", "market", "price", "of", "our", "common", "stock", "on", "the", "day", "of", "the", "grant.", "<tag2>", "Finally,", "in", "connection", "with", "our", "acquisition", "of", "the", "ATI-0918", "and", "ATI-1123", "drug", "candidates,", "we", "hav", "e", "acquired", "know-how", "(including", "proprietary", "processes", "and", "techniques)", "and", "a", "scalable", "nanoparticle", "manufacturing", "plant", "in", "San", "Antonio,", "Texas", "from", "which", "we", "intend", "to", "test,", "validate", "and", "eventually", "manufacture", "commercial", "quantities", "of", "our", "nanoparticle", "drugs.", "<tag3>"], "wordsA": ["The", "fair", "value", "of", "restricted", "stock", "agreements", "granted", "is", "based", "on", "the", "market", "price", "of", "our", "common", "stock", "on", "the", "day", "of", "the", "grant."], "wordsB": ["Finally,", "in", "connection", "with", "our", "acquisition", "of", "the", "ATI-0918", "and", "ATI-1123", "drug", "candidates,", "we", "hav", "e", "acquired", "know-how", "(including", "proprietary", "processes", "and", "techniques)", "and", "a", "scalable", "nanoparticle", "manufacturing", "plant", "in", "San", "Antonio,", "Texas", "from", "which", "we", "intend", "to", "test,", "validate", "and", "eventually", "manufacture", "commercial", "quantities", "of", "our", "nanoparticle", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item7_p25_s2", "idA": "1095981_17_item7_p8_s10", "sentA": "One year results were published in September 2015 in the journal Rheumatology.", "sentB": "The acquired IPR D is in the early stage of development and has no alternative use.", "type": 1, "words": ["<tag1>", "One", "year", "results", "were", "published", "in", "September", "2015", "in", "the", "journal", "Rheumatology.", "<tag2>", "The", "acquired", "IPR", "D", "is", "in", "the", "early", "stage", "of", "development", "and", "has", "no", "alternative", "use.", "<tag3>"], "wordsA": ["One", "year", "results", "were", "published", "in", "September", "2015", "in", "the", "journal", "Rheumatology."], "wordsB": ["The", "acquired", "IPR", "D", "is", "in", "the", "early", "stage", "of", "development", "and", "has", "no", "alternative", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
